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ABSTRACT 
 
 
The innate immune response is the first line of defence against virus infection.  Cells contain 
a diverse array of pathogen recognition receptors (PRRs) that are able to recognise multiple 
pathogen associated molecular patterns (PAMPS) that present themselves during virus 
infection.   The RIG-I (Retinoic acid inducible–gene-I) and MDA5 (melanoma differentiation-
associated gene 5) PRRs detect specific viral RNA ligands and subsequently induce the 
expression of the cytokine Interferon-β (IFN-β).  IFN-β is secreted, acting on the infected cell 
and neighbouring uninfected cells to generate an antiviral state that is hostile to virus 
transcription, replication and dissemination, whilst also orchestrating adaptive immune 
responses. Given IFN-βs crucial cellular antiviral role, understanding its induction is of great 
importance to developing future antiviral drugs and vaccine strategies.   
 
Using A549 reporter cells in which GFP expression is under the control of the IFN-β promoter, 
we show that there is a heterocellular response to parainfluenza virus 5 (PIV5) and infection 
with other negative sense RNA viruses. Only a limited number of infected cells are 
responsible for IFN-β induction.  Using PIV5 as a model, this thesis addresses the nature of 
the PAMPs that are responsible for inducing IFN-β following PIV5 infection.  The previous 
work has shown that PIV5 Defective Interfering particle (DI) rich virus preparations acted as a 
better inducer of IFN-β compared to DI poor stocks. DIs are incomplete virus genomes 
produced during wild-type virus replication as a result of errors in the viral polymerase. To 
investigate this further, A549 Naïve, MDA5/RIG-I/LGP2 Knock down reporter cells were 
infected with PIV5 W3 at a low MOI to examine the inverse correlation of NP and GFP of DIs 
generated during virus replication and not from the initial infection.  GFP+ve cells were cell 
sorted, and using QPCR it was found that cells that have the IFN-β promoter activated 
contain large amounts of DIs relative to GFP-ve cells. This data supports the Randall group’s 
findings that DIs generated during errors of wild-type replication by the viral RNA polymerase 
are the primary PAMPs that induce of IFN-β, as opposed to PAMPs being generated during 
normal wild-type virus replication.   
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1. INTRODUCTION  
 
1.1.  Interferon and the Antiviral State 
 
1.1.1.   Overview of the importance of Interferon in innate immunity 
 
Innate immunity is the first line of defence to virus infection, consisting of a diverse 
array of extracellular and intracellular defences. The innate intracellular immune 
response acts to prevent or slow virus dissemination, and to aid the adaptive 
response to clear the virus infection. The host cell contains a variety of pathogen 
recognition receptors (PRRs) that are able to recognise multiple features of the virus, 
pathogen associated molecular patterns (PAMPs) that are present during infection, 
and discriminate between host and viral patterns (Janeway, 1989) Two such PRRs 
which are the main study of this thesis are retinoic acid inducible gene-I (RIG-I) and 
melanoma differentiation-associated gene 5 (MDA5), which recognise viral RNA 
ligands (Figure 1).  Upon the sensing of viral PAMPs, the PRRs mediate the rapid 
induction of interferon (IFN) via the activation of a signal transduction cascade. The 
signal transduction cascade goes through the signalling platform IFN-β promoter 
stimulator 1 (IPS-1/MAVS/CARDIF), which subsequently recruits the IFN 
transcription factors IFN regulatory factor 3 (IRF3) and nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB). The IFN transcription factors translocate 
to the nucleus and induce IFN.  IFN is secreted by the cell and binds to the IFN 
receptor of neighbouring uninfected cells. This induces the expression of IFN 
stimulated genes (ISGs), which target various aspects of virus entry, replication, 
assembly and egress from the cell.  The induction of IFN and the subsequent 
production of ISGs consequently generates a cellular antiviral state that is hostile to 
virus infection, transcription, replication and assembly.  
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Figure 1. Overview of the IFN system 
IFN induction: 
Viral RNA, generated in the cytoplasm by uncoating, transcription or replication, 
activates the RNA helicases MDA5 and RIG-I. MDA5 and RIG-I are both activated by 
dsRNA, whilst RIG-I can also be activated by RNA molecules with 5’-ppp 
triphosphates. Both helicases have N-terminal CARD domains that recruit the 
adaptor IPS-1/CARDIF/VISA/MAVS. This adaptor, in turn, acts as a scaffold to 
recruit signalling components that feed into either the IRF3 or the NF-kB pathways. 
Once activated, IRF3 and NF-κB enter the nucleus, forming an enhancesome with 
other transcription factors.  This enhancesome binds to the IFN promoter, leading to 
the expression of IFN and its subsequent secretion from the cell. 
 
 
 
 
3 
IFN Signalling: 
The JAK/STAT IFN signaling pathway is initiated by IFN-α/β binding to the type I IFN 
receptor. This leads to the activation of the receptor associated tyrosine kinases 
JAK1 and Tyk2, which phosphorylate STAT1 on tyrosine 701 and STAT2 on tyrosine 
690. Phosphorylated STAT1 and STAT2 interact strongly with each other by 
recognizing SH2 domains, and the stable STAT1/STAT2 heterodimer is translocated 
into the nucleus, where it interacts with the DNA-binding protein IRF9. The 
IRF9/STAT1/STAT2 heterotrimer is called ISGF3, and it binds to the ISRE in target 
promoters, subsequently inducing the expression of ISGs. 
 
See text for details and references. 
 
Figure modified from an original figure provided by Andri Vasou, University of St 
Andrews. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
Types of Interferon 
 
IFNs are a family of cytokines that act as the “gatekeepers” of innate and adaptive 
immunity, orchestrating intracellular and extracellular antiviral immune responses. 
Currently, three groups of IFN have been identified, Type I, Type II and Type III 
(Fontana & Bankamp, 2008; Pestka & Krause, 2004; Randall & Goodbourn, 2008)). 
Type I IFNs were the first to be identified (Isaacs & Lindenmann, 1957), which 
include and IFN-α (13 subtypes) and IFN-β (one subtype). IFN-α is produced 
predominantly in plasmoidal dendritic cells (pDCs) whereas IFN-β, the main study of 
this thesis, is produced in all nucleated cells.   Other less defined Type I IFNs are 
IFN-ω, -ε, -τ, -δ, –κ and –ο.  Type II and Type III IFNs are poorly characterized 
compared to IFN-α/β.  Type II IFNs consists of one member, IFN-γ, that is produced 
by mitogenically activated T-cells or Natural Killer cells (Reviewed in (Schoenborn & 
Wilson, 2007). Type III IFNs (IFN-λ) in humans include IFN-λ1, -λ2, –λ3 and –λ 
(Choppin & Stoeckenius, 1964).  IFN-λ is produced in a variety of cell types similar to 
IFN-α/β and acts in concert with IFN-α/β mediated responses.  The essential role of 
IFN-α/β and IFN-γ has been demonstrated by murine in vivo studies in which the cell 
surface receptors, Type I IFN receptor (IFNAR) and Type II IFN receptor (IFNGR) 
have been knocked down (Broek et al., 1995; Hwang et al., 1995; Kamijo et al., 
1993; Van den Broek et al., 1995). These IFNAR and IFNGR deficient mice are 
highly sensitive to virus infection compared to wild type mice, despite IFNAR and 
IFNGR deficient mice displaying adaptive immune responses.  
 
 
1.1.2.  The detection of Viral PAMPs by the PRRs 
 
The intracellular innate immune response consists of an array of cell surface, 
cytosolic and endosomal PRRs that recognise a variety of viral PAMPs that leads to 
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the subsequent induction of IFN-α/β. It is important to have multiple systems of virus 
recognition so that the cell can initiate an antiviral response to the different temporal 
stages and cellular localisations of virus infection, replication and assembly.  In 
addition, multiple mechanisms of PAMP detection enables the host cell to respond to 
novel virus challenge, caused by the mutation and alteration of viral PAMPs over 
time.   A multisensory approach further confers an advantage to the host cell being 
able to respond if the virus possesses evasion strategies to a particular IFN-α/β 
induction pathway, IFN-α/β signalling pathway or to a particular ISG.   Viral nucleic 
acids are the main source of PAMPs that are recognised by intracellular PRRs. 
Important PRRs that recognise viral nucleic acids are the Toll-Like-Receptors (TLRs) 
and Nucleotide-binding oligomerization domain-containing protein-2 (NOD2).  Other 
receptors are also important, such as RIG-I-like-receptors and gamma interferon 
activation site elements, but these are beyond the focus and scope of this thesis. 
 
TLRs are a family of Type I transmembrane glycoproteins that detect a diverse array 
of pathogens including ssRNA, dsRNA and dsDNA genomic viruses, gram-positive 
and gram-negative bacteria and fungi. IFN-α/β induction by the TLRs have been 
extensively reviewed in the literature (Akira et al., 2006; Hornung et al., 2008; Jensen 
& Thomsen, 2012; Kawai & Akira, 2011; Kumar et al., 2011; Lester & Li, 2014; 
Mikula & Pastoreková, 2010; O'Neill & Bowie, 2010; Takeda & Akira, 2004; 
Yamamoto & Takeda, 2010).   Many viruses use endosomes to enter the cell and 
uncoat their genome.  Endosomal TLRs such as TLR7, -8, -9 and -3, are important 
for detecting viral nucleic acids and inducing IFN-α/β, without the need for virus entry 
and replication in the cytosol of the host cell.  
 
NOD2 is expressed in the cytosol of myeloid derived cells, dendritic cells and 
intestinal epithelial cells (Gutierrez et al., 2002; Ogura et al., 2001; 2003).  NOD2 has 
previously been associated with the detection of peptidoglycan components from 
6 
gram-positive and gram-negative bacteria. NOD2 has recently been shown to bind to 
viral ssRNA, activating the IRF3-dependent induction of IFN-β following infection by 
respiratory syncytial virus (RSV), vesticular stomatitis virus (VSV) and influenza A 
virus (Sabbah et al., 2009). Following recognition of their respective viral PAMPs, the 
TLRs and NOD2 consequently activate signal transduction pathways that lead to the 
induction of IFN-α/β and the generation of an antiviral state.   
 
 
1.1.3.  RIG-I, MDA5 and LGP2 mediated induction of IFN  
 
The primary focus of this thesis are the roles of the intracellular PRRs RIG-I, MDA5 
and Laboratory of Genetics and Physiology 2 (LGP2) in the detection of negative 
sense RNA genome viruses.  RIG-I and MDA5 are localised in the cytosol of all 
nucleated cells in humans (Yoneyama et al., 2004; 2005). In unstimulated host cells, 
RIG-I and MDA5 are expressed at low basal levels to facilitate an immediate 
response upon the presentation of viral PAMPs.  The viral PAMP sensing 
mechanisms of RIG-I and MDA5 have been extensively reviewed in the literature and 
will be briefly described (Brennan & Bowie, 2010; Gerlier & Lyles, 2011; Kumar et al., 
2011; Luo et al., 2013; Matsumiya et al., 2011; Mogensen, 2009; O'Neill & Bowie, 
2010; Onomoto et al., 2010; Randall & Goodbourn, 2008; Wilkins & Gale, 2010).  
Although RIG-I and MDA5 share a similar domain architecture (Figure 2), RIG-I and 
MDA5 recognize distinct viral RNA structures. RIG-I recognizes short (< 1 kb) 
double-stranded RNAs (dsRNAs), 5’-triphosphate (5’-ppp) RNAs and RNAs with 
complex secondary structures (Hornung et al., 2006; Loo et al., 2008). MDA5 detects 
long dsRNAs (> 1 kb) and “non-self” 2’-O-methylation deficient RNAs (Kato et al., 
2006; 2008; Loo et al., 2008; Züst et al., 2011a).  
7 
 
Figure 2. The domain structure of RIG-I, MDA5 and LGP2  
RIG-I and MDA5 comprise of two N-terminal caspase activation and recruitment 
domains (CARDs) fused to a DExD/H-box RNA helicase domain. The RIG-I, MDA5 
and LGP2 RNA helicase domain) share a similar architecture, consisting of two 
subdomains, Hel-1 and Hel-2. Hel-1 and Hel-2 create at their interface an active site 
for ATP binding and hydrolysis, as well as jointly forming an extended RNA-binding 
surface.  The Hel-2 subdomain contains a family-specific large insertion Hel-2i, which 
regulates the CARDs of RIG-I and MDA5. A linker region connects the RNA helicase 
domain to the C-terminal domain (Luo et al., 2011; Saito et al., 2007; Yoneyama et 
al., 2005).  The CTD and linker region of RIG-I and LGP2, but not MDA5, contain a 
repressor domain (Saito et al., 2007), refer to main text for details. Upon virus 
infection RIG-I and MDA5 CARDs interact with the downstream CARDs located on 
the signalling platform IPS-1, leading to the induction of IFN-α/β. 
 
Figure adapted from (Schlee, 2013). 
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Figure 3.  A structure-based model of RIG-I activation.  
A. In the autorepressed state, RIG-I CARDs are sequestered by the repressor 
domain mediating CARD binding to the Hel-2i domain. RIG-I is activated by 
blunt-ended 5’-ppp dsRNA binding to the CTD (Kowalinski et al., 2011) .  
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B. The CTD-bound 5’-ppp dsRNA interacts with the helicase domains Hel-1 and 
Hel-2i, but not Hel-2, leading to displacement of the CARDs bound to Hel-2i. 
The CARDs are now available for downstream interactions with IPS-1. In the 
absence of ATP, the RIG-I active state could revert to the autorepressed 
state (A) (Luo et al., 2011).  
C. ATP binds at the interface of Hel-1 and Hel-2, stabilizing the RIG-I 
conformation structure (Jiang et al., 2011; Kowalinski et al., 2011). ATP 
hydrolysis facilitates the binding of viral dsRNA to the RIG-I helicase domain. 
D. Following ATP hydrolysis and phosphate release, RIG-I changes 
conformation to a viral RNA and ADP bound transition state (Luo et al., 
2011).  This semi-open conformation is similar to the nucleotide free state B, 
whereupon ADP release, transition state D most likely reverts to B, rather 
than immediately reverting to A.  
 
Figure adapted from (Kolakofsky et al., 2012). 
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Upon recognition of their viral PAMPs, RIG-I and MDA5 activate a signal 
transduction cascade that leads to the induction of IFN-β. Detailed analysis of the 
specific viral PAMPs that activate RIG-I and MDA5 will be will be discussed later 
(1.2.3.  The Virus PAMPs of RIG-I, MDA5 and LGP2). 
 
Both the expression of RIG-I (Yoneyama et al., 2004) and MDA5 (Kang et al., 2004) 
are strongly induced by IFN-β, creating a positive feedback mechanism for the rapid 
expression of ISGs upon virus infection.  RIG-I and MDA5 contain two N-terminal 
tandem caspase recruitment domains (CARDs) (Figure 2).   CARDs are interaction 
motifs, activated by virus infections that facilitate downstream protein-protein 
interactions involving antiviral, inflammation and apoptosis pathways.  The CARDs of 
RIG-I and MDA5 interact with the respective CARDs of the signalling platform IPS-1, 
leading to the induction of IFN-α/β (Figure 4).  In contrast, LGP2 lacks the CARDs 
found in RIG-I and MDA5. LGP2 is thus incapable of interacting with IPS-1 and 
inducing IFN-α/β by itself.  This is supported by transient overexpression experiments 
in which LGP2 does not have an intrinsic ability to activate the IFN-α/β promoter 
(Rothenfusser et al., 2005).  Instead, LGP2 acts as a regulator of RIG-I and MDA5.  
 
 
The activation of RIG-I 
 
The mechanism of the activation of RIG-I, MDA5 and LGP2 following recognition of 
their respective viral PAMPs has been obscured by a lack of structural information.  It 
is only recently that four groups independently reported high resolution structures of 
RIG-I in an unstimulated state and in an active conformation bound to dsRNA, 
extending previous structural work of RIG-I bound to 5’-ppp dsRNA (Lu et al., 2010; 
Wang et al., 2010).  A number of studies have now been completed using RIG-I from 
different species.  Two studies used human RIG-I (Jiang et al., 2011; Luo et al., 
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2011) and one mouse RIG-I (Civril et al., 2011), but the most comprehensive results 
were obtained with duck RIG-I in which  the structure of full‐ length RIG‐ I in the 
ligand‐ free state was obtained (Kowalinski et al., 2011).  The model for the 
structural activation of RIG-I has been comprehensively reviewed (Jiang & Chen, 
2012; Kolakofsky et al., 2012; Leung & Amarasinghe, 2012), and will be briefly 
described here (Figure 3).  
 
In unstimulated cells, RIG-I is expressed as a monomer in an autorepressive state 
(Figure 3A). RIG-I CARD activity is inhibited sterically by a repressor domain that is 
mapped onto the C-terminal domain (CTD) and the linker region that connects the 
CTD to the helicase domain (Kowalinski et al., 2011; Saito et al., 2007) (Figure 2).  
The linker region forms a V-shaped conformation, forcing the CARDs to bind to the 
Helicase 2i (Hel-2i) region and sequestering them from interactions with CARDs from 
the downstream signalling platform IPS-1, inhibiting IFN-β induction (Kowalinski et 
al., 2011).  In addition, in vitro studies have determined that the CARDs themselves 
negatively regulate the ATPase activity of the helicase domain (Gee et al., 2008).  
ATP hydrolysis is required for the migration of RIG‐ I along the duplex RNA ligand. 
 
Upon virus infection, virus RNA ligands such as 5’-ppp dsRNA bind to the repressor 
domain of RIG-I (Lu et al., 2010; Wang et al., 2010).  The binding of virus RNA 
ligands to the repressor domain activates the ATPase activity of the DExD/H-box 
RNA helicase domain of RIG-I, a process mediated by the linker region (Civril et al., 
2011; Gee et al., 2008; Luo et al., 2011) (Figure 3B).  These actions induce a 
conformational change in RIG-I, resulting in the virus RNA ligand binding to the 
helicase domain.   The conformational change in RIG-I facilitates the expulsion and 
exposure of the CARDs from the repressor and Hel-2i domains, whilst facilitating the 
dimerization of RIG-I (Saito et al., 2007) (Cui et al., 2008; Kowalinski et al., 2011) 
(Luo et al., 2011) (Figure 3C). The exposed CARDs are polyubiquitinated on Lys63 
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primarily by the E3 ligase TRIM25 (Tripartite motif-containing protein 25) (Gack et al., 
2007; Jiang et al., 2012).  Polyubiquitination is an absolute requirement for the 
activation of RIG-I, as dimerised RIG-I with non-ubiquitinated CARDs is unable to 
induce IFN-β (Zeng et al., 2010).  The polyubiquitinated CARDs recruit the IPS-1 
signalling platform via CARD-CARD interactions, leading to the induction of IFN-β 
(Figure 4) (Gack et al., 2007; Kawai et al., 2005; Meylan et al., 2005; Seth et al., 
2005; Xu et al., 2005).  It is important to control the activation of RIG-I (and the other 
PRRs), as uncontrolled IFN-β induction would result in the production of potentially 
damaging ISGs and cytokines involved in inflammation, the regulation of host cell 
transcription, translation, the host cell cycle and apoptosis. 
 
 
The activation of MDA5 
 
The mechanism of MDA5 activation remains poorly understood compared to RIG-I, 
with few crystal structures obtained of MDA5 in inactive and active states.  This is 
because MDA5 oligermises when bound to dsRNA, forming filamentous structures 
which are hard to crystallise (Berke et al., 2013; Peisley et al., 2011; 2012; Wu et al., 
2013).  It had previously been assumed that MDA5 activation is similar to RIG-I, 
given that RIG-I and MDA5 share the same structural architecture (Fairman-Williams 
et al., 2010; Yoneyama et al., 2005) (Figure 2).  The RIG-I and MDA5 RNA helicase 
domains are highly conserved, sharing 35% sequence homology (Yoneyama et al., 
2008).  In addition, previous structural and functional studies have determined that 
the MDA5 CTD is responsible for binding to blunt end viral dsRNA, using a highly 
conserved positively charged surface common to RIG-I, MDA5 and LGP2 (Cui et al., 
2008; Li et al., 2009b; Pippig et al., 2009; Wang et al., 2010).  Comparing the RIG-I 
linker region to the MDA5 equivalent has revealed important structural differences.  
The MDA5 linker region is longer and has acidic sequences, and the MDA5 C-
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terminus does not appear to contain a repressor domain like that of RIG-I (Saito et 
al., 2007). RIG-I and MDA5 also diverge in the structure and function of their Hel-2i 
domains. The Hel2i α2 helix, which in RIG-I interacts with RIG-I CARDs or viral RNA, 
is shorter in MDA5. A phenylalanine residue essential for binding CARDs in RIG-I is 
not conserved in MDA5, suggesting that in the absence of RNA, MDA5 CARDs are 
regulated differently (Berke et al., 2012). Together, these data demonstrate that in 
contrast to RIG-I, MDA5 has an open and flexible structure in the absence of RNA 
ligands.  These studies raise the question of how MDA5 CARDs are kept inactive if 
not through steric inhibition like that of RIG-I.   
 
Evidence that MDA5 forms ATP-sensitive oligomer filaments on dsRNA, provides a 
working model to describe the activation of MDA5 mediated signalling (Berke et al., 
2012; Peisley et al., 2011; 2012). MDA5 exists as individual inactive monomers in the 
cytosol, lacking the necessary structure to activate IPS-1.  Upon the presentation of 
viral RNA ligands, negative-stain electron microscopy showed that MDA5 forms 
filaments along dsRNA, mediated by the MDA5 CTD. The MDA5 CTD is critical for 
high-affinity interactions between dsRNA and MDA5, and between MDA5 monomers 
(Berke et al., 2012; Peisley et al., 2011).  The formation of MDA5 filamentous 
oligomers along the dsRNA activates MDA5 mediated signalling, a process also 
called positive cooperativity.  A recent study further supports this model, in which the 
crystal structure of MDA5 filamentous oligomers bound to dsRNA was solved (Wu et 
al., 2013). Following the assembly of MDA5 CARDs, the MDA5 CARDs requires 
polyubiquitination on Lys63, similar to RIG-I, in order to activate IRF3 (Jiang et al., 
2012).   
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Figure 4. RIG-I and MDA5 mediated induction of IFN-α/β  
In unstimulated cells, LGP2 binds to and inhibits RIG-I.  Upon virus infection and the 
binding of virus RNA PAMPs to LGP2,  
1) A conformational change in LGP2 leads to the cessation of RIG-I inhibition  
2) LGP2 binds to and enhances the activity of MDA5.   
Viral RNA PAMPs bind to RIG-I and MDA5, activating their CARDs (refer to main 
text). The CARDs of RIG-I and MDA5 bind to the downstream CARDs of IPS-1. IPS-
1 in turn recruits adaptor proteins that lead to activation of the transcription factors 
IRF3, IRF7 and NF-κB (refer to main text). 
 
IRF3 and IRF7 activation: TBK-1 and IKKε phosphorylates IRF3. Phosphorylated 
IRF3 homodimerises and translocates to the nucleus.  Some cells (e.g. pDCs) 
express low levels of IRF7, as well as cells in which IFN-β has been induced. TBK-1 
and IKKε phosphorylate IRF7.  IRF7 as a homodimer or as a heterodimer with IRF3 
translocates into the nucleus. 
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NF-κB Activation: NF-κB is inhibited in unstimulated cells by IκB, which sequesters 
the NF-κB nuclear localisation signal. Upon stimulation, TRAF6 autoubiquitinates, 
leading to the polyubiquitination of RIP1 and the subsequent recruitment of the IκB 
kinase complex (IΚΚ) and TAK1.  The IΚΚ comprises of the NEMO scaffolding 
protein and the catalytic subunits IΚΚα and IΚΚβ.  TAK1 phosphorylates IKKβ, which 
subsequently phosphorylates IκB.  Phosphorylated IκB dissociates from NF-κB, 
whereby it is degraded by the proteasome.  The NF-κB nuclear localisation signal is 
unmasked, enabling NF-κB to be translocated to the nucleus.    
 
IFN-α/β Promoter Activation:  IRF3 and NF-κB, form an enhancesome together 
with other transcription factors in the nucleus.  The enhancesome then binds to the 
IFN-β promoter and induces the expression of IFN-β.  IRF7 and NF-κB can also form 
an enhancesome, binding to the IFN-α promoter and inducing IFN-α expression. 
Following induction, IFN-α/β is secreted from the cell.  
 
IFN-α/β signalling:  Secreted IFN-α/β binds to the IFNAR at the cell surface 
membrane.  The IFNAR subsequently activates the receptor-associated tyrosine 
kinases JAK1 and Tyk2, which phosphorylate STAT1 and STAT2. Phosphorylated 
STAT1 and STAT2 forms a heterodimer via their SH2 domains.  IRF9 binds to 
STAT1/STAT2, forming the ISGF3 complex.  ISGF3 is translocated into the nucleus, 
binding to the IFN Stimulated Response Element (ISRE) and inducing the expression 
of ISGs, subsequently generating an antiviral state in the host cell (refer to 1.1.4.  
IFN-α/β signalling: The JAK/STAT pathway). 
 
Figure adapted from (Randall & Goodbourn, 2008) and adapted with permission from 
an original figure by Andri Vasou, University of St Andrews. 
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The role of LGP2 as a regulator of RIG-I mediated signalling 
 
The role of LGP2 in the induction of IFN has been hotly contested in the literature, 
acting as a regulator of disputed function for RIG-I and MDA5 (Reviewed in (Zhu et 
al., 2014) (Figure 4).   The mechanism of LGP2 regulation of IFN-α/β induction 
remains unclear, with a lack of structures obtained of full length LGP2 in active and 
inactive states when bound to either RNA ligands or with RIG-I and MDA5. Like RIG-
I and MDA5, LGP2 is strongly induced by IFN-β (Komuro & Horvath, 2006; Satoh et 
al., 2010; Yoneyama et al., 2005).  Initial cell culture experiments suggested that 
LGP2 acted as a negative regulator of IFN-β induction. The overexpression of LGP2 
inhibits the induction of IFN-β, downstream IFN-β signaling and ISG expression upon 
infection with Sendai virus (SeV), Newcastle disease virus (NDV) or polyinosinic-
polycytidylic acid [poly(I:C)], a synthetic dsRNA ligand (Broquet et al., 2011; Komuro 
& Horvath, 2006; Murali et al., 2008; Rothenfusser et al., 2005; Yoneyama et al., 
2005).  Like RIG-I, LGP2 contains a C-terminal repressor domain mapped onto the 
CTD and linker region (Figure 2). The LGP2 repressor domain is responsible for 
binding to both dsRNA and ssRNA in a 5’-ppp independent manner with a greater 
affinity than RIG-I, in which the LGP2/dsRNA interaction has been crystallised (Li et 
al., 2009a; Pippig et al., 2009).  Hence it was proposed that LGP2 negatively 
regulates IFN-β induction by sequestering PAMPs from RIG-I and MDA5 
(Rothenfusser et al., 2005; Yoneyama et al., 2005).   
 
The exact mechanism  of LGP2 mediated RIG-I inhibition remains unclear.  Several 
studies indicate that LGP2 functions as an inhibitor of RIG-I by the LGP2 repressor 
domain directly binding to RIG-I in a dsRNA ligand independent manner, inhibiting 
RIG-I dimerisation and subsequent interacts with IPS-1 and the induction of IFN-β 
(Murali et al., 2008; Saito et al., 2007). Mutations in the dsRNA binding activity of 
LGP2 did not abolish its inhibitory capacity of RIG-I (Li et al., 2009a), and further 
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mutagenesis studies revealed that the LGP2 helicase ATPase functionality is 
essential for LGP2 inhibition of IFN-β induction. A recent paper supports the model of 
LGP2 inhibition of RIG-I, utilising the PIV5 V protein, discussed later (Childs et al., 
2012a).  The PIV5 V protein is able to bind to MDA5 and LGP2, but the V protein is 
unable to bind to RIG-I (Childs et al., 2007; 2012a; Parisien et al., 2009).  HEK293 
cells were transiently transfected to express the PIV5 V protein, and then the cells 
were stimulated by RIG-I specific ligands (Childs et al., 2012a).  The PIV5 V protein 
exploits the inhibitory capacity of LGP2, by the V protein forming a complex between 
LGP2 and RIG-I and antagonising the induction of IFN-β. However, the same authors 
found that for inhibition of RIG-I to occur under poly(I:C) stimulation, high levels of 
LGP2 were required, at a greater amount than required for LGP2 activation of MDA5 
(Childs et al., 2013). This indicates that under infections in vivo, LGP2 may have to 
be in excess or induced at significantly high levels in order to exert an inhibitory 
effect on RIG-I.   Further highlighting the complex nature of LGP2 regulation of RIG-I, 
LGP2 may play a role in stimulating RIG-I activity, depending on the infecting virus 
and cell type (Satoh et al., 2010).  Bone marrow-derived dendritic cells from LGP2 
knock out mice were found to produce less IFN-β, not just in response to EMCV, but 
also to RIG-I specific viruses such as VSV, SeV and, Japanese encephalitis.  This 
effect was also seen in the same study where LGP2 appears to stimulate RIG-I 
mediated IFN-β induction in Mouse Embryonic Fibroblasts, but to suppress IFN-β 
induction in HEK293 cells. 
 
 
The role of LGP2 in the regulation of MDA5 mediated signalling 
 
In contrast to RIG-I, LGP2 appears to act as an enhancer of MDA5 mediated 
signalling.  Initial in vivo experiments with LGP2 knockout mice revealed that LGP2 
has a more complex role in the regulation of MDA5 and RIG-I mediated responses 
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(Venkataraman et al., 2007). Consistent with a negative regulatory role, LGP2 
deficient mouse embryonic fibroblasts (MEFs) showed increased levels of IFN-β 
mRNA in response to poly(I:C) and vesicular stomatits virus (VSV) infection, and the 
LGP2 knock out mice were more resistant to VSV infection than wild-type mice. 
However, LGP2 deficient macrophages made less IFN-β in response to EMCV than 
wild-type cells, virus titres were higher, and the LGP2 knock out mice were more 
sensitive to EMCV infection. This data suggests that LGP2 acts as a negative 
regulator of IFN-α/β induction with viruses that are recognized by RIG-I (VSV), and 
as a positive regulator with viruses that are recognized by MDA5 (EMCV) (Figure 3). 
The role of LGP2 acting as an enhancer of MDA5 activity, is supported in a study 
where IFN-β promoter activity was rescued in LGP2 deficient cells by infection with a 
LGP2 expressing retrovirus, prior to infection with EMCV (Satoh et al., 2010).  In 
addition, a recent study found that LGP2 enhances IFN-β induction in response to 
limited levels of poly(I:C) stimulation of HEK293 cells {Childs:2013im). The authors 
showed that LGP2 stimulation by poly(I:C) is dependent upon endogenous MDA5, 
whereby HEK293 cells in the presence of siRNA to MDA5 were unable to induce 
IFN-α/β  .  These findings are in contrast to previous studies that used high levels of 
poly(I:C) in which IFN-β induction was inhibited (Kato et al., 2008).  Co-
immunoprecipitation studies revealed that LGP2 interacts with MDA5 in a dsRNA 
dependent manner (Childs et al., 2013).  Furthermore, in vitro mutagenesis studies 
have determined that full length LGP2 is needed to activate MDA5 (Pippig et al., 
2009).  LGP2 can only form a dimer in response to dsRNA, suggesting that dsRNA is 
LGP2s unique ligand, and that LGP2 is activated in a similar way to RIG-I (Saito et 
al., 2007).  Clearly, the role of LGP2 as a regulator of RIG-I and enhancer of MDA5 
and its role in the induction of IFN-β is complex and needs to be further elucidated.   
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STING Mediated signalling 
 
An additional adaptor for RIG-I, but not MDA5 mediated signalling is the Stimulator of 
interferon genes protein (STING) (Ishikawa & Barber, 2008) (Figure 4).  STING (also 
called MITA, MYPS and ERIS) is localised in the membrane of the endoplasmic 
reticulum. Co-immunoprecipitation and transient transfection studies revealed that 
STING interacts and enhances the interaction between IPS-1, RIG-I TBK-1 and IRF3 
(Ishikawa & Barber, 2008; Zhong et al., 2008).  STING can also be phosphorylated 
by TBK-1, facilitating the activation of IRF3 (Li et al., 2009c).  These studies suggest 
that STING acts as a molecular scaffold for the interaction of RIG-I and downstream 
adaptors, creating a ready state for the recruitment and activation of IRF3 in 
response to virus infection. 
 
 
IPS-1 mediated signalling 
 
Upon binding of their respective ligands, RIG-I and MDA5 undergo conformational 
changes (as described previously) that enables their respective CARDs to interact 
with the downstream CARDs located on IPS-1 (also known as MAVS, CARDIF, or 
VISA) (Figure 4).  IPS-1 functions as the central signalling platform for the RIG-I and 
MDA5 mediated induction of IFN-α/β (Boga et al., 2013; Jacobs & Coyne, 2013; 
Kawai et al., 2005; Xing-Xing & Kai, 2013).  IPS-1 contains a transmembrane domain 
that localises IPS-1 to the outer membrane of mitochondria.  Following the binding of 
the CARDs of RIG-I or MDA5 to IPS-1, IPS-1 recruits the tumour necrosis factor 
receptor (TNFR1)- associated death domain (TRADD) protein. TRADD in turn 
mediates the formation of complexes that mediate the activation of the transcription 
factors IFN regulatory factor 3 (IRF3) and Nuclear Factor kappa B (NF-kB).  NF-κB 
and IRF3 are localized in the cell cytosol in an inactive state, enabling their 
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immediate activation and induction of IFN-β in response to virus infection, without the 
need for de novo protein synthesis  
 
 
Activation of the IFN-β Promoter by NF-κB and IRF3 
 
NF-κB is inhibited by the Inhibitor of NF-kB (IkB), which sequesters the nuclear 
localisation signal located on the NF-κB p65 subunit (DiDonato et al., 1997; Mercurio 
et al., 1997; Rothwarf et al., 1998; Yamaoka et al., 1998).   Following virus infection 
and the activation of IPS-1, TRADD recruits TRAF6 (TNF receptor-associated factor 
6) and RIP1 (Receptor Interacting Protein 1) (Cusson-Hermance et al., 2005; Jiang 
et al., 2004; Meylan et al., 2004; Michallet et al., 2008; Yamamoto et al., 2003). Upon 
the recruitment of TRAF6 to TRADD, TRAF6 auto-polyubiquitinates and then also 
polyubiquitinates RIP1.  The polyubiquitinated RIP1, forms a scaffold for the 
recruitment of the IκB kinase complex and the TAK1 (transforming growth factor β- 
activated kinase 1) binding proteins 2 and 3, that in turn recruit TAK1 (reviewed by 
Chen, 2005; Deng et al., 2000; Kanayama et al., 2004; Wang et al., 2001).  The IκB 
kinase complex consists of the NF-κB Essential Modulator (NEMO) scaffolding 
protein and the catalytic subunits IΚΚα and IΚΚβ.  TAK1 directly phosphorylates the 
IKKβ subunit (Wang et al., 2001).  The phosphorylated IKKβ subunit in turn 
phosphorylates IκB.  Phosphorylated IκB is dissociates from NF-κB, whereby 
phosphorylated IκB is then degraded by the proteasome.  The nuclear localisation 
signal is consequently unmasked from the newly free NF-κB, allowing NF-κB to be 
translocated to the nucleus.  
 
In contrast to NF-κB, IRF3 is constitutively expressed in cells as a monomer in an 
inactive state (Au et al., 1995). Upon stimulation, TRAF3 is recruited to the 
TRADD/IPS-1 complex (Häcker et al., 2006; Michallet et al., 2008; Oganesyan et al., 
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2006). TRAF3 in turn recruits TANK (TRAF family member-associated NF-κB 
activator) (Balachandran et al., 2004; Hoebe, 2006; Li et al., 2002; Michallet et al., 
2008; Xu et al., 2005).  NEMO interacts with TANK to enable the recruitment of TBK-
1 and IKKε (Pomerantz & Baltimore, 1999; Yamamoto et al., 2003; Zhao et al., 
2007). TBK-1 and IKKε phosphorylate Serine/threonine residues in the IRF3 C-
terminus.  Phosphorylated IRF3 homodimerises, causing a conformational change in 
IRF3 that reveals a nuclear localization signal (Fitzgerald et al., 2003; Sharma et al., 
2003).  The phosphorylated IRF3 homodimer then translocates into the nucleus. 
 
In the nucleus, phosphorylated IRF3 homodimers and NF-κB interact, forming a IFN-
β transcription factor complex called the enhancesome.  The enhancesome 
comprises of other important transcription factors such as activator protein 1 (AP-1, 
formed of the subunits ATF-2 and c-Jun) (Wathelet et al., 1998) and high mobility 
group proteins.  Following the formation of the enhancesome complex, the 
enhancesome recruits the co-activator cAMP-responsive-element binding protein 
(CREB)-binding protein and p300, whereby the enhancesome complex binds to the 
IFN-β promoter and subsequently initiates IFN-β transcription (Munshi et al., 1998).  
IFN-β is subsequently secreted by the cell.   
 
 
Activation of the IFN-α promoter by IRF7 and NF-κB 
 
In addition to phosphorylating IRF3, TBK1 and IKKε phosphorylate and activate a 
second IFN transcription factor, IRF7. The majority of cell types have undetectable or 
very low basal levels of expression of IRF7 (Au et al., 1995; Erlandsson et al., 1998; 
Génin et al., 2009; Marié et al., 1998; Sato et al., 1998; Yeow et al., 2000) (Wathelet 
et al., 1998; Yang et al., 2004). IRF7 is required for the rapid induction of IFN-α in 
immune cells such as pDCs (Prakash, 2005; Raftopoulou, 2005).  Upon the 
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phosphorylation of IRF7 by TBK1 and IKKε, IRF7 homodimerises or heterodimerises 
with IRF3 to reveal the IRF7 nuclear localization signal.  Once translocated to the 
nucleus, IRF7 interacts with NF-κB and the enhancesome, activating the IFN-α 
promoter. Unlike IRF3, IRF7 is IFN-β inducible.  Hence in cells where the IFN-β 
induction cascade has been activated, IRF7 is induced which subsequently induces 
IFN-α.  This aids the host cell to rapidly express ISGs and to generate the antiviral 
state. 
 
 
1.1.4.  IFN-α/β signalling: The JAK/STAT pathway 
 
The JAK/STAT pathway is the key classical signalling pathway activated by IFN-α/β 
that leads to the induction of ISGs and the generation of an antiviral state.  Upon 
induction and secretion from cells, IFN-α/β acts in a paracrine and autocrine manner, 
binding to the IFN-α/β receptor (IFNAR) (Figure 3). The IFNAR is composed of two 
subunits, IFNAR1 and IFNAR2 (Abramovich et al., 1994; Novick et al., 1994). Prior to 
activation by IFN-α/β, the tyrosine kinase Tyk2 is constitutively expressed and 
associated with IFNAR1, whilst JAK1 is constitutively expressed and associated with 
IFNAR2 (Abramovich et al., 1994; Colamonici et al., 1994; Müller et al., 1993; Novick 
et al., 1994).  Prior to activation by IFN-α/β, STAT2 is associated with IFNAR2, and 
STAT1 is weakly associated with STAT2 (Precious et al., 2005; Stancato et al., 
1996).  IFN-α/β binds to the IFNAR, inducing IFNAR dimerization and causing a 
conformational change in which Tyk2 is able to phosphorylate tyrosine 466 on 
IFNAR1.  The phosphorylation of IFNAR1 forms a docking site that allows STAT2 to 
strongly associate with IFNAR1 via their corresponding Src homology 2 (SH2) 
domains, permitting STAT2 phosphorylation on Tyrosine 690 by Tyk2 (Stahl et al., 
1995).  Phosphorylation of STAT2 enables the JAK1 mediated phosphorylation of 
STAT1 at Tyrosine 701, consequently enabling the formation of a stable heterodimer 
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between STAT1 and STAT2 (Leung et al., 1995). Formation of the heterodimer 
permits binding of IRF9 to STAT1/STAT2, forming the Interferon-stimulated gene 
factor 3 (ISGF3) transcription factor complex.  The formation of the ISGF3 complex 
exposes a nuclear localization signal that promotes ISGF3 translocation to the 
nucleus (Fagerlund et al., 2002; Melen et al., 2003).  ISGF3 subsequently binds to 
the cis element IFN-stimulated response element (ISRE) contained in the promoter 
of certain ISGs and induces ISG transcription (Darnell, 1997; Levy & Darnell, 2002).  
The ISGF3 complex is eventually broken down via the dephosphorylation of the 
STAT1/STAT2 heterodimer, exposing the nucleus export signals and subsequent 
translocation to the cytosol (Banninger, 2004; McBride & McDonald, 2000). The 
JAK/STAT pathway is tightly regulated given its critical role in the expression of ISGs 
following the induction of IFN-α/β.  This has been extensively reviewed in the 
literature and beyond the scope of this thesis (Dalpke et al., 2008; HAQUE & 
SHARMA, 2006; Kohanbash & Okada, 2012; Krämer & Heinzel, 2010; Najjar & 
Fagard, 2010; Platanias, 2005).  There are other mechanisms of ISG induction 
independent of the JAK/STAT pathway such as gamma activated sequence (GAS) 
elements, but these are beyond the scope of this thesis. 
 
 
1.1.5.  The Generation of the Antiviral state by IFN-α/β 
 
IFN-α/β upregulates the expression of over 380 ISGs which are able to establish an 
antiviral state in the infected cell and neighbouring uninfected cells, directly inhibiting 
further virus infection, replication, transcription, assembly and dissemination 
(Schoggins et al., 2011; Yoneyama et al., 2005).  IFN-α/β also upregulates the 
expression of components involved in IFN-α/β induction and the JAK/STAT pathway, 
priming uninfected cells to illicit a rapid, thorough antiviral response upon infection.  
There have been many comprehensive reviews in the literature of ISGs that inhibit 
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RNA viruses, and those that have been well characterised are summarised in Table 
1 (reviewed in (Liu et al., 2011; Randall & Goodbourn, 2008; Sadler & Williams, 
2008).  The primary ISGs examined in this project are MxA and ISG56, utilised as 
markers for the induction of IFN-α/β and are the main focus of this section.  IFN-α/β 
also upregulates genes involved in cell cycle arrest, apoptosis and the 
immunomodulation of innate and adaptive immune cells.  Together, these responses 
act in concert to create a hostile environment against the infecting virus before the 
other arms of the immune system are able to respond.  
 
 
Mx GTPases 
 
The Mx family of genes encode large GTPases which are involved in the inhibition of 
viral ribonucleocapsids (Reviewed in (Verhelst et al., 2013).  Human MxA is localised 
in the cytosol, recognizing and binding to the viral ribonucleocapsids of a large range 
of viruses, including orthomyxoviruses, paramyxoviruses, rhabdoviruses, 
togaviruses, bunyaviruses, hepatitis B virus and Coxsackie virus (Chieux et al., 2001; 
Gordien et al., 2001; Haller et al., 2007; Landis et al., 1998). It is not known how Mx 
proteins can suppress such a diverse range of viruses lacking an obvious common 
molecular pattern. Although its antiviral mechanism has not been fully elucidated, 
MxA appears to oligomerize to form rings around the ribonucleocapsids, blocking 
early viral replication events (Andersson et al., 2004; Kochs, 1999; Kochs et al., 
2002; Malsburg et al., 2011; Weber & Haller, 2000).  Furthering this, Xiao et al 
determined that human MxA inhibits the early stages of influenza A virus infection by 
retaining the incoming viral genome in the cytosol (Xiao et al., 2013).  Supporting this 
are structural studies of MxA, which revealed intra- and inter-molecular interactions 
required for their antiviral activity, consistent with the proposed ring model of 
inhibition of viral replication (Gao, n.d.; Sadler & Williams, 2011).   
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Table 1.  Summary of well characterised ISGs that inhibit negative strand RNA 
viruses.   
ISG Target Viruses affected Mechanism of action 
 
Protein Kinase R 
 
Viral 
dsRNA 
 
ECMV, Vaccinia Virus, HIV-1, 
VSV. HSV-1 (Herpes Simplex 
Virus) (Adelson et al., 1999; 
Balachandran et al., 2000; 
Lee & Esteban, 1993; Meurs 
et al., 1992; Tallóczy et al., 
2006). 
 
 
 
 
PKR is a serine threonine kinase that binds to 
viral dsRNA, inducing a conformational change 
in which PKR homodimerises and 
autophosphorylates (Gale et al., 1998; Nanduri 
et al., 2000; Taylor et al., 1996).  Activated PKR 
phosphorylates eukaryotic translational initiation 
factor 2α (eIF2α), preventing eIF2α recycling 
and thus inhibiting the initiation of ribosomal 
virus translation and recycling of IKKβ for NF-κB 
activation.  eIF2α phosphorylation also induces 
cellular autophagy (Balachandran et al., 1998; 
Tallóczy et al., 2002). 
 2'-5' 
Oligoadenylate 
Synthetase (2-
5OAS)/ RNase L 
Viral 
dsRNA  
ssRNA viruses including 
Picornaviridae, Reoviridae, 
Togaviridae,Paramyxoviridae, 
Orthomyxoviridae, 
Flaviviridae and Retroviridae 
(Hovanessian, 2007) (Lin et 
al., 2009; Silverman, 2007)  
2-5’ OAS catalyses the synthesis of 2'-5' 
adenosine phosphodiester bond linked 
oligomers from ATP, which in turn activate 
endoribonuclease L (RNase L) (Slattery & 
Ghosh, 1979; Zhou et al., 1993).  RNase L 
degrades cellular and viral ssRNA and mRNA, 
inhibiting viral protein translation and inducing 
cellular apoptosis (Silverman, 2007; Zhou et al., 
1998)  
ISG15 Cellular 
and virus 
protein 
machinery 
involved in 
Influenza, Sindbis Virus, 
HSV1, Chikungunya Virus, 
Lymphocytic choriomeningitis 
Virus, Hepatitis C virus 
(HCV), Human Papilloma 
Virus, HIV-1 (Okumura et al., 
ISG15 is a ubiquitin homologue that is 
conjugated to cellular proteins following virus 
infection (Loeb & Haas, 1992), including IRF3, 
STAT1, Jak1, PKR and MxA (Malakhova et al., 
2003; Shi et al., 2010; Zhao et al., 2005). The 
addition of ISG15 to cellular proteins 
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Table Modified from (Liu et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
virus 
release  
2006) (Lenschow et al., 2007) 
(Chen & Li, 2011; Ritchie et 
al., 2004; Werneke et al., 
2011) (Lenschow et al., 2005) 
(SGylation), enhances protein translocation 
(Loeb & Haas, 1994) and stabilization  (Lu et al., 
2006). ISG15 inhibits multiple stages of HIV-1 
release from the cell, preventing virion budding 
(Pincetic et al., 2010).  This could be the 
mechanism that ISG15 affects other viruses.   
Viperin Host cell 
Lipid Rafts 
Human cytomegalovirus, 
HCV, influenza, HIV-1 (Chin 
& Cresswell, 2001; Jiang et 
al., 2008; Wang et al., 2007) 
Viperin is associated with the endoplasmic 
reticulum membrane.  Viperin disrupts cell 
surface membrane and lipid raft integrity, 
preventing virus budding and release e.g. during 
Influenza A infection (Wang et al., 2007), or the 
release of viruses from lipid droplets that use 
them as a site for replication e.g. HCV (Jiang et 
al., 2008; Miyanari et al., 2007). 
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ISG56 
 
ISG56 (also known as Interferon Induced protein with tetratricopeptide protein 
repeats 1, IFIT1) belongs to the ISG56 family of genes that are evolutionary 
conserved in humans, mice, birds, fish and amphibians (Fensterl & Sen, 2011).  Most 
cell types do not express detectable levels of ISG56 in the absence of viral stimuli.  
Upon virus infection, ISG56 is rapidly induced following the induction of IFN-α/β (Der 
et al., 1998; Kusari & Sen, 1986; Terenzi et al., 2008).  Furthermore, the ISG56 
promoter can be activated independently of the IFN-α/β and the JAK/STAT signalling 
pathway.  The ISG56 promoter contains an IRF3 binding cis-element (Nakaya et al., 
2001), enabling IRF3 to directly induce ISG56 (Grandvaux et al., 2002; Nakaya et al., 
2001; Peters et al., 2002).  
 
ISG56 is composed of a single structural motif, the tetratricopeptide repeat (TPR). 
The TPRs form scaffolds that allows ISG56 to interact and modulate the activities of 
a wide range of cellular and viral proteins involved in viral translation, such as eIF3 
(eukaryotic initiation factor 3) (D'Andrea, 2003; Lamb et al., 1995). eIF3 is a large 
protein complex made up of 13 subunits (a-m).  eIF3 controls the assembly of the 
48S translation initiation complex on mRNA that have a 5' cap or an Internal 
Ribosomal Entry Site.  eIF3 prevents binding of the 60S ribosomal subunit to the 40S 
subunit until the translation initiation complex has been formed.  The 48S translation 
initiation complex is formed by eIF3 acting as a scaffold for the recruitment of the 
40S ribosome, the ternary complex (eIF2-GTP-Met-tRNA), eIF4F and mRNA (Guo et 
al., 2000; Hinnebusch, 2006). ISG56 inhibits the ternary complex formation step of 
translation initiation by binding to the eIF3e subunit of eIF3, leading to the inhibition 
of protein synthesis (Hui et al., 2003; Terenzi et al., 2006).   
 
A recent study showed that for West Nile virus, ISG56 can restrict the replication of 
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mutant viruses deficient for 2’-O methyltransferase activity.  2’-0 methyltransferase 
methylates the 2’-hydroxyl group of ribose sugars in the 5’-cap viral mRNA.   The 
wildtype and mutant viruses induced similar levels of IFN-β, but the mutant viral 
mRNAs were extremely sensitive to ISG56 compared to the wildtype virus.  This 
indicates that viral mRNA or virus RNAs lacking 2’-O methylated sites are ligands for 
ISG56. In comparison, two recent studies have shown that for PIV5, the viral mRNAs 
are methylated at the 5’-cap, but this feature does not reduce ISG56 activity 
(‘ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of 
parainfluenza virus type 5 transcription and protein synthesis’, 2013; Killip et al., 
2012a).  Instead, ISG56 was shown to be the primarily ISG responsible for in the 
inhibition of translation of viral mRNAs, independent of whether the 5’-cap was 
methylated or not. The mechanism of action of ISG56 remains to be fully elucidated.   
 
 
IFN-α/β mediated regulation of the Cell cycle and Apoptosis 
 
In addition to the regulation of ISGs, IFN-α/β also upregulates genes involved in cell 
cycle arrest.  IFN-α/β modulates cell cycle progression through the upregulation of 
cyclin-dependent kinase inhibitors  (Sangfelt et al.,1999, Sangfelt et al., 1997b, 
Mandal et al., 1998, Mandal et al., 1998) and the p200 family of proteins (reviewed in   
(Lengyel, 2008).   Treatment with IFN-α/β delays and inhibits cell growth, forcing the 
cell to remain longer in the G1, S and G2 phases, whilst also promoting cellular 
apoptosis (Balkwill & Taylor-Papadimitriou, 1978). As certain viruses use host cell 
machinery for viral transcription and translation, upregulating genes that cause cell 
cycle arrest would reduce viral transcription and translation of some viruses.  
 
The establishment of a pro-apoptotic state in cells by IFN-β mediates the clearance 
of those cells that have been overwhelmed by virus infection, before completed virus 
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assembly and egress from the cell can be achieved (reviewed in (Clemens, 2003).  
IFN-β upregulates pro-apoptotic ISGs including PKR, PML nuclear bodies and the 
OAS/RNase L (Tanaka et al., 1998, Sedger et al., 1999).  
 
 
IFN-α/β mediated immunomodulation of innate and adaptive immunity 
 
IFN-α/β upregulates Major Histocompatibility Complex (MHC) Class I machinery 
involved in cytotoxic T-cell (CD8+ T-cells) antigen presentation including MHC class I 
molecules, proteasome subunits and transporters (Der et al., 1998a, Schroder et al., 
2004, Epperson et al., 1992).  The upregulation of MHC Class I components 
counters the virus specific downregulation of MHC class I expression (Der et al., 
1998a). Furthermore, IFN-α/β can sustain the proliferation of antigen specific 
cytotoxic T cells and upregulate their effector mechanisms (Tough et al., 1996, 
Marrack et al., 1999, Kolumam et al., 2005). In addition, IFN-α/β promotes dendritic 
and natural killer cell maturation (Le Bon et al., 2003).  Together, these features act 
to aid the immediate proliferation and enhance the activity of innate and adaptive 
immune cells, leading to the rapid clearance of virus-infected cells.   
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1.2. The interplay between PIV5, IFN and the antiviral 
state 
 
To study the mechanisms behind the induction of IFN, we use parainfluenza virus 
subtype 5 (PIV5) as a model virus, acting as the stimulator of the PRRs RIG-I, MDA5 
and LGP2.  PIV5 has been used as a model to study the fundamental properties of 
the Paramyxoviridae and the host cell response since it’s discovery and 
characterisation in the 1950s and 1960s (Chanock, 1956; Choppin & Stoeckenius, 
1964; Hull & Minner, 1957). PIV5 was first originally isolated in rhesus monkey 
kidney cells and was therefore named simian virus 5 (SV5).  It has since been 
recovered from several species, such as dogs and humans  
(Goswami et al., 1984; Gur & Acar, n.d.; McCandlish et al., 1978) and it was 
therefore suggested that it should be re-named parainfluenza virus 5 (Chatziandreou 
et al., 2004).   The International Committee on Taxonomy of Viruses has accepted 
this change in nomenclature.  PIV5 infects a range of epithelial cell types including 
human A549 cells (adenocarcinomic human alveolar basal epithelial cells) and 
primary human cells (Arimilli et al., 2006; Chatziandreou et al., 2004).  Indeed, there 
has been no report of a cell line that is resistant to PIV5 infection In the following 
section PIV5 structure, life cycle and replication will be described in the context of 
detection by the PRRs and the consequent induction of IFN.  
 
 
1.2.1.  Introducing PIV5 and the Paramyxoviruses 
 
PIV5 is a prototypic member of the Paramyxoviridae family of non-segmented 
negative strand RNA viruses (NNSVs) (Figure 5; reviewed in (Samal, 2011) 
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Paramyxoviruses infect a diverse range of hosts, capable of causing significant 
morbidity and mortality to humans and other mammals, poultry and fish.  Some of the 
human pathogens include measles virus (MeV), mumps virus (MuV), and 
metapneumoviruses, which can cause severe respiratory infections in children and 
infants (Black, 1991).  A recent epidemiological study estimated that 199,000 
children under 5 years of age died globally from respiratory syncytial virus (RSV) 
(Nair et al., 2013).  The same study revealed the morbidity of RSV infections, in 
which 3.4 million children were admitted to hospital.  There are also important animal 
pathogens such as rinderpest virus, bovine respiratory syncytial virus and Newcastle 
disease virus (NDV), which cause serious economic impact on farmers.  
 
Paramyxoviruses usually have a narrow host range with no cross species 
transmission. However, paramyxoviruses have been identified in various types of 
bat, across Africa, Australia, Asia and South America, and also in European fruit bats 
(Chua et al., 2000; Drexler et al., 2012; Kurth et al., 2012). Recently, two new 
zoonotic paramyxoviruses emerged, Nipah and Hendra viruses, with high mortality in 
humans and animals (Eaton et al., 2006; Vigant & Lee, 2011).   Alarmingly, these 
new findings suggest a potential risk of emerging zoonotic paramyxoviruses. (Aljofan, 
2013; Virtue et al., 2009).  Clearly, it is important to find out how these viruses 
interact with host immune responses with the objective to developing vaccines 
against these pathogens. 
 
 
1.2.2.  The structure of PIV5 
 
Like other paramyxoviruses, PIV5 has a host-derived lipid membrane that envelops 
the virion (Figure 6). The lipid envelope contains two integral membrane proteins, 
haemagglutinin-neuraminidase (HN) and fusion (F).  
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Figure 5. Classification of the Paramyxoviridae Family of viruses 
The family Paramyxoviridae is classified into two subfamilies: the Paramyxovirinae 
and the Pneumovirinae. The Paramyxovirinae contains five genera: Respirovirus, 
Rubulavirus, Avulavirus, Morbillivirus, and Henipavirus. The Pneumovirinae contains 
two genera Pneumovirus and Metapneumovirus.  The classification is based on 
morphologic criteria, the organization of the genome, the biological activities 
of the proteins, and the sequence relationship of the encoded proteins now that the 
genome sequences have been obtained.  
 
Figure adapted from (Samal, 2011). 
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HN is required for cell attachment whilst F is required for fusion of the lipid envelop to 
the host cell membrane.  Associated with the lipid envelop is the SH (small 
hydrophobic) protein (Hiebert et al., 1985).  The SH protein has been implicated in 
the inhibition of apoptosis of the host cell (He et al., 2001; Lin et al., 2003; Wilson et 
al., 2006).  Lining the lipid envelope is the Matrix (M) which plays a role in virus 
assembly.  PIV5 has ssRNA genome that is helically encapisidated by the 
nucleoprotein (NP). Found in association with NP are the V protein and the viral RNA 
polymerase components, the phosphoprotein (P) and large (L) proteins.   
 
The PIV5 V protein is multifunctional, playing key roles as an IFN antagonist, in viral 
RNA encapsidation (Precious et al., 1995; Randall & Bermingham, 1996), viral RNA 
synthesis (Gainey et al., 2008; Lin et al., 2005) and cell cycle regulation (Lin & Lamb, 
2000). 
 
 
1.2.3.  The Life cycle of PIV5 
 
In order to investigate the mechanisms by which potential virus PAMPs are 
generated during virus replication, it is important to understand the life cycle of PIV5.  
The lifecycle of PIV5 has been extensively reviewed and will be briefly described 
(Knipe et al., 2013; Samal, 2011). Upon infection, the viral lipid envelope localized 
HN and F proteins mediate the attachment and fusion of the viral lipid envelope to 
the host cell plasma membrane (Figure 7).  
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Figure 6. The structure of PIV5 
The PIV5 virion consists of a lipid bilayer derived from the host cell plasma 
membrane. Two glycoproteins are embedded in the lipid envelope: the 
haemagglutinin-neuraminidase (HN) protein and the fusion (F) protein. The matrix 
(M) protein lines the inside of the membrane. Inside the virion is the single-stranded 
negative-sense RNA genome encapsidated by the nucleocapsid (NP) protein and 
associated with the phosphoprotein (P) and the large (L) protein as well as the V 
protein. Embedded in the membrane is also the small hydrophobic (SH) protein.  
 
Figure courtesy of Dr. N. Chatziandreou. 
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Figure 7. Life cycle of PIV5  
The HN glycoprotein facilitates the attachment of virions to the host cell surface.  The 
F protein mediates the fusion of the viral envelope with the cell surface plasma 
membrane of the infected cell. The virus is then uncoated and the nucleocapsid is 
released into the cytosol, where viral RNA synthesis occurs. Negative sense 
genomes are first transcribed into capped and polyadenylated mRNAs, which are 
translated into viral proteins. When levels of NP have increased, the viral polymerase 
switches from transcription to replication to produce full-length antigenomes (positive 
sense). These antigenomes are used to synthesise further viral progeny genomes 
and together, the antigenomes and genomes are encapsidated by NP.  Correctly 
folded viral proteins are then transported to the Golgi apparatus, where proteins are 
packaged and then assembled at the cell membrane where the M protein directs the 
assembly and budding of virions.  
 
Figure courtesy of Hannah Norsted, University of St Andrews. 
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The HN glycoprotein attaches to sialic acid receptors on the cell surface membrane, 
whilst the F protein initiates infection through pH-independent fusion of the virion lipid 
bilayer with the host cell plasma membrane.  The virus genome is absorbed into the 
cytosol of the cell.  The encapsidated genome (but not NP) is uncoated, and viral 
RNA synthesis takes place in the cytosol.  Potentially, PAMPs that are sensed by 
RIG-I, MDA5 and LGP2 could be generated when the genome is uncoated and also 
at the RNA synthesis step.  Following RNA synthesis, the Golgi apparatus sends 
viral proteins to the cell surface membrane. The M protein facilitates virion assembly 
and budding.  At later stages of infection, the F protein facilitates fusion between 
infected cells and neighbouring uninfected cells. The F proteins are inactive when 
synthesized and have to be cleaved by a host cell protease to become biologically 
activated.  
 
 
1.2.4.  PIV5 RNA synthesis 
 
PIV5 RNA synthesis takes place in the cytosol of the cell using the virus RNA 
polymerase.  Potentially, it is at this level of the virus life cycle that could generate 
RNA PAMPs that could be detected by MDA5, RIG-I and LGP2.   The genome of 
PIV5 for isolate W3A is 15,246 nucleotides (nt) in length and contains seven genes 
that encode eight known viral proteins NP, P and V, M, F, SH, HN and L  (Paterson 
1984b). The PIV5 genome contains a terminal noncoding 55nt leader (Le) and 31nt 
trailer (Tr) sequences at its 3′ and 5′ ends of the genome.  The Le and Tr sequences 
act as bipartite promoters inducing viral transcription and replication (Murphy & 
Parks, 1997) (Figure 8).  The P and L proteins form the viral RNA polymerase, which 
mediates virus transcription and replication. 
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PIV5 Transcription 
 
Early in infection, the 3′ Le genomic promoter directs synthesis of both viral mRNAs 
and the replication of genomic RNA to produce positive sense antigenomes (the full-
length complement of the genome)  (Figure 8) (Knipe et al., 2013; Samal, 2011; 
Whelan et al., 2004).  The viral polymerase can only attach to the template at a 
single site at the 3’ genome terminus. PIV5 transcription occurs in a 3’ to 5’ direction, 
directed by the cis-acting regions of the gene junctions. PIV5 employs the same 
stop-start mechanism that is shared among NNSVs.  The first gene transcribed is 
NP, followed by P/V, M, F, SH, HN and L. Each gene terminus contains a sequence 
of several U residues that serve as the template for polyadenylation, followed by 
signals that are recognized by the viral polymerase to terminate transcription.  
 
The polymerase stays attached to the template while it reads along the intergenic 
region until it reaches the start of the downstream gene, which contains signals for 
reinitiation of transcription and the addition of a methylated 5’ guanine cap to the 
mRNA (Lamb & Parks, 2006; Whelan et al., 2004).  Viral mRNA is 5’ capped and 3’ 
polyadenylated to sequester it from cellular RNAses that would destroy foreign 
RNAs. Sometimes the polymerase fails to reinitiate transcription and disengages 
from the template. Measurement of the amount of virus mRNAs demonstrated that 
viral transcription of PIV5 (and other paramyxoviruses) occurs in a transcriptional 
gradient, with decreasing transcription of the genes the further away from the 3’ Le 
(Cattaneo et al., 1987a, b;Villarreal et al., 1976).  
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Figure 8. PIV5 RNA Synthesis 
The viral polymerase (P-L) transcribes the genome template, starting at its 3’ Le 
terminus, to generate the successive capped 5’ capped and polyadenylated (An) 
mRNAs.  The Viral RNA polymerase stops and restarts at each gene junction, 
whereby the polymerase can “drop off” ceasing transcription. The NP, P/V, M F, SH, 
HN and L genes are thus transcribed along a transcriptional gradient.  Once these 
primary transcripts have generated sufficient viral proteins, unassembled NP (as a P-
N complex) begins to assemble the nascent leader chain.  Encaspidation of the 
nascent chain by NP causes the viral RNA polymerase to ignore the junctions, 
yielding the positive sense antigenomic RNA (bottom). The 3’ antigenomic promoter 
directs the viral RNA polymerase to produce genomic RNA that is immediately 
encapsidated by NP.  See text for details. 
 
Figure courtesy of Rick Randall, University of St Andrews. 
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The V protein is a faithful transcript of the P/V gene however, both the V and P 
proteins are transcribed from the P/V gene, as the open reading frames of V/P gene 
are overlapping resulting in two different gene products. The P gene mRNA is 
generated by RNA editing, which was first described for PIV5 and is common to 
other paramyxoviruses (Thomas et al., 1988). RNA editing is the pseudotemplated 
addition of nucleotides at the open reading frame of mRNAs derived from the gene 
encoding both the P and V proteins. The addition of two G residues results in a frame 
shift in the translational open reading frames downstream of the insertion site.   
 
 
PIV5 Replication 
 
Firstly, during PIV5 replication an antigenomic template is generated.  The 
antigenomic 3’ Tr directs replication by the viral polymerase of the template 
antigenomic RNA to produce progeny negative sense genomes (Figure 8). The 3’ Tr 
antigenomic promoter is stronger than the genomic promoter, reflecting the 
requirement of the virus to generate greater numbers of genomes than antigenomes 
(Le Mercier et al., 2002). Associated with the viral polymerase P protein is a soluble 
form of NP, NP0 (Precious et al., 1995).  PIV5 replication follows the “rule of 6”, in 
which the genome size is a multiple of six for efficient replication by the viral RNA 
polymerase (Calain & Roux, 1993). PIV5 replication is most efficient when it follows 
the “rule of 6”, but this has been shown to not be a strict requisite (Murphy & Parks, 
1997).  During PIV5 replication, nascent viral RNA is immediately encapsidated with 
firstly NP0 at the 5’ terminus as it emerges from the polymerase complex, in order to 
resist degradation by cellular RNAses. Each NP associates with 6 nucleotides as the 
full length genome is replicated, which also stops the formation of dsRNA.  
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1.2.4. The Induction of IFN by PIV5: The Viral PAMPs of RIG-I, 
MDA5 and LGP2 
 
The critical importance of RIG-I and MDA5 in the detection of paramyxoviruses, 
using Newcastle Disease virus (NDV) and VSV as a model has been demonstrated 
using in vivo studies (Kato et al., 2006) Infections of RIG-I and MDA5 knock-out mice 
confirmed the essential roles of these PRRs in the induction of antiviral immune 
responses.  Further in vivo and in vitro studies demonstrated that RIG-I and MDA5 
sense different sets of RNA viruses summarised in Figure 9. Our current 
understanding of the recognition of synthetic and potential viral RNA structures by 
RIG-I, MDA5 and LGP2 has been comprehensively reviewed in (Schlee, 2013).  The 
following sections will discuss our current understanding of the nature of potential 
viral PAMPs generated during infection by negative-sense RNA viruses, how these 
PAMPs are potentially detected by the host cell and induce IFN, and finally how the 
IFN antagonist function of the V protein may or may not point to a different source of 
PAMPs generated by PIV5 other than that of the wildtype virus. 
 
 
RIG-I and MDA5 recognition of PAMPs based on the length of dsRNA 
 
Viral dsRNA is a PAMP that is presented by dsRNA genome viruses such as 
reoviruses, or potentially generated as intermediates during virus replication of 
negative sense and positive sense RNA viruses.  DsRNA is not produced by host 
cells and hence supports discrimination of host cellular and viral patterns.  Whilst the 
in vivo viral dsRNA ligands have not been identified, many studies have used the 
synthetic poly(I:C) dsRNA analogue to tease apart the potential ligands for  RIG-I 
and MDA5. Cellular in vitro studies revealed that both RIG-I and MDA5 are able to 
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signal in response to transfected poly (I:C)  (Marques et al., 2006) (Kawai et al., 
2005). 
 
MDA5 has been shown to have a greater role than RIG-I in the induction of IFN-β in 
poly(I:C) infected mice,  macrophages, poly(I:C) transfected embryo-derived 
fibroblasts (Kato et al., 2006) and poly (I:C) treated dendritic cells (Gitlin et al., 2010). 
RIG-I recognises short poly(I:C) structures whereas MDA5 can detect longer poly 
(I:C) structures. RIG-I, but not MDA5 recognises short blunt ended dsRNA, between 
24bp-200bp in length (Kato et al., 2008; Li et al., 2009b; Loo et al., 2008; Lu et al., 
2010; Marques et al., 2006; Schlee et al., 2009; Schmidt et al., 2011). Using next 
generation sequencing it has been shown that RIG-I preferably binds to short viral 
RNA in infected cells (Baum et al., 2010).   
 
In contrast to RIG-I, MDA5 is able to detect long dsRNA greater than 1kbp (Gitlin et 
al., 2010; Kato et al., 2006; 2008; Pichlmair et al., 2009). The MDA5 CTD binds to 
blunt-ended dsRNA (Li et al., 2009b; Wu et al., 2013).  MDA5 can recognise RNA 
complexes formed from ssRNA and dsRNA (Pichlmair et al., 2009). Further evidence 
for this is displayed when poly(I:C) is converted from a longer structure to a shorter 
structure.   When long poly(I:C) dsRNA is digested with RNase III, this transforms 
poly(I:C), from a ligand that is able to induce MDA5 into a ligand that induces RIG-I, 
which suggests that MDA5 recognizes long dsRNA, whereas RIG-I recognizes short 
dsRNA (Kato, 2008).  
 
 
RIG-I Recognition of 5’-ppp RNA  
 
A substrate difference between RIG-I and MDA5 in the detection of negative sense 
RNA viruses, is the recognition by RIG-I, but not by MDA5, of 5’-triphosphate (5’-ppp) 
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groups that are present on viral genomic ssRNA of certain viruses (Hornung et al., 
2006; Pichlmair et al., 2006). DNA template dependent RNA transcription occurs 
primer independently from the 5′- to the 3′- terminus (Banerjee, 1980). Hence, in the 
host cell nucleus, cellular RNA primary transcripts initially contain a 5’-ppp group.  
Before host cell mRNA is exported to the cytosol it undergoes processing to remove 
this potential molecular PAMP, including CAP ligation, 5’ terminus removal or the 5’-
ppp modification of ribosomal RNA.  Viral mRNAs generated by certain viruses 
where transcription is localised in the cytosol have a 5’-ppp group. The 5’-ppp group 
present on viral ssRNAs allows RIG-I to discriminate between viral and host RNA, as 
host cell ssRNAs in the cytosol do not contain a 5’-ppp group.  It has been repeatedly 
shown that the 5’ terminus of 5’-ppp ssRNA detected by RIG-I contains a dsRNA 
sequence at least 10-19bp in length (Lu et al., 2010; Schlee et al., 2009; Schmidt et 
al., 2009; Wang et al., 2010) (Kolakofsky et al., 2012) 
 
Unsurprisingly, certain viruses that have viral transcription localised in the cytosol 
have developed evasion strategies to RIG-I sensing of 5’-ppp mRNAs (Fechter, 
2005). Influenza virus steals a 5’ cap from host cell mRNA to be used as primers for 
initiating synthesis of their viral mRNA.  Other negative sense viruses such as 
paramyxoviruses (including PIV5) avoid RIG-I recognition of viral 5’-ppp ssRNAs by 
placing a 5’ cap on viral mRNA via their respective RNA viral polymerases.    
 
RIG-I dominates the immune response to many negative sense ssRNA viruses 
(Cardenas et al. 2006; Habjan et al. 2008; Hornung et al. 2006; Kato et al. 2005, 
2006; Loo et al. 2008; Plumet et al. 2007; Yoneyama et al. 2005).  An additional 
study revealed that Influenza RIG-I activation occurs exclusively by the genomic 
RNA and not mRNA of Influenza (Rehwinkel et al. 2010). Analysis of RIG-I-bound 
viral RNA from Influenza infected cells revealed that only 5’-ppp viral genomic RNA 
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coprecipitated with RIG-I. RIG-I (and MDA5) is also important in the detection of 
dsRNA genomic viruses and positive ssRNA genomic viruses, that also generate 
cytosolic dsRNA species, such as replicative dsRNA intermediates during their 
replication (Feng et al. 2012; Targett-Adams et al. 2008; Triantafilou et al. 2012; 
Weber et al. 2006). Together with 5’-ppp, such RNA species represent ideal RIG-I 
target structures. 
 
Picornaviruses do not activate RIG-I during infection (Gitlin et al., 2006; Kato et al., 
2006) because instead of a 5′-ppp group, their RNA genomes possess a Vpg peptide 
linked via a tyrosine residue to a 5′monophosphate (Lee et al., 1977). In line with 
these findings, Feng et al. observed that purified picornavirus RNA did not stimulate 
RIG-I, but instead stimulated MDA5 (Feng et al., 2012). 
 
 
MDA5 recognition of 2’-O deficient 5’ cap mRNA structures 
 
Recent studies have uncovered an additional potential feature for MDA5 recognition 
of viral mRNA based on the 2’-O methylation status of RNA, that is analogous to 
RIG-I sensing of 5’-ppp RNA (García-Sastre, 2011). Host cell mRNA has a 5’ cap 
which prevents recognition by RIG-I and 5’ exonucleases (as well as promoting 
mRNA stability and RNA translation by ribosomes). The 5’ cap structure is 
methylated at the N7 position of the capping guanosine residue (cap 0), the ribose-2′-
O position of the 5′ penultimate residue (cap 1) and sometimes at adjoining residues 
(cap 2).  Whilst the physiological function of 2’-O methylation unknown, many virus 
families including Flaviviridae, Coronaviridae and Poxviridae encode not only N7-
methyltransferases, but also 2′-O methyltransferases that modify the 5′ end of their 
viral mRNAs. 
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Figure 9. Viruses recognized by RIG-I and MDA5  
S: segmented, NS: non-segmented, ssRNA: single-stranded RNA, dsRNA: double-
stranded RNA, (+): positives sense genome, (−): negative sense genome.  
See text for details. 
 
Figure adapted from (Schlee, 2013). 
 
 
 
. 
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A recent study showed that deficiency of the viral cap N-terminal 2’-O-
methyltransferase by murine hepatitis virus (MHV) provoked recognition by MDA5 
and TLR7 (Züst et al., 2011b).  This study suggested MDA5 mediated  5’ dependent 
RNA recognition. This finding contrasts with studies by Luthra et al., in which MDA5 
stimulatory mRNA was expressed from promoter that supported normal capping 
including N-terminal 2’-O-methylation (Luthra et al., 2011). Later studies on a N-
terminal 2
′ O-methyltransferase-lacking West Nile virus did not reveal a role for 
MDA5 in the recognition of non-methylated cap structures (Szretter et al., 2012), 
suggesting that N terminal 2’-O-methylation does not generally impair MDA5 
engagement.  
 
 
Viral RNA PAMPs generated by ISGs 
 
Interestingly, it has been reported that RIG-I and MDA5 are activated by RNA 
products produced by the RNase L system (Malathi et al., 2007). RNase L, an ISG, is 
an endonuclease that degrades both cellular and viral RNAses and generates short 
fragments with 3’ monophosphates (see section 1.1.5. The generation of the 
Antiviral State by IFN-α/β).  Malathi et al found that both MDA5 and RIG-I induced 
IFN-β upon RNase L activation, dependant on the presence of the 3’ monophosphate 
groups generated by RNase L. A further study by the authors identified that RNase L 
products produced during HCV infection were able to bind to RIG-I and induce IFN-β 
(Malathi et al., 2010). Luthra et al. discovered an mRNA fragment from PIV5 that 
activated type-I IFN expression in a MDA5-dependent manner (Luthra et al., 2011). 
Since type I IFN induction by this RNA required RNase L, the authors concluded that 
RNase L recognises and processes viral mRNA into a MDA5 activating structure.  
 
46 
Viral PAMPs of LGP2   
 
The viral PAMPs that activate LGP2 have yet to be fully characterized. As mentioned 
previously, the CTD of the RIG-I inhibiting helicase LGP2 is closely related to the 
RIG-I CTD (Li et al., 2009b; Pippig et al., 2009).  Similar to RIG-I, LGP2 was reported 
to preferentially bind to blunt ended dsRNA (Li et al., 2009b; Murali et al., 2008; 
Pippig et al., 2009), in a 5′-ppp independent manner.  Amino acids mediating the 
interaction with the 5′ terminal base pair and the ribose backbone are conserved or at 
least functionally related between the RIG-I and the LGP2 CTD, while triphosphate-
interacting amino acids were found to be involved in dsRNA binding of the LGP2 
CTD. Mutation of lyseine amino acids in the LGP2 CTD led to a loss of RNA binding 
but did not impair LGP2-mediated inhibition of RIG-I activation, suggesting a ligand-
independent RIG-I inhibiting mechanism by LGP2 (Li et al., 2009b) 
 
 
1.2.5.  PIV5 Inhibition of IFN mediated responses 
 
To survive in nature all viruses appear to require a strategy to circumvent the IFN 
response. The evasion strategies can be classified as (i) generally inhibiting cellular 
transcription and/or protein synthesis, (ii) specifically inhibiting components of the 
IFN induction or IFN signalling pathways, or (iii) inhibiting IFN-induced factors that 
have antiviral activity (Randall & Goodbourn, 2008).  PIV5 primarily follows the 
second strategy of inhibiting IFN induction and signalling (Figure 10).  It has 
previously been shown that during PIV5 infection of cells in an IFN-induced antiviral 
state, there are significant changes to the localisation and pattern of virus protein 
synthesis and cytoplasmic bodies containing the NP, P and L proteins (Carlos et al., 
2005) and virus genomes (Carlos et al., 2009).  
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Figure 10. RIG-I and MDA5 mediated induction of IFN-α/β  
PIV5 V protein inhibition of IFN induction: 
The PIV5 V protein is able to bind to MDA5, inhibiting its activity.  The V protein acts 
as a competitive inhibitor against MDA5s substrate, viral dsRNA.  The V protein also 
binds to LGP2 and RIG-I, forming a trimeric complex.  As LGP2 is a natural inhibitor 
of RIG-I, the PIV5 V protein mediated trimeric complex leads to the inhibition of RIG-I 
mediated signalling. 
 
PIV5 V protein inhibition of IFN signalling: 
The PIV5 V protein binds to STAT1, targeting it for proteasomal mediated 
degradation. 
 
Figure adapted with permission from an original figure by Andri Vasou, University of 
St Andrews. 
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Under these conditions the virus continues to slowly spread from cell-to-cell despite 
inducing limited amounts of IFN. The IFN induced antiviral state is extremely 
effective at reducing virus replication. However, PIV5 is not eliminated from these 
cells, whereby PIV5 is localised in cytosolic bodies whilst the V protein dismantles 
the antiviral state by the V protein targeting STAT1 for proteolytic degradation 
(Andrejeva et al., 2002; Didcock et al., 1999; Precious et al., 2007; Young et al., 
2000).  Destruction of STAT1 leads to the absence of continuous IFN signalling, in 
which the cell cannot maintain its anti-viral state indefinitely, and eventually normal 
virus replication is established. Nevertheless, the potential of IFN to significantly slow 
virus spread presents a formidable obstacle, and thus the V protein has evolved to 
antagonise IFN induction as acting as a competitive inhibitor of TBK-1 (Lu et al., 
2008) and via inhibition of the PRRs.   
 
 
PIV5 V protein inhibition of MDA5 mediated signalling 
 
The PIV5 V protein  (as well as those of other paramyxoviruses) can limit IFN 
induction by competitively competing with MDA5 ligands and directly binding to 
MDA5, inhibiting its activity (Andrejeva et al., 2004; He et al., 2002; Poole et al., 
2002). The V protein only directly binds to MDA5 and not to RIG-I, whereby MDA5 
mediated activation of the IFN-β promoter was inhibited (Childs et al., 2007; 
Yoneyama et al., 2005) .  The mechanism of action of V inhibition of MDA5 has been 
proposed to involve the inhibition of MDA5 homo-oligomerisation.  As mentioned 
previously, activation of MDA5 by dsRNA requires homo-oligomerisation through its 
helicase domain. Since the V-binding site of MDA5 has been mapped to a stretch of 
residues in its C-terminal helicase domain, the V protein competes with dsRNA 
ligands for MDA5 binding, to inhibit MDA5 oligomerisation (Childs et al., 2007; 2009). 
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PIV5 V protein inhibition of RIG-I mediated signalling 
 
The PIV5 protein inhibits RIG-I mediated induction of IFN by binding to LGP2.   
The PIV5 V protein (as well as those of other paramyxoviruses) interacts directly with 
LGP2 (Parisien et al., 2009). Yeast hybridization studies and co-immunoprecipitation 
studies (Childs et al., 2012b) showed that a complex is formed between V and LGP2, 
and between RIG-I, LGP2 and V, but not between RIG-I and V confirming previous 
results (Childs et al., 2007). LGP2 and the V protein were shown to co-operatively 
inhibit IFN induction via luciferase assays following influenza A infection and with 
induction by artificial RIG-I RNA ligands. The V protein exploits the LGP2 mediated 
inhibition of RIG-I to impede the induction of IFN.   
 
 
Observations on the Induction of IFN by PIV5 and interference by the PIV5 V protein 
 
The current model of IFN induction holds that viruses generate viral RNA PAMPs 
during their normal replication cycle. Seminal studies by Marcus and colleagues in 
the 1970s and 1980s generated a paradigm in which both RNA and DNA viruses 
induced IFN by the production of viral dsRNA (Marcus & Sekellick, 1977; Sekellick & 
Marcus, 1985).  Thus, negative-sense RNA viruses were proposed to generate a 
dsRNA molecule dependent upon transcription, positive-stranded RNA viruses to 
generate a dsRNA molecule via replication, and even DNA viruses were proposed to 
generate dsRNA as a result of convergent transcription that induced IFN.   
 
Further developing this model, it is assumed that the IFN inducing PAMPs generated 
during PIV5 wild-type replication are effectively suppressed by the V protein IFN 
antagonist. This is supported by the observations that PIV5 has been found to 
establish highly productive long term persistent infections in many tissue culture cell 
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lines with only minimal activation of host cell antiviral responses (Choppin, 1964; 
Hsiung, 1972; Young et al., 2007).  In epithelial cells, PIV5 is a poor inducer of IFN, 
where infected cells display very low levels of Type I IFNs and other proinflammatory 
cytokines such as IL-6 (Didcock et al., 1999; He et al., 2002; Poole et al., 2002; 
Wansley & Parks, 2002).  This has further been displayed in primary cultures of 
human epithelial cells (Young & Parks, 2003) and monocyte-derived dendritic cells 
(Arimilli et al., 2006). In addition, further studies were carried out using a PIV5 
recombinant virus called PIV5 VΔC.   PIV5 VΔC makes a non-functional C-terminally 
truncated V fragment.  PIV5 VΔC thus lacks a functional V protein and therefore it 
does not have a functional IFN antagonist.  Infection of cells with PIV5 VΔC 
generated severely reduced plaques compared to the wildtype virus (He et al., 2002; 
Poole et al., 2002). Molecular studies showed that PIV5 VΔC is extremely sensitive 
to the IFN system, being unable to either block IFN signalling or limit IFN production.  
Complicating this picture is that the limited induction of IFN generated during wild-
type virus infections can still exert an antiviral effect that limits viral replication. PIV5 
produces larger plaques on cells that have been engineered to either fail to produce 
or respond to IFN than they do on unmodified IFN-competent cells (Young et al., 
2003). The apparent incomplete block to the IFN system suggests that the PAMPs of 
the PRRs are being produced during virus infection and inducing IFN, and that this is 
a dynamic and complex process.  
 
However, the interactions between wild-type virus PAMPs and the PRRs have not 
been characterised and the corresponding structures have not been reported in the 
literature. To confirm that PIV5 PAMPs were generated from wild-type virus 
replication, the Randall group studied the induction of IFN by PIV5 at the single-cell 
level.  A549 cells expressing GFP under the control of the IFN-β promoter were 
infected with PIV5 VΔC (Killip et al., 2011).  They demonstrated that infection of 
these reporter cells with PIV5 VΔC, strikingly, does not activate the IFN-β promoter in 
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the majority of infected cells, despite the absence of the IFN antagonist. This 
indicates that the viral PAMPs capable of activating the IFN induction cascade are 
not produced or exposed during the normal replication cycle of PIV5, and these 
results suggest instead that another source, such as defective interfering viruses 
generated during virus replication, are primarily responsible for inducing IFN during 
PIV5 infection. 
 
 
1.2.6. Defective Interfering Particles as potential primary inducers 
of Interferon 
 
Defective interfering Particles (DIs) are incomplete copies of the wild type virus 
spontaneously generated during wild type virus replication, due to errors in the viral 
polymerase (Reviewed in (López, 2014).   DIs of negative sense RNA viruses were 
first described for influenza virus in the late 1940s (Magnus, 1947) , and were first 
identified in paramyxoviruses over 30 years ago for SeV and VSV (Kolakofsky, 1976; 
Lazzarini et al., 1981; Leppert, 1977; Perrault, 1981). It has since been found that 
DIs are generated during replication of other paramyxoviruses.   These DIs are 
subgenomic and contain deletions (often extensive) that render the virus unable to 
complete a full replication cycle by themselves in the absence of co-infecting, wild 
type non-defective, “helper” viruses.  Just as for their respective wild type genomes, 
SeV and VSV DI genomic replication follows the “rule of six”, whereby for efficient 
replication the genome length is a multiple of 6 (Calain & Roux, 1993; Pattnaik et al., 
1992).  For PIV5 DIs, the rule of six is optimal but not essential for efficient DI 
replication (Murphy & Parks, 1997). The replicated DI RNAs were shown to 
assemble into virus particles. 
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DIs efficiently inhibit the replication of non-defective genomes due to the replicative 
advantage conferred by their smaller genome size, or through successful competition 
for viral or host factors that are required for genome replication.   DI genomes have 
therefore the ability to successfully compete with their helper non-defective genomes 
for the viral replication substrates provided by the latter; hence, they are also 
“interfering” (Kolakofsky, 1979; Lazzarini et al., 1981; Leppert, 1977; Perrault, 1981; 
Wu et al., 1986)  Further to this, a characteristic feature of DI particles is their 
emergence and outgrowth during high multiplicities of infection (MOI), where 
numerous copies of the wild type non-defective virus infect each host cell. Ecological 
models of predator-prey behaviour have been proposed and examined to describe 
the kinetics of paramyxoviruses and influenza A virus DI particle populations in 
relation to non-defective virus genomes (Bangham, 1990; Thompson & Yin, 2010) 
(Kirkwood & Bangham, 1994; Frank, 2000; Frensing et al., 2013; Nelson & Perelson, 
1995; Szathmáry, 1992; 1993).  Under such conditions “predator” DI particles can 
productively utilize the resources such as NP and viral RNA polymerase of “prey” 
non-defective viruses.  DI genomes invariably accumulate in the cell, whereby the DI 
levels reach a tipping point whereby no viral substrates are available due to the lack 
of non-defective virus being replicated. As a result DI levels rapidly decrease or 
“crash” until enough non-defective virus genomes have been replicated, whereby the 
cycle repeats itself.  
 
Four potential DI genomes can be generated for PIV5 and paramyxoviruses from 
either or both from the genome strand or the antigenome strand during replication 
(Figure 11, Figure 12).  Firstly, DI genomes are generated that have extensive 
internal deletions between the 5’ and 3’ terminus (Figure 11i).   Internal deletion DIs 
are essentially truncated versions of the wild type virus genome that usually share 
the 3’ and 5’ termini with the wild type virus. They retain the leader and trailer 
sequences of the genome and therefore possess transcription and replication signals 
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and have been shown to generate viral translation products (Hsu et al., 1985) (Re & 
Kingsbury, 1986). Internal deletion DIs are generated when the viral polymerase falls 
off the original template and reattaches further downstream, resulting in a genomic 
deletion. A second form of the internal deletion DIs comprises an authentic 5′ 
terminus and an inverted repeat of the same terminus at the 3’ end (Figure 11ii).  
 
Copyback DIs (Figure 11iii, iv) comprise of a segment of the viral genome flanked 
by reverse complementary versions of its 5’ terminus. Copybacks occur when the 
viral polymerase detaches from the template and reattaches to the newly 
synthesizing strand, copying back the 5’ terminus end of the genome.  In the 
absence of nucleoproteins that would prevent base pairing, the copyback DI RNA 
can form a panhandle structure, formed by the authentic 5’ terminus complementary 
binding to the corresponding bases of the inverted 3’ terminus (Figure 11iv).  The 
panhandle structure thus consists of a short complementary stem region and a loop 
region.  5’ leader copyback DIs are formed during replication from the genomic 
strand, with complementary 5′–3′ ends. Similarly, a 3’ trailer copyback DI can be 
generated from the antigenomic strand as well.  Given the prevalence of DIs that are 
generated during wild type virus replication, it is unsurprising that it has been found 
that DIs interact and influence the host innate immune response.   
 
 
DIs and the induction of IFN-β 
 
Various groups have characterised some of the interactions between DIs and the 
induction of IFN-β.  Strahle et al infected HEK293 IFN-β promoter reporter cells with 
SeV stocks containing DI copybacks, and found that the presence of DI copybacks 
correlated with that of the activation of the IFN-β promoter (Strahle et al., 2006).  
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Figure 11.  Schematic of the different types of DI RNA (not to scale).  
The virus genome is shown at the top with terminal sequences containing the 
replication signals labelled at the 5′ terminus (a) and at the 3′ terminus (g). The 
remainder of the genome is arbitrarily divided into sections to indicate the possible 
origin of some of the DI RNA sequences.  
 
Section (i): Internal Deletion 
Section (ii): Internal Deletion with inverted repeat (a’) of the 5’ (a) sequence. 
Section (iii): Copyback DIs 
Section (iv): Copyback DI with panhandle “loop” structure 
 
See text for details of sections i to iv. 
 
Figure taken from (Dimmock and Easton, 2014) 
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Figure 12.  PIV5 potential DIs 
 Le copybacks, Tr copybacks and internal deletion DIs are spontaneously generated 
during wild type virus replication due to errors by the viral polymerase.  PIV5 DIs can 
potentially be generated from either or both from the genome strand and the 
antigenomic strand.   See text for details.   
 
Figure modified from an original figure supplied generously by Rick Randall, 
University of St Andrews. 
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The level of IFN-β activation was found to be proportional to that of DI genome 
replication and to the ratio of DI to non-defective genomes during infection.  Another 
group showed this using the same system for infections with DI rich stocks of VSV 
(Panda et al., 2010).  It was found that DI rich stocks not only upregulated the 
induction of IFN-β, but also upregulated IFN-β signalling via the ISRE promoter.  
Further studies by Strahle et al. have correlated Sendai virus (SeV) induced RIG-I 
activation with the occurrence of copyback DI genomes (Strahle et al., 2007).  The 
copybacks that are generated during infection are not always encapsidated, and are 
thus able to form the snapback panhandle structures in infected cells.  In 
concordance with this data, by applying a deep sequencing approach after 
purification of RNA attached to RIG-I from SeV infected cells, Baum et al. determined 
preferred binding of DI genomes to RIG-I (Baum et al., 2010). Similarly to RIG-I, 
Yount et al. has demonstrated that MDA5 can detect SeV DI particles in vitro.  The 
authors created a dendritic cell line which constitutively expresses the SeV V protein 
(DC2.4), a viral antagonist that inhibits MDA5 (but does not inhibit RIG-I).  Using 
QPCR to detect levels of IFN-β, it was found that infection of DC2.4 and of dendritic 
MDA5 knockout cells with a SeV DI enriched stock, displayed decreased levels of 
IFN-β compared to naïve dendritic cells.  In all of the studies mentioned previously, it 
was found that the DIs normally generated during wild-type virus replication for VSV 
and SeV were copyback DIs.  Furthermore, infection with stocks enriched for 
copyback DIs were found to be far greater inducers of IFN-β than infection with 
internal deletion DI enriched stocks. Clearly, there is an interplay between copyback 
DIs, the PRRs and the induction of IFN-β, which remains to be fully elucidated. 
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Characterizing PIV5 DIs 
 
This project uses PIV5 as a model for other paramyxovirus infections.  In order to 
investigate the mechanisms by which DIs interact with the PRRs and induce IFN-β, it 
is first necessary to characterise the specific types of DIs generated during PIV5 (wt) 
replication.  PIV5 has the potential to generate leader copybacks, trailer copybacks 
and internal deletion DIs during virus replication (Figure 12).   Killip et al. 
investigated the types of DIs produced during high MOI passages of PIV5 (wt) and of 
PIV5 VΔC (Killip et al., 2013).   Sequential high MOI passages are referred to as 
VM1, VM2, etc., after Von Magnus (Magnus, 1947). PIV5 VΔC DI rich preparations 
(PIV5 VΔC VM2)  are utilised as they have been previously been shown to be 
efficient inducers of IFN-β (Chen et al., 2010; Killip et al., 2011).  Furthermore, PIV5 
VΔC VM2 DIs can be readily detected as opposed to infections with non-DI enriched 
stocks of PIV5 VΔC VM0 and PIV5 (wt) VM0. Preparations of PIV5 that are enriched 
for DIs are generated by high multiplicity passage in Vero cells (that do not produce 
IFN) in order to accumulate DI genomes. Nucleocapsid RNA from these virus 
preparations was extracted and subjected to deep sequencing. Sequencing data 
were analysed using methods designed to detect internal deletion and copyback DIs, 
in order to identify and determine which species of DIs were most abundant (Figure 
13).   
 
Deep sequencing analysis of RNA extracted from PIV5 (wt) VM12 infected cells 
showed that the vast majority of DIs generated during high MOI passaging at VM12 
are trailer copybacks (Figure 13B). For PIV5 VΔC, the generation of DI enriched 
preparations was much quicker, at VM2 (Figure 13A).  
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Figure 13.   Deep sequencing analyses of RNA isolated from Vero cells infected 
with PIV5 DI enriched preparations. 
Viral RNPs were extracted from Vero cells infected with PIV5 VΔC VM0 and VM2. 
Associated RNA was subjected to deep sequencing using the Illumina GA2x 
platform, and sequencing reads were mapped to the PIV5 VΔC (A) or the PIV5 (wt) 
reference genome. The frequency of reads at each nucleotide is shown in red for 
VM0 virus preparations and in black for the DI rich virus preparations PIV5 VΔC VM2 
(A) and PIV5 (wt) VM12 (B). Coverage from nt 14000 to 15246 is shown as an inset 
in order to highlight the peaks at the 5′ end of the genome. See text for details. 
 
Figure taken from (Killip et al., 2013). 
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The V protein itself may play a role in regulating DI generation, leading to PIV5 VΔC 
accumulating DIs at a higher rate than PIV5 (wt). Like PIV5 (wt) VM12, the vast 
majority of PIV5 VΔC VM2 DIs are trailer copybacks. That the majority of DIs found 
are trailer copybacks reflects the need for the 3’ antigenomic promoter to be stronger 
than the 3’ genomic promoter (which directs antigenome synthesis and transcription), 
reflecting the requirement of the virus to generate greater numbers of genomes for 
virus assembly than antigenomes.   
 
Killip et al. identified a range of distinct trailer copybacks, and these varied 
considerably in the site of the copyback error, the length of the predicted dsRNA 
stem, and the size of the DI genome. Furthermore, no major trailer copyback species 
were detected that were present in both PIV5 (wt) and PIV5 VΔC DI rich 
preparations.  
 
The lack of conserved copyback points suggested that there is no particular part of 
the trailer in which a template switching error is substantially more likely to occur.   
In addition, during PIV5 (wt) VM12 infections, and during co-infections of PIV5 (wt) 
vM0 and DI rich virus preparations it was found that interference from co-infecting DI 
trailer copybacks impaired the replication of non-defective PIV5 (wt), consistent with 
previous findings for SeV, Influenza A and VSV as mentioned previously. These 
previous studies have been conducted with virus preparations at high MOI infections. 
The disadvantage of this method is that even with infection with stocks not enriched 
for DIs, it is still possible for DIs to be present in these stocks and co-infect with wild 
type viruses during a high MOI infection.  In order to determine the impact of DIs 
generated exclusively during infection and replication, a low MOI infection needs to 
be carried out in which the initial infection is only by a wild type non-defective virus.  
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Features of the PIV5 Trailer copyback DI 
 
The PIV5 trailer copyback is generated due to template switching of the viral RNA 
polymerase from the antigenome to the nascent strand during synthesis of genomic 
RNA (Figure 14).  The viral RNA polymerase thus uses the nascent genomic strand 
as the template for further RNA synthesis.  The 3′- genomic promoter in trailer 
copyback DI genome has been replaced by a sequence complementary to the 5′ 
antigenomic promoter of the termini of the DI trailer copyback. These complementary 
sequences are able to bind together and form a dsRNA stem-loop structure when 
SDS treatment is used to dissociate the RNA genomes from encapsidating NP 
protein (Kolakofsky, 1976).  It is this structure that is thought to be responsible for the 
ability of DI trailer copybacks to act as potent inducers of IFN (Baum et al., 2010; 
Killip et al., 2011; Shingai et al., 2007; Strahle et al., 2006).   The substitution of the 
weak genomic promoter for the stronger antigenomic promoter in DI trailer copyback 
genomes additionally confers a significant replicative advantage over non-defective 
virus genomes, and this leads to their accumulation in virus stocks that are 
generated at high multiplicity.   
 
 
1.2.7. Investigating PIV5 DIs: The A549 pr/(IFN-β).GFP Reporter cell line 
 
 
 
To enable examination of IFN-β promoter activation by PIV5 DI rich and non-DI rich 
preparations, we can use the A549 pr/(IFN-β).GFP reporter cell line that was 
developed and characterised by Shu Chen to follow the dynamics of IFN induction 
(Figure 15A). A549 pr/(IFN-β).GFP reporter cells express green fluorescent protein 
(GFP) under the control of the IFN-β promoter.  A549 naïve cells were infected with a 
lentivrus containing the pdl′pIFNβ′GFP plasmid, and subsequently underwent 
selection.  
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Figure 14.  Generation of the PIV5 Trailer copyback DI. 
1) Wild Type Replication  
- Replication occurs normally by the viral RNA polymerase 
- Full length Genomic strand is generated from the antigenomic template  
 
2) Generation of  PIV5 Trailer copyback DI 
- The vRNA polymerase switches templates from the original antigenomic 
template to the nascent formed genomic strand 
- The vRNA polymerase uses the nascent genomic strand as the template 
- An antigenomic sequence that is complementary to the genomic template is 
generated.  The antigenomic sequence binds to the corresponding nts on the 
genomic sequence forming a stem structure and a loop.    
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Figure 15.  The A549 pr/(IFN-β).GFP reporter cell line 
A) In the A549/pr(IFN-β).GFP reporter cell line (Naïve reporter cells), GFP 
expression is under the control of the IFN-β promoter 
B) Confluent monolayers of Naive reporter cells were grown in 60 mm dishes 
that contained coverslips and infected at MOI 10 with MuV(ori). At 8hrs p.i. 
the coverslips were fixed and those cells expressing GFP visualised using a 
Nikon Microphot-FXA fluorescence microscope. 
C) Naive reporter cells were infected with MuV (Ori) at MOI 10.  At 8hrs p.i. cells 
were trypsinised to a single cell suspension and the percentage of GFP+ve 
cells estimated by flow cytometry analysis. 
 
See text for details. 
 
Figure modified from (Chen et al., 2010)  
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The resulting cells were screened for their ability to express GFP following infection 
with a stock of MuV that contains a high number of DIs that is a good inducer of IFN-
β (Figure 15B).  At 8 hours p.i. 90% of the cells were strongly positive for GFP, 
indicating that the vast majority of cells were able to respond to the presence of a 
PAMP.   Flow cytometry analysis of MuV infected cells showed that a discrete 
population of cells were strongly positive for GFP expression, as opposed to there 
being a gradient of GFP expression.   This suggests that the IFN-β promoter is either 
‘on’ or ‘off’ in infected cells (Figure 15C). In conclusion, the expression of GFP 
under the control of the IFN-β promoter in the A549 pr/(IFN-β).GFP reporter cell line 
(referred to as naïve reporter cells from now on), is a reliable marker to identify cells 
that are positive for activation of IFN-β induction and it has been shown that these 
cells faithfully report activation of the IFN-β induction cascade (Chen et al., 2010; 
Killip et al., 2011). 
 
 
1.3.  Aims 
 
This thesis firstly investigates the nature of the host cellular IFN-β response to virus 
challenge by negative strand viruses.  Secondly, the roles of the PRRs RIG-I, MDA5 
and LGP2 in the induction of IFN-β following infection with negative strand viruses 
are investigated.  Thirdly, PIV5 DIs generated during virus replication are 
investigated in their role as potential PAMPs of the cytosol PRRs RIG-I, MDA5 and 
LGP2, and the subsequent activation of the IFN-β promoter and induction of IFN-β.  
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2. MATERIALS and METHODS 
 
2.1.  Mammalian Cells and Tissue Culture 
 
2.1.1.  Cell lines used in this Study 
 
A549 cells 
A549 cells are human lung carcinoma cells routinely used to study paramyxovirus 
and Influenza A virus infection of the respiratory tract (European Collection of Cell 
Cultures (ECACC)). 
 
 
A549 Npro cells 
A549 cells expressing the Npro protein of BVDV. 
 
 
A549/pr(IFN-β).GFP reporter cell line  
With the A549/pr(IFN-β).GFP reporter cell line (Naïve reporter cells), GFP expression 
is under the control of the IFN-β promoter.  Cell line originally generated by Shu 
Chen, University of St Andrews. 
 
 
A549 pr/(IFN-β).GFP RIG-I Knock Down cell line 
A549 pr/(IFN-β).GFP RIG-I Knock Down cell line (RIG-I KD reporter cells) expresses 
shRNA that knocks down RIG-I. Cell line originally generated by Shu Chen, 
University of St Andrews. 
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A549 pr/(IFN-β).GFP MDA5 Knock Down cell line 
A549 pr/(IFN-β).GFP MDA5 Knock Down cell line (MDA5 KD reporter cells) 
expresses shRNA that knocks down MDA5.  Cell line originally generated by Shu 
Chen, University of St Andrews. 
 
 
A549 pr/(IFN-β).GFP LGP2 Knock Down cell line 
A549 pr/(IFN-β).GFP LGP2 Knock Down cell line (LGP2 KD reporter cells) expresses 
shRNA that knocks down MDA5.  Cell line generated by the author. 
 
 
A549 pr/(IFN-β).GFP ISG56 Knock Down cell line  
A549 pr/(IFN-β).GFP ISG56 Knock Down cell line (ISG56 KD reporter cells) 
expresses shRNA that knocks down MDA5. Provided by Lena Andrejeva, University 
of St Andrews. 
 
 
HEK293T:  
A highly transfectable derivative of the human embryonic kidney 293 
Cell line, constitutively expressing the SV40 large T-antigen.  Provided by Prof. R. 
Iggo, University of St Andrews. 
 
 
MDCK  
Canine kidney cells (ECACC). 
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Vero 
Fibroblast-like cells established from the kidney of an African Green monkey (ICN 
Pharmaceuticals Ltd.). 
 
 
2.1.2.  Cell Maintenance 
 
Cell monolayers were maintained in 25cm2 or 75cm2 tissue culture flasks (Greiner) in 
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) supplemented with 10% 
(v/v) heat-inactivated foetal calf serum (FCS; Biowest) and incubated at 37oC/ 5% 
CO2. Cells were routinely passaged using trypsin/ethylenediaminetetraacetic acid 
(EDTA; Becton Dickinson Ltd.), and passed every 3-5 days as appropriate. 
 
 
2.1.3.  Cell line stock storage and resuscitation   
 
Adherent cells were trypsinised, resuspended in DMEM/10% FCS, and centrifuged at 
1000rpm for 5mins. Pelleted cells were resuspended in DMEM supplemented with 
20% FCS and 10% (v/v) dimethyl sulfoxide (DMSO) and aliquoted into cryovials. Cell 
stocks were frozen at -70oC, to slow down the temperature decrease, before long-
term storage in liquid nitrogen. For resuscitation of cells, cryovials were thawed at 
37oC before centrifugation at 1000rpm. Pelleted cells were then resuspended and 
grown in DMEM/10% FCS at 37oC/ 5% CO2. Medium was replaced after 24 hours in 
order to remove traces of DMSO. 
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2.1.4.  Treatment of cells 
 
IFN treatment 
 
Cells were treated overnight (at least 16 hours, unless where otherwise stated) with 
media supplemented with Roferon A recombinant human IFN-α-2a (Roche 
Diagnostics) at a concentration of 1000 units/ml in DMEM/10% FCS. 
 
Z-VAD-FMK  
 
Samples were treated with with Z-VAD-FMK Caspase family inhibitor (Enzo Life 
Sciences) at 100μM final concentration per sample.  This was carried out at the 
same time as the infection of cells. 
 
 
Transfections with plasmid DNA 
 
Transfection of cells with plasmid DNA was carried out using FuGENE 6 transfection 
reagent (Roche) according to the manufacturer’s instructions. 
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2.2.  Viruses and virus infections 
 
2.2.1.  Viruses used in this study 
 
PIV5 (wt) 
 
Two original PIV5 isolates were isolated from rhesus and cynomolgus monkey 
kidney cell cultures and are referred to as WR and W3A (or W3) as wild-type (wt) 
viruses.  
 
 
PIV5 VΔC 
 
A mutant strain of PIV5 wt (W3A) has been isolated from a recombinant PIV5 (rSV5) 
which has deletions at the V protein specific C-terminal cysteine-rich domain (VΔC). 
This virus is unable to block IFN production or signalling. 
 
 
PIV5 VΔC VM2 and defective interfering particles 
PIV5 VΔC VM2 was generated from the original PIV5 VΔC stock by passaging PIV5 
VΔC twice at a high MOI in confluent Vero cells   This was performed in order to 
increase the ratio of defective interfering particles to non-defective virus within the 
virus population. Virus stocks kindly supplied by Dan Young (University of St 
Andrews, UK).  
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PIV2 (wt) 
 
Parainfluenza virus 2 wild-type strain. 
 
 
PIV3 (rwt) 
 
Parainfluenza virus 3 recombinant wild-type strain. 
 
 
Influenza A (Udorn) 
 
Recombinant wild-type influenza A virus (A/Udorn/72; H3N2), provided by David 
Jackson (University of St Andrews, UK). 
 
 
Bunyamwera Virus (wt) 
 
Wild-type strain kindly provided by Richard Elliott. 
 
 
2.2.2.  Preparation of Virus stocks 
 
PIV5 (wt), PIV3 (rwt), PIV2 (wt) 
 
Vero cells at 90% confluency were infected with the virus master stock 
(prepared by Dan Young) and incubated at 37°C and 5% CO2 until the  
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cytopathic effect was visible in the monolayer. Subsequently, the supernatant was 
harvested and centrifuged at 2000rpm for 5 minutes to remove cellular debris. The 
supernatant was then used to infect larger monolayers grown in roller bottles. Cells 
were incubated with the virus inoculum on a rolling platform for 1-2 hours at 37oC 
before it was replaced with fresh DMEM supplemented with 2% FCS. When fusion 
could be detected in the cell monolayer (approximately two days later), the 
supernatant was harvested and centrifuged to precipitate cell debris, aliquoted into 
cryovials and stored at -70oC. 
 
 
Other Virus stocks 
 
Stocks of PIV5 VΔC VM0 and PIV5 VΔC VM2 were maintained and kindly provided 
by Dan Young (University of St Andrews, UK). 
 
Stocks of BUNV (wt) were maintained and kindly provided by Richard Elliott. 
 
 
2.2.3.  Virus infection  
 
To infect with paramyxovirus isolates, monolayers were inoculated with virus diluted 
in DMEM supplemented with 2% FCS (with the exception of PIV3 (rwt) with no FCS) 
at an appropriate multiplicity of infection (MOI), or DMEM only (for mock infections). 
For virus infections in 6-well plates, cells were inoculated in a volume of 1ml per well 
and placed on a rocking platform at 37°C for an adsorption period of 1-2 hours. 
Inoculations in 96-well plates were carried out without rocking in a volume of 50μl per 
well. Virus inoculum was then removed and replaced with DMEM/ 2% FCS. Cells 
were incubated at 37°C/ 5% CO2 until harvested. 
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Influenza A (Udorn) infections were carried out in serum-free DMEM. Monolayers 
were washed in DMEM prior to infection to remove all traces of serum. Cell 
monolayers were infected with 400μl virus (per well of a 6-well plate) diluted in 
serum-free DMEM at an appropriate MOI (or DMEM only for mock infections). Cells 
were incubated for 1hr at 37°C, with gentle agitation at regular intervals. Inoculations 
in 96-well plate were carried out as for paramyxoviruses (see above). Virus inoculum 
was removed and replaced with serum-free DMEM. Cells were incubated at 37°C/ 
5% CO2 until harvested. 
 
 
2.2.4.  Virus Titration 
 
To titrate paramyxovirus isolates, Vero cells were grown in 6-well plates (Greiner, 
UK) until 80-90% confluent. Cells were incubated with 10-fold dilutions of virus and 
DMEM containing 2% FCS (1 ml/well). After 1 hour on a rocking platform at 37oC  the 
inoculum was removed and 5-7 ml of medium overlay (0.5% Methicel; 
Sigma-Aldrich) was added to each well. Cells were incubated at 37oC and 
5% CO2 for 10-12 days until plaques had formed in the monolayer. The overlay was 
then aspirated and plaques were fixed with 5% formaldehyde in PBS for 10-15 
minutes. Plaques were stained with crystal violet (0.1% crystal violet, 3.6% 
formaldehyde, 1% methanol, 20% ethanol in H2O). Virus titres were then estimated in 
pfu/ml, taking into account the original dilutions made. 
 
Titration of influenza A (Udorn) was carried out on confluent MDCK monolayers in 6-
well plates.  Cells were washed twice in serum-free DMEM in order to remove all 
traces of serum. Virus preparations were serially diluted 10-fold in serum-free 
DMEM, and cells were inoculated with 400µl of each virus dilution per well. Cells 
were incubated at 37°C/ 5% CO2 and plates were agitated every 10 minutes to 
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ensure even adsorption of the virus. During this period, 2x overlay medium (13.4g 
DMEM/3.7g NaHCO3 per 485ml water supplemented with 4µg/ml NAT) was 
incubated at 37°C. 2% agarose in water was melted and placed in a 55°C water bath 
until required. After an adsorption period of 1 hour, virus inoculum was removed, the 
2x overlay medium and the 2% agarose (Biogene Ltd.) were mixed in a 1:1 ratio, and 
2ml of this was added to each well. After the overlay had set, plates were inverted 
and incubated at 37°C/5% CO2 until distinct plaques had formed (~3 days). Cells 
were fixed by adding 2ml PBS/5% formaldehyde/ 2% sucrose on top of the agarose 
plugs, and the monolayers were left to fix overnight. Agarose plugs were then 
removed and plaques were stained with crystal violet. 
 
 
2.3.  Plasmid DNAs 
 
2.3.1.  Plasmids used in this study 
 
pJET-PIV5-A1/C 
 
This plasmid encodes the PIV5 VΔC VM2 Large DI, present at the highest proportion 
of total DIs following detection by deep sequencing of high MOI passages of PIV5 
VΔC  (Killip et al., 2013).  The Large DI A1/C primer PCR product is 965bps in size.  
The plasmid was generated by Craig Ross, Goodbourn group, St George’s Hospital. 
Medical School. 
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pJET-PIV5-A3/C 
 
This plasmid encodes the Small DI, present as the second highest proportion of DIs 
following detection by deep sequencing of high MOI passages of PIV5 VΔC (Killip et 
al., 2013).  The Small DI A3/C PCR product is 220bp in size. The plasmid was 
generated by Craig Ross, Goodbourn group, St George’s Hospital. Medical School. 
 
pCAGGS-PIV5-NP 
 
The pCAGG-PIV5-NP plasmid encodes the full length NP of PIV5.  This plasmid was 
kindly donated by Dr. Lena Andrejeva, University of St Andrews. 
 
 
pCMVR8.91  
 
Plasmid expressing the gag/pol, tat and rev genes of HIV-1 (used in lentivirus 
production, provided by Y.-H. Chen). 
 
 
pMD-G  
 
Plasmid expressing the vesicular stomatitis virus glycoprotein (VSV-G) gene (used in 
lentivirus production, provided by Y.-H.Chen). 
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pdlNOTI MCS R-IRF3 
 
IRF3 is under the control and driven by the SFFV promoter. 
 
 
p.LKO.1-puro shRNA LGP2 
 
LKO.1-puro plasmid expressing a shRNA against human LGP2 kindly provided by 
Prof. Steve Goodbourn, originally purchased from Sigma-Aldrich. 
 
 
2.3.2.  Generation of plasmid stocks 
 
E. coli DH5α cells were grown in Luria-Bertani (LB) medium (10g/l bacto-tryptone, 
5g/l yeast extract, 10mM NaCl, pH 7.5), or plated on solid LB medium supplemented 
with 1.5% (w/v) agar and 10mM MgSO4. As appropriate, media was supplemented 
with ampicillin (100 µg/ml) for selection. 
 
 
Transformation of competent cells 
 
1μg plasmid was added directly to 100μl of thawed, competent cells (Invitrogen). 
After incubation on ice for 1h, cells were transferred to a 42oC water bath for 2mins 
before being immediately returned to ice for a further 2mins. Cells were resuspended 
in 1ml LB broth and incubated at 37oC for 1h. The cell suspension was plated out 
onto LB-agar plates supplemented with ampicillin (90 mm-diameter Petri dishes; 
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Scientific Laboratory Supplies Ltd., U.K.). Plates were inverted and incubated at 37oC 
overnight. Mini-cultures were prepared from selected colonies. 
 
 
Preparation of plasmid DNA 
 
To produce large scale plasmid DNA preparations, 100ml of bacterial culture was 
grown overnight in a 37oC shaking incubator. DNA was extracted from cells using the 
QIAfilter Plasmid Maxi-Prep Kit (according to the manufacturer’s instructions; 
QIAGEN). 
 
 
2.3.3.  Measurement of Plasmid concentration 
 
The concentration of plasmid DNA was quantified by measurement of Abs260 using a 
NanoDrop ND-1000 spectrophotometer (Thermo Scientific). DNA purity was 
estimated by calculating the Abs260/Abs280 ratio. Ratios greater than 1.8 were 
considered acceptable. 
 
 
2.4.  Lentivirus generation of transient cell lines 
 
The pdlNOTI MCS R-IRF3 plasmid was transfected using FuGENE 6 transfection 
reagent following the standard Promega protocol.  Mock cells were transfected with 
an empty vector.   48 hours post-transfection, cells were trypsinised and fixed with 
5% formaldehyde/ PBS in suspension, before resuspension in suspension solution 
(5% FCS/ PBS).  Cells were then analysed by flow cytometry for GFP expression. 
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2.5.  Lentivirus generation of stable cell lines 
  
Lentivirus Production 
 
To generate recombinant lentivirus, a 75 cm2 tissue culture flask HEK293T cells 
(70% confluent) was co-transfected with three plasmids: 3μg pCMVR8.91, 3μg pMD-
G, and 5μg of the pdl vector containing the construct of interest. Supernatants were 
harvested at 48 hours and 72 hours post-transfection and pooled. Cellular debris was 
removed by centrifugation at 3,000xg for 10mins and filtering through 0.45μm Tuffryn 
membrane filters (Invitrogen). Virus aliquots were stored at -70oC until required. 
 
 
Transduction 
 
30% confluent target cell monolayers (25cm2 flask) were infected with the harvested 
lentivirus supernatant (estimated MOI of 1 pfu/cell) in the presence of polybrene 
(8µg/ml; Sigma-Aldrich). 48 hour post-infection, transformed cells were selected by 
resistance to puromycin (Invivogen); MRC5 cells, 1µg/ml; A549 cells 
2µg/ml. Puromycin-containing medium was replaced every four days until control 
naïve cells were dead. Cells were kept under continuous selection with puromycin. 
 
 
Subcloning 
 
Subcloning was required to generate LGP2 KD reporter cell line. Cells were 
trypsinised, counted using a haemocytometer, and diluted to around 1 cell/100µl in 
DMEM (10%FCS), and plated into 96-well microtitre plates (Greiner Bio-One, UK). 
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To compensate for mis-counting, cells were also diluted to 3 cells/100µl, and 1 cell/ 
300µl, and plated into 96-well microtitre plates. Cells were normally cultured, 
replacing growth medium every 3-7 days, and observed under the microscope to pick 
single cell colonies growing in single wells. The cells from selected wells were 
trypsinised, and passed into either a 24-well microtitre plate (Nunc A/S, Denmark) or 
25cm2 tissue culture flask according to the growth rate and cell number. When 
enough cells were obtained from single cell colonies, candidate was tested via 
endpoint PCR for LGP2 mRNA expression. Colonies which showed most knock 
down of LGP2 were then frozen in DMEM (30% FCS, 10% DMSO) at either -70°C, or 
in liquid nitrogen for long-term storage. 
 
 
2.6. Antibodies 
 
2.6.1. Primary antibodies 
 
Mouse Monoclonals 
 
PIV5-NP-a; PIV5 NP;  (Randall et al., 1987) 
PIV5-HN-4a; PIB5 HN; (Randall et al., 1987) 
PIV2; NP; Dan Young, University of St Andrews   
PIV3: NP; Dan Young , University of St Andrews 
MxA; a kind gift from Otto Haller, University of Freiburg, Germany, 
β-actin; Sigma-Aldrich 
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Other Antibodies 
 
Bun 592; Rabbit polyclonal Ab; Bun N; Kindly provided by Prof. Richard Elliott 
(University of St. Andrews)  
  
α-X31 (H3N2, Udorn); Sheep Polyclonal Ab; A kind gift from A. Douglas, National 
(Institute for Medical Research, London) 
 
 
2.6.2.  Secondary antibodies 
 
Anti-mouse, rabbit and sheep IgG Texas Red were from Oxford Biotechnology.  
 
Phycoerythrin (PE) and Cy5 were supplied by Abcam. 
 
Horseradish peroxidase (HRP)-conjugated anti-mouse IgG was supplied by Sigma-
Aldrich. 
 
 
2.7.  Protein analysis 
 
2.7.1.  SDS-polyacrylamide gel electrophoresis 
 
Mammalian cells were lysed by adding disruption buffer (6M Urea, 4% 
(w/v) SDS, 2M β-mercaptoethanol coloured with bromophenol blue). 
Lysates were sonicated (15 seconds) to reduce viscosity and proteins were 
separated on 4-12% NuPAGE polyacrylamide gradient gels (Invitrogen) by 
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electrophoresis at 170V, 1 hour in MOPS [3-(N-morpholino) propanesulphonic acid] 
buffer (Invitrogen). 
 
 
2.7.2.  Immunoblotting 
 
Proteins were separated by SDS-PAGE as described above and transferred to a 
polyvinylidene difluoride (PVDF) membrane using the XCell II Blot Module according 
to the manufacturer’s instructions (Invitrogen). The membranes were then incubated 
for 30 minutes  in blocking buffer (5% (w/v) skimmed milk powder 0.1% Tween 20 in 
PBS ), followed by a further incubation for 1 hour to overnight with primary antibody 
diluted in blocking buffer. After three washes with 0.1% Tween 20 in PBS, 
membranes were incubated with secondary antibody conjugated with HRP for 1 to 3 
hours. This was followed by washing again with 0.1% Tween 20 in PBS before 
proteins were detected using ECL Plus Western Blotting Detection Reagents (GE 
Healthcare). Membranes were then exposed to Kodak XOmat film. 
 
 
2.8.  Cell/virus Visualisation techniques 
 
2.8.1.  Immunofluorescence Microscopy 
 
Cells were grown on 10mm coverslips and were fixed for 10mins in 5% 
formaldehyde/ 2% sucrose/ PBS then permeabilised with 0.5% NP-40/10% 
sucrose/PBS. Non-specific binding sites were blocked for at least 30 min with PBS/ 
1% FCS/ 0.1% sodium azide, then monolayers were incubated with appropriately 
diluted primary antibody for 1 hour (10%FCS/PBS). Unbound antibody was washed 
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away with PBS, and cells were incubated for 1 hour with Texas Red (routine Nikon 
Microscopy) or PE conjugated secondary antibody (confocal microscopy) (Oxford 
Biotechnology Ltd., U.K.) in 10%FCS/ PBS solution.  
 
If staining of the nucleus was required, the DNA-binding fluorochrome 4', 6-
diamidino-2-phenylindole (DAPI; 0.5 µg/ml; Sigma Aldrich) was also added to this 
solution at 1/500. Coverslips were washed in PBS, fixed again in 5% formaldehyde/ 
2% sucrose/ PBS and mounted on slides using Citifluor AF-1 mounting solution 
(Nikon microscopy) or Prolong Gold; Fermentas (confocal microscopy). All reactions 
were performed at room temperature in a humidified chamber. Immunofluorescence 
was visualised using a Nikon Microphot-FXA microscope or Zeiss Pascal Meta 510 
Confocal Imaging system. 
 
 
2.8.2.  Immunostaining of Viral Plaque Assays 
 
Fixed monolayers were permeabilised (0.5% IGEPAL, 10% sucrose/ 0.1% 
sodium azide in PBS) for 15 min, and then incubated in PBS supplemented with 1% 
FCS for 1 hour. Monolayers were incubated for 1 hour at room-temperature with 
500µl/well of diluted (1/2000) primary antisera; diluted in PBS/10% FCS. Cells were 
washed with PBS/0.1% TWEEN, and monolayers were subsequently incubated for 
1h at room-temperature with 500µl/well of the appropriate diluted (1/2000) secondary 
IgG alkaline phosphatase (AP)-conjugated antibody. Monolayers were subsequently 
washed with PBS/0.1% TWEEN, and incubated with 500µl/well of alkaline 
phosphatase substrate (as per manufacturer's instructions; Sigma-Aldrich) until 
plaques were easily visualised. Monolayers were rinsed with water in order to stop 
the reaction. 
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2.9.  Flow cytometry analysis 
 
2.9.1.  Monostaining reporter cells  
 
Following treatment/infection in a T25cm2 flask, cells were trypsinised to a single cell 
suspension, fixed and permeabilised as for immunofluorescence, and 
immunostained with the mAbs.  Viral NP was secondary stained with PE.  Following 
immunostaining, cells were resuspended in 2% FCS/ PBS in BD Falcon 5ml 
polystyrene round bottom tubes. The percentage of fluorescent cells, and intensity of 
their fluorescence in 10,000 events was determined by using the LYSYS programme 
on a Becton Dickinson FACScan.  Analysis of flow cytometry data was performed 
using the FlowJo programme 
 
 
2.9.2.  Live Cell sorting via flow cytometry 
 
Following treatment/infection in a T25cm2 flask, cells were trypsinised to a single cell 
suspension and resuspended in 2% FCS/ PBS.   At all intermediate steps the cells 
are kept on ice. In order to determine the minimum number cells required for DI 
detection, an initial flow cytometry analysis was performed.  GFP intensity was 
measured against side scatter (SSC).  Cells were initially gated into two separate 
distinct populations, “true” GFP+ve and “true” GFP-ve cells. The middle population 
containing a mixture of GFP+ve and GFP-ve cells was discarded.   Subsequently, 
cells were live sorted into discrete GFP+ve and GFP-ve populations into two 
collecting vials respectively.  The cell sorter machine used was the Beckman Couture 
MOFLO (cytomation). 
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2.10.  Nucleic acid analysis 
 
2.10.1. Total cellular RNA extraction 
 
Infected/treated cells were lysed using TRIzol (Invitrogen) with 2 ml per 25cm2 flask. 
Cell lysates were incubated at room temperature for approximately 30 min before 
being transferred to 1 ml Eppendorf tubes and RNA was extracted according to the 
manufacturer’s instructions. 
 
 
Determination of RNA concentration 
 
RNA concentration was determined using the same method as for DNA 
concentration as previously described. 
 
 
RNA reverse transcription 
 
Complementary DNA was generated in a two-step reaction using reagents 
from Promega, as described below.  Samples were normalised based on the RNA 
used in the reaction, at 1μg.  For housekeeping genes such as β-actin, the Oligo(dT) 
primer was used in the reverse transcription reaction.   
 
RNA (1μg) X μl 
Reverse primer (5μM) 1μl 
H2O up to 10μl 
- Incubate for 10 min at 72°C in a thermocycler. 
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- Add the following: 
dNTPs (10 mM each); 2μl 
DTT (0.1 mM); 2μl 
5x M-MLV buffer; 4μl 
M-MLV (reverse transcriptase); 1μl 
RNasin; 1μl     
 
- Incubate for 1 hour at 42°C in a thermocycler. 
 
 
2.10.2. Endpoint PCR 
 
All PCR reactions were performed with the GoTaq DNA polymerase 
(Promega). Samples were transferred using pre-sterilised filter tips (Axygen). The 
reactions were prepared using 0.5 ml thin-walled tubes and analysed with a 
thermocycler, according to the parameters described below: 
 
Standard PCR protocol using GoTaq DNA polymerase 
 
5x reaction buffer 10μl 
dNTPs (10 mM each) 1μl 
DNA template x μl 
Forward primer (2 μM) 1μl 
Reverse primer (2 μM) 1μl 
GoTaq polymerase (5U/ml) 0.25μl 
ddH2O (up to 50 μl) x μl 
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PCR programme for GoTaq DNA polymerase 
 
Polymerase activation; 95°C; 2min 
Denaturation:  95°C; 30 sec 
Annealing: 55°C; 30 sec           25 cycles 
Elongation; 72°C; 1 min 
Final extension; 72°C; 10 min 
 
 
2.10.3. Real-Time Quantitative PCR 
 
Total cellular RNA was extracted using TRIzol as described above and 1μg of RNA 
was then used in a reverse transcription PCR reaction (total volume 20μl). The cDNA 
produced was subsequently used in the real-time quantitative PCR reaction, which 
was performed using a SYBR Green-based master mix (MESA Blue MasterMix Plus 
for SYBR Assay; Low ROX, Eurogentec). Primer concentrations were optimised for 
each primer pair.  Reactions were prepared in 96-well flat deck thermofast real-time 
QPCR plates (Thermo-Scientific). The wells were sealed with a Thermaseal RTS 
(VWR) plastic seal followed by centrifugation of the plate at 1000 rpm for 2 minutes.  
The RT-QPCR reaction reagents are described below: 
 
cDNA; 2.5μl 
Forward primer (final concentration 100-300nM) 2.5μl 
Reverse primer (final concentration 100-300nM) 2.5μl 
MESA Blue MasterMix Plus, Low ROX; 12.5μl 
RNase free ddH2O; 5μl  
Total reaction mix volume: 25μl 
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Real-time quantitative PCR programme: 
 
Activates polymerase 5min, 95°C; 1 Cycle     
Denaturation; 0.15min, 95°C; 1 min      40 Cycles 
Annealing/extension; 1 min, 60°C   
 
Final step: meltcurve/dissociation curve 60°C-95°C 
 
Real-time quantitative PCR was analysed using a Stratagene Mx3005p 
thermocycler. 
 
Negative controls included Non-primer control (NPC), Non-template control (NTC), 
reaction master mix (-SYBR) and minus Reverse transcription enzyme (-RT).  The 
positive control was respective plasmid encoding NP, the Small DI or the Large DI.  
Samples were performed in triplicate unless otherwise stated.   
 
 
2.10.4. Visualisation of PCR products by Agarose gel 
electrophoresis 
 
DNA was separated using 1% (w/v) agarose/TAE buffer. Four μg/ml of ethidium 
bromide was added to the agarose before the gels were covered in 1x TAE buffer 
(40 mM Tris-acetate, 1 mM EDTA). Samples were mixed together with loading dye 
and separated by electrophoresis at 100V. The gels were analysed by UV light. 
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3.  RESULTS 
 
The results chapter is split into three parts.  The first part concerns the heterocellular 
induction of IFN-β in A549 cells by paramyxoviruses and Influenza A virus (Udorn).  
Secondly, the identification of the primary PRR(s) responsible for IFN-β induction and 
signalling is studied, by examining viral plaque development and activation of the 
IFN-β promoter in Naïve reporter cells by immunofluorescence and FACs analysis.  
The third part concerns the role of DIs as inducers of IFN-β, as detected by RT-
QPCR from cell-sorted GFP+ve cells following PIV5 (wt) infection.  
 
 
3.1.1. The Heterocellular induction of IFN-β by negative sense 
RNA viruses 
   
IFN-β is induced and secreted by cells upon virus infection, subsequently inducing 
the expression of ISGs that generate an antiviral state by inhibiting further infection 
and virus replication.  This was visualized via a simple plaque assay whereby A549 
cells (referred to as Naïve cells from now on) and A549 BVDV Npro cells were 
infected with PIV5 (wt) at an MOI of 0.001 pfu/cell.  A549 BVDV Npro cells express 
the BVDV Npro protease, in which Npro targets IRF3 for proteasomal mediated 
degradation.  As a result, A549 BVDV Npro cells lack a functional IFN-β induction 
pathway and do not express IFN-β.  At five days post infection (p.i.), cells were fixed 
and ELISA stained for PIV5 NP.   At five days p.i. a significant increase in plaque 
size can be seen in the infected A549 BVDV Npro cells compared to A549 naïve 
cells (Figure 16A). Thus, despite the existence of potent virus-encoded antagonists 
of the IFN-β system, IFN can still exert an antiviral effect that limits PIV5 (wt) virus 
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replication before PIV5 is able to dismantle the antiviral state. This raises the 
question of whether in a given cell population under virus challenge, all the cells 
express IFN or whether it is only a minority of cells that express IFN.   
 
To determine if the antiviral response of cells to virus infection is homo- or 
heterogenous in the developing plaque, Naïve cells were grown as a monolayer and 
infected at an MOI of 0.001 pfu/cell with PIV5 (wt).  At two days p.i. cells were fixed 
and stained for PIV5 NP and for MxA, an ISG used as a marker for the production of 
IFN-β (Figure 16B). Cells were subsequently stained with the NP secondary 
antibody, Texas Red and MxA secondary antibody, Cy5 for visualisation by confocal 
fluorescence microscopy.  At two days p.i., viral plaques consisting of 10–30 cells 
expressing viral antigen were seen, indicative of viral replication and spread. 
Surprisingly, only some of the developing plaques were surrounded by cells that 
were positive for MxA expression. From these observations it can be concluded that 
although some of the cells must have produced and secreted IFN, leading to the 
induction of MxA expression, this was not the case for all infected cells in which no 
MxA expression could be seen surrounding the developing plaque.  Clearly, this 
shows that there is a heterogeneous cellular response to virus infection.   
 
In order to address the question of the nature of the cellular response to virus 
infection, we generated an A549 reporter cell line in which IFN-β induction was 
monitored by placing the eGFP gene under the control of the IFN-β promoter (1.2.7.  
Investigating PIV5 DIs: The A549 pr/(IFN-β).GFP Reporter cell line).  With the 
development of the A549/pr(IFN-β).GFP reporter cell line (referred to from now on as 
Naive reporter cells), the activation of the IFN-β promoter can be examined in a 
population of cells following virus infection. Naive reporter cells were grown as a 
monolayer in 60 mm dishes that contained coverslips. 
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Figure 16.  Response of Naïve cells to PIV5 (wt) infection   
A) Naïve cells and A549 BVDV Npro cells were grown as monolayers and 
infected at a low MOI of 0.001 in 60mm dishes.  At 5 days p.i. cells were fixed 
and ELISA stained to PIV5 NP.  
B) Naïve cells were grown as a monolayer on coverslips and infected with PIV5 
wt at low MOI of 0.001. At 2 days p.i.,cells were fixed and co-stained with 
antibodies for PIV5 NP with Phycoerythrin secondary; MxA with Cy5 
secondary.  Cells were visualised by confocal microscopy.  Plaque 1 = viral 
plaque surrounded by cells negative for MxA expression.  Plaque 2 = viral 
plaques surrounded by cells positive for MxA expression. 
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The Heterocellular induction of IFN-β in response to infection  
 
Monolayers were infected at a low MOI of 0.001 with PIV5 (wt) (Figure 17A), PIV3 
(rwt) (Figure 17B), PIV2 (wt) (Figure 17C), BUNV (wt) (Figure 17D) and influenza A 
(Udorn) (Figure 17E).  At two days p.i. cells were fixed.  Cells infected with influenza 
A (Udorn wt) which was fixed at one day p.i. Cells were subsequently stained for 
virus NP with Texas Red secondary antibody, and co-stained for MxA and Cy5 
secondary antibody for visualization by confocal immunofluorescence microscopy.  
 
In addition, a positive control was generated by treating a cell monolayer with IFN-α 
(Roferon A, Roche) at 1000 U/ml for 12 hours before fixation and staining (Figure 
17A).  The cell monolayer of the positive control at 12 hours post-treatment was 
100% for MxA expression.  This showed that the Naïve reporter cells could all 
respond to IFN.  Following infection with PIV5 (wt), at two days p.i. plaques could be 
readily visualized (Figure 17B).  Some developing plaques were visualized that 
contained no GFP+ve cells, suggesting that IFN-β had not been produced by any of 
the infected cells within these plaques. Supporting this, the layer of cells surrounding 
these plaques which were negative for GFP expression and were also negative for 
MxA expression.   This is unsurprising, as without the induction and secretion of IFN, 
the expression of ISGs such as MxA is not induced following virus infection.   
 
However, following PIV5 infection, some plaques were visualized in which they 
contained by one to three GFP+ve cells and were surrounded by a layer of cells 
expressing MxA (Figure 17B Plaque 2).  These GFP+ve cells strongly suggest that 
the IFN-β promoter has been activated and IFN-β subsequently expressed and 
secreted by the cell.  The secreted IFN subsequently diffuses through the cell 
monolayer, activating the JAK/STAT pathway in neighbouring uninfected cells and 
inducing the expression of MxA expression (and other ISGs) that is observed.  
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Figure 17. The Heterocellular induction of IFN-β in Naive reporter cells 
Naïve reporter cell monolayers were infected with PIV5 (wt) (B), PIV3 (rwt) (C), PIV2 
(wt) (D), BUNV (wt) (E) and Influenza A (Udorn wt) (F) at low MOI 0.001 pfu/cell.  At 
2 days p.i. cells were fixed and co-stained for virus NP and for MxA, with the 
secondary antibodies phycoerythrin and Cy5 respectively. Plaque 1 = plaque 
surrounded by cells negative for GFP expressing cells and negative for MxA 
expression.  Plaque 2 = plaque surrounded by cells positive for GFP expression and 
positive for MxA expression.  Green cells = cells which have the IFN-β promoter 
activated and the subsequent expression of GFP (The GFP gene is under the control 
of the IFN-β promoter).  A positive control was generated in which Naïve reporter 
cells were treated with IFN-α (Roferan A) at 1000U/ml for 12 hours before fixation 
and staining.  Cells were visualised on a Zeiss LSM 5 Exciter confocal microscope. 
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Therefore the expression of MxA is directly correlated with the presence of a GFP+ve 
cell within the developing plaques.  From these observations, it is clear that there is a 
heterocellular response to infection, in which only a minority of infected cells has IFN 
been induced in.  This heterocellular response was observed with infection by wild 
type strains of PIV3 (Figure 17C), PIV2 (Figure 17D), BUNV (Figure 17E) and 
influenza A (Udorn) (Figure 17F).  This suggests that the heterocellular response 
observed is a general feature of negative strand viruses. The vast majority of infected 
cells are negative for GFP expression.  These results strongly suggest that only a 
few cells within developing plaques of negative strand viruses produce the IFN-β that 
is responsible for generating the antiviral state in the surrounding uninfected cells.  
 
 
3.1.2. Heterocellular Induction of IFN-β in reporter cells by PIV5 lacking 
a functional IFN antagonist 
 
The heterocellular response of Naïve reporter cells to low MOI infections of negative 
sense RNA viruses indicates that the PAMPs that induce IFN are generated during 
PIV5 infection.   However, what is not known is whether the PAMPs generated are 
sourced as a feature of normal wild-type non-defective virus replication. To answer 
this, the % of GFP+ve cells can be measured in response to infection by a virus 
lacking a functional IFN antagonist.  If the sources of PAMPs are generated during 
normal wildtype virus replication, then following infection of the Naïve reporter cell 
line with a virus lacking an IFN antagonist, it would be expected that the majority of 
the infected cells would be positive for GFP expression and thus positive for 
activation of the IFN-β promoter.  
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As mentioned previously, PIV5 encodes a potent IFN antagonist, the V protein, which 
targets the establishment of an antiviral state at multiple levels (see 1.2.5. PIV5 
Inhibition of IFN mediated responses).   The PIV5 VΔC virus encodes a C-
terminally truncated version of the V protein which cannot interact with MDA5 or 
target STAT1 for proteasome-mediated degradation, and is consequently impaired in 
its ability to inhibit IFN-β induction and IFN-β signalling.  We examined whether the 
heterocellular activation of the IFN-β promoter observed in response to PIV5 (wt) 
infection in Naive reporter cells is observed for infection with PIV5 VΔC.  Cell 
monolayers of Naïve reporter cells was grown and infected with PIV5 VΔC VM0 at a 
low MOI of 0.001 pfu/cell.  At two days p.i., cells were fixed and then co-stained for 
PIV5 NP and for MxA, and stained with secondary antibodies for phycoerythrin and 
Cy5 respectively for confocal fluorescence microscopy (Figure 18A).  Furthermore, a 
second set of Naïve reporter cell monolayers were grown and infected at an MOI of 
0.001 pfu/cell with PIV5 VΔC VM0 (Figure 3B).  At two days p.i. cells were 
trypsinised, fixed in suspension and then resuspended in suspension solution (PBS; 
5% FCS, 0.01% sodium azide). These cells were then analysed by flow cytometry for 
GFP expressing cells. 
 
PIV5 VΔC is extremely sensitive to the effects of IFN, and so only forms small 
plaques in Naive reporter cells; nevertheless, plaque development can be followed at 
2 days p.i. before enough IFN is produced to prevent further plaque development 
(Figure 18A).  As seen for infection with PIV5 (wt) (Figure 17B), it is observed with 
infection by PIV5 VΔC that only a minority of infected cells are positive for GFP 
expression and thus in only a minority cells has the IFN-β promoter been activated. 
As expected, the uninfected cells surrounding plaques containing a GFP+ve cell 
were positive for MxA expression. The observation that only a minority of cells are 
positive for GFP expression is supported by the flow cytometry analysis of PIV5 VΔC 
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infected Naïve reporter cells.   Only 14.7% of cells were positive for GFP expression 
(Figure 18B).  
 
However, plaques could also be seen that contained no GFP+ve cells, indicating that 
the IFN-β promoter had not been activated within these developing plaques (Figure 
18A).  Furthermore, an antiviral state had not been established in the uninfected cells 
surrounding these plaques, as demonstrated by a lack of MxA expression, indicating 
that no endogenous IFN-β had been secreted by any of the infected cells in the 
plaque. 
 
These results confirm that the IFN-β promoter is only activated in a minority of cells 
infected with PIV5 VΔC VM0, and that there is a heterocellular response to infection 
to a virus with a non-functional IFN antagonist. The significance of this was that the 
loss of the PIV5 IFN antagonist did not lead to IFN-β promoter activation in all of the 
PIV5 VΔC VM0 infected cells.  If the loss of a functional V protein were the primary 
reason for IFN induction in infected cells, then it would be expected that infection with 
PIV5 VΔC would activate the IFN-β promoter in all infected cells.  However, as the 
IFN-β promoter is not activated in the majority of cells infected with PIV5 VΔC this 
demonstrates that the PAMPs capable of inducing IFN are not generated during 
PIV5 VΔC transcription and replication processes. 
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Figure 18. The Heterocellular induction of IFN-β following infection with 
PIV5 lacking an IFN-β antagonist 
Naïve reporter cell monolayers were infected with PIV5 VΔC VM0 at an MOI of 0.001 
pfu/cell.   
(A) At 2 days p.i. cells were fixed and co-stained for PIV5 NP and for MxA, with 
the secondary antibodies phycoerythrin and Cy5 respectively for 
immunofluorescence confocal microscopy.  
(B) Plaque 1 = viral plaque surrounded by cells negative for GFP expression and 
negative for MxA expression.   
Plaque 2 = viral plaque surrounded by cells positive for GFP expression and 
positive for MxA expression. 
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(C) At 2 days p.i. cells were trypsinised and fixed in suspension.  Cells were then 
resuspended in suspension solution and subsequently subjected to flow 
cytometry analysis to determine GFP expression.  The percentage of cells 
considered to be GFP+ve (based on the line gate indicated) is given in the 
top right hand of each panel. 
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3.1.3. Section Summary 
 
We investigated the activation of the IFN-β promoter by the PAMPs generated during 
plaque development following a low MOI infection of reporter cells infected with 
negative sense RNA viruses.  Infecting at a low MOI ensures that the cells at the 
initial site of infection are infected with wild-type virus, and not by any PAMPs 
present in the viral stock. It was clear from the immunofluorescence and flow 
cytometry of infected samples, that during plaque development only a minority of 
cells were positive for the expression of GFP and hence only a minority of reporter 
cells have activation of the IFN-β promoter and are responsible for the induction of 
IFN during an infection.   
 
We also found that only a small minority of Naïve reporter cells expressed GFP when 
infected with PIV5 VΔC when analysed by flow cytometry and by 
immunofluorescence.  The most striking result of this study was that the loss of the 
PIV5 IFN antagonist did not lead to IFN-β promoter activation in all PIV5 VΔC-
infected cells.  The data presented here, challenges the notion that paramyxoviruses 
generate PAMPs capable of activating the IFN response during their normal 
replication cycle, and we suggest that these PAMPs are not generated during normal 
non-defective PIV5 (wt) replication.  
 
Our data indicate that the loss of this fine control of transcription and replication via 
the V protein, does not affect the level of activation of the IFN-β promoter during 
infection, since we do not see IFN-β promoter activation in the majority of PIV5 VΔC 
(VM0) infected cells.  These results suggest that, in this reporter system, DI viruses, 
generated due to errors in the viral polymerase, are primarily responsible for IFN 
induction during infection with PIV5, and will be discussed in the next section.  
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3.2. Determining the PRRs involved in the induction of IFN 
following Paramyxovirus infection 
 
Both RIG-I and MDA5 have the capacity to induce IFN following infection with PIV5 
(wt). To determine which PRR is the primary sensor that subsequently induces IFN 
following infection with paramyxoviruses, reporter cell lines in which the RIG-I and 
MDA5 sensors had been knocked down were utilised in subsequent experiments. 
These were created using a lentivirus shRNA strategy, and cells that were knocked 
down for the respective sensors were subsequently subcloned (cell lines generated 
by Shu Chen, University of St Andrews).  The PRR knock down reporter cell lines 
generated were the A549 pr/(IFN-β).GFP RIG-I Knock Down cell line and the A549 
pr/(IFN-β). GFP MDA5 Knock Down cell lines (referred to as the RIG-I KD reporter 
cells and the MDA5 KD reporter cell line from now on).  All infections (as in the 
previous section) are performed at a low MOI.  This is so that the impact of PAMPs 
generated during virus replication and dissemination throughout the cell monolayer, 
and not PAMPs present in the virus stock at the site of the initial infection, can be 
examined in their ability to induce the activation of the IFN-β promoter. 
 
 
3.2.1.   Characterising the RIG-I KD and MDA5 KD reporter cell 
lines for RIG-I and MDA5 expression and for IFN-β promoter 
activation 
 
Before utilizing the RIG-I and MDA5 KD reporter cell lines for future studies, it was 
first needed to characterize them to confirm that they had reduced levels of RIG-I 
and MDA5 expression respectively.  As RIG-I and MDA5 are IFN inducible, a simple 
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test of their expression is to treat a cell monolayer with IFN and probe for RIG-I and 
MDA5 expression.  RIG-I KD and MDA5 KD reporter cells were grown as a cell 
monolayer and stimulated with Roferon A for 16 hours.  Post-incubation, cells were 
lysed and samples loaded onto an SDS-PAGE gel.  Samples were immunoblotted for 
RIG-I, MDA5 and actin (Figure 19).  Following stimulation with IFN, RIG-I KD 
reporter cells express MDA5 equivalent to Naïve reporter cells. In contrast, the RIG-I 
KD cells have severely reduced RIG-I expression compared to Naive reporter cells.  
In contrast following stimulation with IFN, MDA5 KD reporter cells express RIG-I 
similarly to Naïve reporter cells, but MDA5 KD reporter cells contain little MDA5 
compared to Naïve reporter cells.  In conclusion RIG-I and MDA5 have been 
successfully knocked down in their respective cell lines. 
 
For future studies, it is important to test if the RIG-I KD and MDA5 KD reporter cell 
lines have consistent GFP expression which correlates with IFN-β promoter 
activation compared to Naïve reporter cells. To determine this, a transient 
transfection of the Naïve, RIG-I KD and MDA5 KD reporter cell lines was carried out 
with a plasmid encoding IRF3, pdlNOTI MCS R-IRF3.  In pdlNOTI MCS R-IRF3, the 
gene of interest, IRF3 is transiently expressed under the control and driven by the 
SFFV promoter. As IRF3 is downstream of RIG-I and MDA5, the transient expression 
of IRF3 would activate the IFN-β promoter and thus GFP expression in the reporter 
cell lines. The pdlNOTI MCS R-IRF3 plasmid was transfected using FuGENE 6 
transfection reagent following the standard Promega protocol.  Mock cells were also 
transfected with an empty vector.  Following incubation of 48 hours post-transfection, 
cells were trypsinised and fixed in suspension, before resuspension in suspension 
solution.  Cells were then analysed by flow cytometry for GFP expression (Figure 
20).   
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Figure 19.  Characterising the Reporter cell lines for RIG-I and MDA5 
expression 
Naïve, RIG-I KD and MDA5 KD reporter cell lines were stimulated with Roferon A for 
16 hours before cells were lysed and samples put onto an SDS-PAGE gel.  Samples 
were immunoblotted for RIG-I, MDA5 and actin. 
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Figure 20. The reporter cell lines display similar levels of IFN-β promoter 
activation following the transient expression of IRF3 
Naïve, RIG-I KD and MDA5 KD reporter cell lines were transfected with an 
expression plasmid for the transient expression of IRF3 (pdlNOTI MCS R-IRF3). 
Following transfection, cells were trypsinised and fixed and then subsequently 
resuspended in cell suspension solution.  Cells then underwent flow cytometry 
analysis measuring for the number of GFP expressing cells.  The percentage of cells 
considered to be GFP+ve (based on the line gate indicated) is given in the top right 
hand of each panel. 
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Following transfection with the IRF3 encoding plasmid, Naïve, RIG-I KD and MDA5 
KD reporter cell lines display similar % of GFP+ve cells as a proportion of total cells, 
within 0.6% of each other. Although these values are ~14%, a minority of total cells, 
this is due to the poor transfection efficiency of the A549 cell line.  Furthermore, there 
are clearly defined discrete peaks of GFP+ve and GFP-ve cells , indicating that the 
IFN-β promoter is either “on” or “off” in the absence or presence of stimuli. The RIG-I 
KD and MDA5 KD reporter cell lines are thus consistent in their GFP expression in 
their response to activation of the IFN-β promoter compared to Naive reporter cells.  
 
 
3.2.2.  Measuring paramyxovirus virus spread in the reporter cell 
lines lacking a PRR 
 
To study the effect of removing a PRR sensor on virus infection and spread in a cell 
monolayer, plaque assays were performed using the reporter cell lines.  Naïve, RIG-I 
KD and MDA5 KD reporter cell lines were grown to 90% confluence in 60mm plates 
and infected with PIV5 (wt) (Figure 21A), PIV3 (rwt) (Figure 21B) and PIV2 (wt) 
(Figure 21C) at an MOI of 0.001 pfu/cell.   As a positive control, A549 BVDV Npro 
cells were also infected.  At 5 days p.i. when plaques had developed to a suitable 
size and observed via a Nikon microscope, cells were fixed.  Cells were ELISA 
stained for PIV5, PIV3 and PIV2 NP.  Plaques sizes were then measured and 
averaged for each reporter cell line.   
 
Firstly, comparing plaque sizes following PIV5 (wt) infection of Naïve reporter cells to 
A549 BVDV Npro cells, it can be observed that there are significant differences 
between the two (Figure 21A).   
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Figure 21. Comparison of viral plaques generated from infecting reporter cell 
lines with paramyxoviruses  
A549 Naive, RIG-KD, MDA5 KD reporter cells and BVDV Npro cells were infected 
with (A) PIV5 (wt); (B) PIV3 (rwt); (C) PIV2 (wt) at an MOI of 0.001 pfu/cell.  At 5 
days p.i. for PIV5 and PIV2 infections, and at 3 days for PIV3 infections when the 
developing plaques were visible using a Nikon microscope, cells were fixed. 
Following fixation, plaques were ELISA stained for NP of PIV5, PIV3 and PIV2. 
Plaques sizes were measured and averaged.  Error bars indicate the standard 
deviation of plaque sizes in each data set.   
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As expected, the plaque sizes are far larger in the cell population that lack a 
functional IFN induction signalling pathway, the A549 BVDV Npro cells, than those 
observed in Naïve reporter cells in which IFN can be induced.  As a result, virus 
replication and dissemination in the cell monolayer is reduced compared to cells that 
are unable to induce IFN.  However, the largest plaques of PIV5 infected RIG-I KD 
reporter cells are comparable, albeit slightly smaller to those found in infections of 
A549 BVDV Npro cells.  This suggests that knocking down RIG-I expression severely 
limits the sensing of viral PAMPs generated during virus infection.  Supporting this, 
the RIG-I KD plaques are significantly larger than those found in infections of Naïve 
reporter cells. This indicates that cells lacking the RIG-I sensor are significantly less 
able to induce IFN in response to infection where the virus is better able to replicate 
and spread increasing the size of the plaques in RIG- KD reporter cells compared to 
Naïve reporter cells. 
 
In contrast, following infection of MDA5 KD reporter cells with PIV5, the plaques 
observed were of a similar, being slightly larger size to those observed in infections 
of Naïve reporter cells, and MDA5 KD reporter cell plaques were far smaller than that 
of those plaques observed in A549 BVDV Npro cells.   This suggests that cells that 
primarily possess the RIG-I sensor are able to respond to virus infection and sense 
the PAMPs generated, leading to the induction of IFN and the generation of an 
antiviral state. Supporting this, the plaque size of MDA5 KD reporter cells were 
around 50% smaller than that of plaques found in RIG-I KD reporter cells, indicating 
that the removal of the RIG-I sensor led to increased virus spread within the cell 
population than the removal of the MDA5 sensor.  
 
As the plaque sizes for RIG-I KD cells are smaller than those visualised for A549 
Npro cells, this suggests that virus PAMPs are being generated during infection that 
are able to activate MDA5 mediated induction of IFN. This is supported by the plaque 
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sizes of MDA5 KD reporter cells being slightly larger than Naïve reporter cells, which 
indicates that some PAMPs are generated during infection that activate MDA5 
mediated induction of IFN.   
 
Furthermore, infections of RIG-I KD reporter cells generated a mixed population of 
plaque sizes, where some were as small as Naïve reporter cells, whilst others were 
far larger comparable to those observed in A549 BVDV Npro cells.  This could be 
due to the presence of a mixed population of RIG-I KD reporter cells, where only 
some of the cells are knocked down for RIG-I expression, or that there are differing 
levels of shRNA expression of RIG-I being expressed in the cell population. It is 
possible that not all the cells could be knocked down for RIG-I expression uniformly.  
A second possible explanation is that during PIV5 replication, MDA5 PAMPs are 
generated at a relatively slow rate compared to RIG-I activating PAMPs. A way to test 
this is that if the IFN inducing PAMPs can be identified, then if the PAMPs being 
generated during virus infection activate MDA5, then it would be possible to detect 
these PAMPs via RT-QPCR in GFP+ve RIG-I KD reporter cells that had been cell 
sorted from GFP-ve cells. 
 
The plaque assay patterns detected for PIV5 infections can also be observed for 
infections of the reporter cells with PIV2 (wt) (Figure 21B).  This data suggests that 
RIG-I is the primary sensor for the PAMPs generated during virus replication for PIV5 
(wt) and PIV2 (wt).  However, for infection with PIV3 (rwt) (Figure 21C), the patterns 
observed appear to be less pronounced that for infections with PIV5 (wt) or PIV2 
(wt). The relative plaque sizes observed of PIV3 (rwt) infected Naïve and MDA5 KD 
reporter cells are comparable to PIV5 (wt) and PIV2 (wt), suggesting that RIG-I 
appears to be the primary sensor as explained earlier for inducing IFN.  However, the 
plaques observed in PIV3 (rwt) infected RIG-I-KD and A549 Npro cells, although still 
107 
larger than that in MDA5 and Naive reporter cells, are relatively smaller in difference 
that that found between PIV5 and PIV2 infected cells.  This suggests that perhaps 
another pathway other than IFN is important for inhibiting PIV3 (rwt) infection. 
 
 
3.2.3. Immunofluorescence of developing viral plaques in reporter 
cell lines 
 
The heterocellular induction of IFN observed in response to virus infections, means 
that one or both of the PRRs, RIG-I and MDA5, are being activated by the PAMPs 
generated during virus infection and replication.  In order to determine the PRRs 
responsible for inducing IFN-β, the percentage of cells that are GFP+ve and thus 
have activation of the IFN promoter, can be measured following infection of the 
reporter cell lines that lack either RIG-I or MDA5.  Naïve, RIG-I KD and MDA5 KD 
reporter cells were grown as a monolayer and infected with PIV5 (wt) (Figure 22A), 
PIV3 (rwt) (Figure 22B) and PIV2 (wt) (Figure 22C) at an of MOI 0.001.  Cells were 
infected at a low MOI with a DI poor prep of virus in order to reduce the chances of 
large numbers of DIs in the initial infection.  
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Figure 22.  Immunofluorescence of developing plaques in reporter cell lines 
Naïve, MDA5 KD and RIG-I KD reporter cells were grown as a monolayer and 
infected with (A) PIV5 (wt), (B) PIV3 (rwt) and (C) PIV2 (wt) at an MOI of 0.001 
pfu/cell.  Cells were fixed at 2 days p.i and were stained for NP, with secondary 
antibody conjugated to Texas Red.  Developing plaques were then observed via the 
Nikon microscope.  Error bars indicate the standard deviation of each data set. 
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Cells were fixed at 2 days p.i. where cells were stained for virus NP, with the 
secondary antibody conjugated to Texas Red for immunofluorescence microscopy.  
The number of infected cells and the number of cells that were GFP+ve were 
counted from 10 fields of vision and averaged (Figure 22).   It was observed that 
following infection with PIV5 (wt), PIV3 (rwt) and PIV2 (wt), Naïve and MDA5 KD 
reporter cells both had at least 5% of cells that were GFP+ve found at the developing 
plaque. There were fewer GFP+ve cells observed at the developing plaque for 
infections of RIG-I KD reporter cells than for infections of Naïve and MDA5 KD 
reporter cells. Thus, by removing the RIG-I sensor, fewer cells are able to respond to 
virus infection.  This supports the previous plaque assay data (Figure 21), as larger 
plaque sizes are observed of infections of the RIG-I KD reporter cell line compared to 
Naïve and MDA5 KD reporter cells.  This suggests that RIG-I is the primary sensor 
for recognizing virus PAMPs generated by PIV5 (wt), PIV3 (rwt) and PIV2 (wt). 
 
 
 
3.2.4.   Creating the A549 pr/(IFN-β).GFP LGP2 KD cell line 
 
During this investigation it became apparent from the literature that LGP2 could have 
a role in the induction of IFN-β following virus infection.  As mentioned previously, 
LGP2 is incapable of inducing IFN itself, but instead inhibits RIG-I in the absence of 
viral RNA PAMPs and is an enhancer of MDA5 is the presence of viral RNA PAMPs.  
In order to study the role of LGP2, a stable cell line was created in which LGP2 
expression was knocked down by shRNA.  The A549/pr(IFN-Β).GFP LGP2 Knock 
Down reporter cell line (referred to as the LGP2 KD reporter cell line from now on) 
was created using a shRNA lentivirus strategy (Figure 23).  A lentivirus plasmid 
expressing shRNA against LGP2 (pBCK shRNA LGP2 KD) was supplied by the 
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Goodbourn group.  To produce the desired recombinant lentivirus, the pBCK shRNA 
LGP2 KD plasmid (also encoding the puromycin gene) and packaging plasmids 
pCMVR8.91 and pVSV-G were co-transfected into HEK293T cells using FUGENE 6 
transfection reagent. The harvested recombinant lentiviruses were then used to 
infect Naïve reporter cells.  At 48 hours p.i. cells underwent puromycin selection.  
The LGP2 KD reporter cell line was then subcloned. As expected, the LGP2 KD 
reporter cell line expresses both RIG-I and MDA5 following IFN treatment (Figure 
24A).  As LGP2 could not be detected by Western Blot, primers were designed to 
detect the expression of LGP2 by PCR.  As LGP2 is IFN inducible, expression levels 
of LGP2 mRNA in the LGP2 KD reporter cells was tested compared to Naïve reporter 
cells.  Naïve and LGP2 KD reporter cells were grown as monolayers and then 
treated with +/IFN for 16 hours.  Following treatment, RNA was extracted and 
analysed for LGP2 mRNA expression by PCR (Figure 24B).  It was found that the 
Naïve reporter cells expressed LGP2 after IFN treatment, but the subclone of the 
LGP2 KD reporter cell line did not express detectable levels +/- IFN by PCR.   
 
In addition, the LGP2 KD reporter cell line was tested for the % of cells that express 
GFP compared to Naïve reporter cells.  Naive and LGP2 KD reporter cells were 
transiently transfected with pdlNOTI MCS R-IRF3 in order for the cells to transiently 
express IRF3 in the cell.  Following transfection, cells were trypsinised, fixed, and 
then underwent flow cytometry analysis measuring for the number of GFP expressing 
cells.  It was found that similar levels of GFP+ve cells could be detected between 
LGP2 KD reporter cells and Naïve reporter cells that transiently expressed IRF3 
(Figure 24C).  In light of this, the LGP2 KD reporter cell line can be used in future 
studies as LGP2 has successfully been knocked down and that the cell line has 
equivalent levels of GFP responsiveness and activation of the IFN-β promoter to 
Naïve reporter cells. 
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Figure 23. Generation of the A549/pr(IFN-β).GFP/KD.LGP2 KD cell line 
Step 1: The lentivirus plasmid expressing shRNA to LGP2 were co-transfected into 
HEK 293T cells with packaging plasmids pCMVR8.91 and pVSV-G.  The lentivirus 
supernatant was harvested at 72hr p.i. The supernatant was centrifuged to remove 
cell debris.  
Step 2: The lentivirus supernatant was used to infect A549/pr(IFN-β).GFP cells. 
Step 3: Lentivirus transduced cells were selected using puromycin at 48hr p.i. 
Step 4.  The lentivirus transduced cells were then subcloned. 
Step 5.  Subclones were further characterized for inhibition of LGP2 expression 
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Figure 24. Characterising the A549/pr(IFN-β).GFP LGP2 KD cell line  
(A) A549 pr/(IFN-β).GFP LGP2 KD cells express MDA5 and RIG-I following IFN 
treatment 
-  A549 pr/(IFN-β).GFP LGP2 KD cells (referred to as LGP2 KD cells) were 
stimulated +/-IFN for 16 hours before cells were lysed and samples put onto an SDS-
PAGE gel.  Samples were probed for RIG-I and MDA5, analysed by immunoblotting 
 
(B) Following IFN treatment, LGP2 KD cells do not express detectable levels of 
LGP2 by PCR compared to Naïve cells.  
Cells were treated +/-IFN for 16 hours before TRIzol RNA extraction and endpoint 
PCR.  The LGP2 KD cells were found not to contain LGP2 when probed compared to 
the Naïve cells. 
 
(C) Naïve and LGP2 KD reporter cells display similar levels of GFP+ve cells 
following transient transfection with pdlNOTI MCS R-IRF3, for transiently expressing 
IRF3 in the cell.  See text for details. 
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3.2.5.   Flow cytometry analysis of virus infected reporter cells 
 
The previous plaque assay and immunofluorescence data suggests that RIG-I is the 
primary sensor that detects PAMPs generated during virus infection, resulting in the 
induction of IFN.  In order to examine this more quantitatively, the levels of GFP 
expressing reporter cells in which the IFN-β promoter has been activated as % total 
of cells was analysed by flow cytometry. Cell monolayers of Naïve, RIG-I KD, MDA5 
KD and LGP2 KD reporter cell lines were grown and infected at an MOI of 0.001 
pfu/cell with infections of PIV5 (wt), PIV3 (rwt) and PIV2 (wt).  At 2 days p.i. cells 
were trypsinised and fixed in suspension.  Cells were then stained for virus NP and 
with secondary antibody conjugated to phycoerythrin (PE) for analysis by flow 
cytometry.  Cells expressing (NP-PE) and GFP were counted in a total viable cell 
population of 10,000 cells.  Cell populations were gated based on analysis of mock 
infected cells that were negative for GFP and NP-PE.   
 
Analysing the flow cytometry data for infections of the reporter cell lines with PIV5 
(wt) (Figure 25A), it is important to note that the majority of cells are negative for NP 
(and GFP expression) at the time of fixation.  This means that not all of the cells had 
detectable levels of NP expression caused by virus infection and viral protein 
transcription.    This allows us to study IFN induction generated in the cell monolayer 
during the development of the viral plaque, before all of the cells are infected. 
Several discrete cell populations can be detected when analysing infected Naïve 
reporter cells there is a cell population that is positive only for GFP expression.  In 
GFP+ve/ NP-ve cells, the IFN-β promoter has been activated due to the 
infection/uptake of a viral PAMP that has been sensed by the PRR(s).  This has 
occurred in the absence of a co-infection with a non-defective wild-type virus, as NP 
expression is not detected in this cell population.   
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Figure 25. Flow cytometry analysis of reporter cells following infection. 
Naïve, RIG-I KD, MDA5 KD and LGP2 KD reporter cell monolayers were infected at 
an MOI of 0.001 pfu/cell with (A) PIV5 (wt), (B) PIV3 (rwt) and (C) PIV2 (wt). At 2 
days p.i cells were trypsinised and fixed in suspension.  Cells were then stained for 
virus NP and then with secondary antibody conjugated to phycoerythrin (PE) for 
analysis by flow cytometry.  Cells expressing NP-PE and GFP were counted in a 
given total cell population of 10,000 cells.  Cell populations were gated based on 
analysis of mock infected cells that were negative for GFP and NP-PE. 
 
Graph 1) The total numbers of cells that were GFP+ve, i.e. total number of cells that 
were positive GFP for expression (+/- for the expression of NP) were counted for 
each infected cell line and plotted. 
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Graph 2) The ratio of NP+ve cells to GFP+ve cells was taken by the sum of total 
NP+ve cells (+/- for the expression of GFP) divided by the sum of total GFP+ve cells 
(+/- for the expression of NP) and plotted for each infected cell line. 
 
Secondly, there is a cell population that is exclusively strongly positive for NP 
expression.  This due to the wild-type non-defective virus infecting the cell, and 
subsequently viral transcription and replication has occurred without the uptake or 
generation of a PRR activating PAMP. Thirdly, there is a population of cells that are 
positive for both NP and GFP expression.  This indicates that successful non-
defective wild-type virus infection of the cell has taken place due to positive NP 
expression. During virus infection or replication, a viral PAMP has been produced or 
has been taken up by the cell that has been sensed by one or more of the PRRs and 
led to the induction of activation of the IFN-β promoter and hence the expression of 
GFP.  As mentioned before, the previous results (3.1.2.  Heterocellular Induction of 
IFN-β in reporter cells by PIV5 lacking a functional antagonist) point to a source 
of PAMPs such as DIs that are potentially the primary inducers of IFN.  As the 
reporter cells were infected at low MOI, this data suggests that the cells positive for 
NP and GFP expression are infected with a wild-type virus and that a DI(s) that has 
been generated during wild-type virus replication.  This DI(s) has triggered one or 
more of the PRRs and led to the activation of the IFN-β promoter and the subsequent 
induction of IFN in these GFP+ve cells. These findings above were again found for 
PIV3 (rwt) (Figure 25B) and PIV2 (wt) (Figure 25C) infections. The co-infection of a 
GFP+ve cell with a wildtype virus and a DI that has induced the activation of the IFN-
β promoter needs to be characterised, and will be examined in the next section of the 
results (3.3. Investigating Defective Interfering Particles as the primary inducers 
of IFN).  
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Several patterns can be observed when studying the total % GFP+ve cells generated 
following infections of the Naïve and PRR knock down reporter cell lines (Figure 25A 
Graph 1).  Supporting the previous findings, PIV5 (wt) infection of Naïve reporter 
cells generates a heterocellular antiviral response. Only a small minority of cells are 
positive for GFP expression, at 1.26%, and thus only a minority of cells have IFN 
induced by a viral PAMP generated during virus infection and replication.   
 
Compared to the other reporter cell lines that have reduced expression of the PRRs, 
Naïve reporter cells have the highest % GFP+ve cells as a proportion of the total cell 
population.  This is unsurprising, as Naive reporter cells possess the full complement 
of PRRs that are able to sense viral PAMPs generated during viral infection and 
replication and subsequently induce the activation of the IFN-β promoter and the 
subsequent expression of GFP. 
 
Clear important differences emerge between infections of the reporter cell lines 
depending on which PRR has been knocked down. PIV5 (wt) infections of the RIG-I 
KD reporter cell line generates far fewer GFP+ve cells, at 0.15% of total cells, a 
reduction of 88% compared to Naïve reporter cells. The level of RIG-I KD reporter 
GFP+ve cells observed is closer to that found in Mock infected reporter cells.  In 
contrast, the % of total cells that are GFP+ve in MDA5 KD reporter cells at 0.96%, is 
much closer to that observed for Naïve reporter cells, a reduction of 23%.   In the 
absence of RIG-I expression, this results in significantly fewer cells that are able to 
respond and have the IFN-β promoter activated following infection, compared to the 
Naïve and MDA5 KD reporter cell populations.  The RIG-I KD reporter cells are thus 
severely reduced in their ability to recognise viraL PAMPs generated during infection.  
Supporting this, despite the fully functional expression of MDA5 in RIG-KD reporter 
cells, IFN-β promoter activation is negligible compared to Naïve reporter cells.  
Furthermore, MDA5 KD reporter cells have fully functional expression of RIG-I and 
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shRNA inhibited expression of MDA5, and it is clear that these cells are able to 
respond to the virus PAMPs generated during virus infection.  That there is some 
reduction in the total % of GFP+ve cells observed for MDA5 KD reporter cells 
compared to Naïve reporter cells, suggests that some viral PAMPs are generated 
during virus infection and replication that activate MDA5 mediated signalling. 
However, this is a rarer event, possibly due to selection pressure by the V protein 
that inhibits MDA5 mediated signalling.  
 
The flow cytometry data from the PIV5 (wt) infection of LGP2 KD reporter cells 
(Figure 25A) supports the above conclusion that RIG-I is the primary IFN inducing 
sensor for PIV5 infections. As LGP2 is an enhancer of MDA5 mediated signalling, if 
MDA5 has been a primary or a significant sensor of PIV5 viral PAMPs, then with the 
removal of LGP2 expression, the % of GFP+ve cells observed would have been 
severely reduced compared to Naïve reporter cells and comparable to that observed 
in RIG-I KD cells.  However, this is not the case as it can be observed that the % total 
LGP2 KD reporter GFP+ve cells is at a similar level to that found in MDA5 KD 
reporter cells, and is 5.7 times greater than that observed in RIG-I KD reporter cells.  
However, that there is a reduction of 38% of GFP+ve cells found in LGP2 KD 
reporter cells compared to Naïve reporter cells, suggesting that LGP2 may have a 
role as an enhancer of other PRRs or be involved as an adaptor in the IFN induction 
signalling pathway. 
 
Further supporting the conclusion that RIG-I is the primary sensor that detects PIV5 
virus PAMPs, is when the flow cytometry data is analysed for the ratio of NP 
expressing cells to GFP expressing cells (Figure 25A Graph 2).  It is clear from 
Graph 2 that for PIV5 (wt) infection of Naïve, MDA5 KD and LGP2 KD reporter cells, 
they display equivalent low NP+ve:GFP+ve cell ratios in comparison to the 
NP+ve:GFP+ve cell ratio of the RIG-I KD reporter cells.  The RIG-I KD reporter cell 
120 
NP+ve:GFP+ve ratio is 5.7 times greater than the ratios found in the other reporter 
cell lines. This strongly indicates that viral dissemination throughout the monolayer of 
the Naive, MDA5 KD and LGP2 KD reporter cells is being inhibited by the sensing of 
virus PAMPs by the fully functionally expressing RIG-I, subsequently inducing IFN 
and the generation of the antiviral state.  Removal of RIG-I means that the cells have 
a severely reduced response to the virus PAMPs generated during infection, thus 
resulting in increased virus infection replication and spread throughout the 
monolayer, observed by the high NP+ve:GFP+ve cell ratio observed in PIV5 (wt) 
infection of RIG-I KD reporter cells.  The results and conclusions observed for PIV5 
(wt) infections of the reporter cell lines are replicated for infections with PIV3 (rwt) 
(Figure 25B) and PIV2 (wt) (Figure 25C).  This indicates that the results observed 
could be true for other paramyxoviruses.   
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3.2.6. Section Summary 
 
It has been demonstrated in this thesis via immunofluorescence, plaque assays, flow 
cytometry that RIG-I is the primary sensor for the detection of the DI PAMPs 
generated during PIV5 replication.  Reporter cells that are knocked down for RIG-I 
have larger plaques developed over the course of infection.  Furthermore, far fewer 
GFP+ve RIG-I KD reporter cells are detected compared to Naïve, MDA5 and LGP2 
KD reporter cells following infection with PIV5 (wt). By removing the RIG-I sensor, 
reporter cells are significantly reduced in their ability to recognize the DI PAMPs 
generated during PIV5 infection, and consequently far fewer cells do not have 
activation of the IFN-β promoter when compared to Naïve, MDA5 KD and LGP2 KD 
cells. 
 
The data also points to a role of MDA5 and LGP2 in the induction of IFN.  Firstly, 
viral plaques in MDA5 KD reporter cells infected with PIV5 (wt) were not the same 
size, but were smaller than those found for Naïve reporter cells.  Furthermore, flow 
cytometry analysis of PIV5 (wt) infected MDA5 KD reporter cells showed decreased 
numbers of GFP+ve cells when compared to Naïve reporter cells.  This 
demonstrates that DI PAMPs containing ligands unique to detection by MDA5 are 
being generated, as removal of the MDA5 sensor does reduce the % of total cells 
that are GFP+ve when compared to Naïve reporter cells.  The role of LGP2 as an 
enhancer of MDA5 is supported by the flow cytometry data.  The % of cells that are 
GFP+ve is reduced when LGP2 is knocked down in reporter cells infected with PIV5 
(wt).  
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3.3. Investigating Defective Interfering Particles as the 
primary inducers of IFN 
 
This section concerns the investigation of PIV5 DIs as the primary inducers of IFN. 
To investigate the role of DIs in the induction of IFN, a strategy was devised to detect 
DIs from PIV5 (wt) infected reporter cells. Following infection of reporter cells with 
PIV5 (wt), Naïve reporter cells would be cell sorted into two discrete populations, 
GFP+ve and GFP-ve cells.  These two distinct populations, following RNA extraction 
and reverse transcription, would be probed for DIs via real time-Quantitative PCR 
(RT-QCR).  The amount of DIs and viral genomic NP detected in the samples would 
be analysed via relative quantification compared to housekeeping genes with stable 
expression. Relative quantification allows the comparison of samples probed under 
different experimental conditions.  If DIs are the primary inducers of IFN, then they 
would only be detected in cells that have the IFN-β promoter has been activated. i.e. 
GFP+ve cells.  Complementing this, GFP-ve cells would be expected not to contain 
DIs. In addition, by infecting the PRR KD reporter cell lines and probing for the 
presence of DIs and a reduction in NP expression in GFP+ve cells, the primary PRR 
that recognises the DIs generated during PIV5 infection can be determined. 
 
 
3.3.1.  Detection of the Large and Small DIs from Control Plasmids 
 
As mentioned previously, it is relatively easy to generate DI rich virus stocks by 
passaging PIV5 VΔC at high multiplicity, where DIs can readily be detected at 
passage VM2.  Two DI sequences that were present at most abundance following 
high MOI passaging of PIV5 VΔC were the Large DI trailer copyback (copyback 
junction at nt position 14043/4-15023/4) and the Small DI trailer copyback (copyback 
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junction at nt position 14827-15157) (Killip et al., 2013).  The Large DI is 1427nt in 
size and the Small DI is 510nt in size.  Plasmids encoding the Large DI and the 
Small DI for use as positive controls for subsequent experiments and primers used 
for detecting DIs were developed and supplied by the Goodbourn group, St Georges 
Medical School. Both of the Forward Primers for the large DI and small DI, primer A1 
and A3 respectively, bind to the loop of the DI structure (Figure 26A). Furthermore, 
the Large DI and Small DI Forward primers bind to loop sequences present in DI 
species for PIV5 (wt) found by deep sequencing.   The Large DI and Small DI share 
the Reverse primer C, which binds to the stem structure of the DI, as both the Large 
DI and small DI share a common stem trailer sequence (this is true for other species 
of trailer copyback DIs) (Figure 26B). Primer combinations A1/C and A3/C are 
located on the same antigenomic strand.  They thus only produce PCR products if 
template switching of strands has taken place such as when a Trailer copyback DI is 
generated.  In comparison, the B1/C PIV5 genomic primers are located in opposing 
orientations, and thus permit amplification of any PIV5 genomic RNA generated by 
authentic replication.  To determine if the primers could successfully probe for the 
respective DIs for QPCR, the Large and Small DI plasmids were diluted in 
concentration.  The Large and Small DIs were successfully detected by endpoint 
PCR using the Promega GoTAQ kit (Figure 26C). The Large DI A1/C primer PCR 
product is 965bps in size, and the Small DI A3/C PCR product is 220bp in size. The 
lowest concentration that the DI can be visualised was used as the initial 
concentration of the plasmid for QPCR.  The Large DI plasmid at ~2.5ng/μl is the 
initial concentration for QPCR.  The Small DI plasmid at ~1x10-4 ng/μl is the initial 
concentration to be utilised for QPCR. 
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Large DI Primers 
Primer 
Name 
Primer Sequence Primer 
binding site  
PCR 
product 
Size 
A1 5’- CCAAGAAGACCTAAATTGTAAGGAG – 3’ 
Forward 
Loop of DI 900bps 
C 5’- CCAAGGGGAAAACCAAGATTAATCCTC 
– 3’ Reverse 
Stem of DI 
 
Small DI primers 
A3 5'- TTTGGAGAAAGCTTCAGGAACC-3’ 
Forward 
Loop of 
DI 
220bps 
C 5’-CCAAGGGGAAAACCAAGATTAATCCTC – 
3’ Reverse 
Stem of 
DI 
A 
B 
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PIV5 Genomic RNA (vRNA) Primers 
B1 5'- CTCCTTACAATTTAGGTCTTCTTGG-3’ 
Forward 
- 500bps 
C 5’-CCAAGGGGAAAACCAAGATTAATCCTC-3’ 
Reverse 
- 
 
 
 
Figure 26. Detecting DIs from Control plasmids by Endpoint PCR 
A. Primer Binding Strategy 
The Forward primer for reverse transcription and the detection of DIs bind to 
sequences located in the loop section of the DI structure.   
B. Primer combinations for the Large DI, Small DI and PIV5 genomic wild 
type RNA  
C. Detecting large and small DIs from Control Plasmids using Endpoint 
PCR 
Control Plasmids supplied by Goodbourn group.  Primers were ordered from Sigma-
Aldrich.  The DI plasmids were detected by Endpoint PCR, 40 Cycles on a Biometra 
T Gradient Thermocycler, using the Promega GoTAQ kit.   
C 
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3.3.2.  Detection of DIs from cells following virus infection 
 
The next stage was to detect the Large and Small DIs from Naïve reporter cells 
infected with PIV5 (wt), PIV5 VΔC VM0 and PIV5 VΔC VM2.  Naive reporter cells 
were infected for 18 hours at a high MOI of 10pfu/cell.  Cells were then probed with 
primers for detection by endpoint PCR (40 cycles) for virus genomic RNA (vRNA), 
the large DI and small DI (Figure 27).  Firstly, for all infections PIV5 virus genomic 
RNA was detected, indicating that there was a successful infection.  Secondly, the 
large and small DIs were detected following infection of Naïve reporter cells with 
PIV5 VΔC VM2.  In contrast, DIs were not detected following infection with DI poor 
virus preparations of PIV5 (wt) or PIV5 VΔC VM0.  This could be due to the absence 
of DIs present within the DI poor virus preparations of PIV5 (wt) and PIV5 VΔC VM0.  
This is extremely unlikely as previously, by deep sequencing analysis of the virus 
preparations, they were found to contain DIs {Killip:2013cbb}.  This leads to the 
second more probable explanation, whereby endpoint PCR is too insensitive a 
technique for detecting DIs following infection with DI-poor virus preparations.  This 
highlights the need for using the far more sensitive technique of  RT-QPCR for 
detecting DIs in the low numbers of GFP+ve cells generated following infection at a 
low MOI with PIV5 (wt).   
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Figure 27.  Detection of DIs from infected Naive Reporter cells 
Naïve Reporter cells were infected with PIV5 (wt), PIV5 VΔC VM0 and PIV5 VΔC 
VM2 at a high MOI of 10pfu/cell for 18hrs.  RNA was extracted from samples and 
analysed by endpoint PCR using the Promega GoTAQ kit. 
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3.3.3.  Detection of DIs from cells post-fixation 
 
As mentioned previously, in order to determine if DIs are the primary inducers of IFN 
following infection, cell sorted reporter cells that are GFP+ve and thus have the IFN-
β promoter activated would be probed for the Large and Small DIs in comparison to 
GFP-ve cells.  There are two routes by which reporter cells can be cell sorted 
following infection and trypsinisation.  Firstly, cells could be fixed and then samples 
sent to a cell sorting facility.  The potential advantage is that following fixation there 
would be little degradation of viral DI RNAs, and cell degradation is reduced.  
Secondly, infections could take place on site by a cell sorting facility.  Immediately 
after infection, live cell sorting could take place.  There are a number of problems 
that can occur with fixing cells prior to cell sorting.  The use of formaldehyde in 
fixation solutions can crosslink RNA, preventing its purification and extraction using 
TRIzol.  Secondly, alcohol fixatives can destroy some of the cells in suspension prior 
to cell sorting. In order to determine if cells could be fixed prior to sorting, a range of 
fixation conditions was tested (Table 2).  Trypsin contains EDTA, which is superior to 
DPEC for inhibiting RNAses.  Sucrose was tested, as this acts as a “cushion” for 
cells, increasing osmolarity and stabilizing the integrity of cell membranes. During 
fixation everything was kept on ice to minimize RNA degradation. Cells were fixed in 
5mls of solution, where by fixing in larger volumes, cell “clumpage” and degradation 
can be reduced.   
 
Naïve reporter cells were infected with PIV5 VΔC VM2 and cells fixed using several 
different fixation methods (Table 2).   It was found that following fixation with all of 
the different methods, the Large DI and Small DI could not be detected by endpoint 
PCR following RNA extraction (Figure 28).  As a result, the investigation 
methodology was altered to use to live cell sorting of samples following infection with 
the Goodbourn group, St Georges Medical School.   
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Table 2.  Fixation conditions for Naïve reporter cells infected with PIV5 VΔC 
VM2.  
Fixation solution Fixation conditions 
1% Formaldehyde (2% Sucrose) PBS 10mins on ice 
1% Formaldehyde (2% Sucrose) PBS 
Complexes were eluted and cross-links 
attempted to be reversed by the addition of 
300 μl of elution buffer (50 mM Tris–HCl, pH 
6.8, 200 mM NaCl, 1 mM EDTA, 1% SDS) 
and incubation at 65 °C for 12 h. 
(Chan et al., 2006) 
10mins on ice 
75% Ethanol in PBS at -20°C 15mins on ice 
75% Ethanol in PBS 2% Sucrose at -20°C 15mins on ice 
95% Ethanol/ 5% Acetic Acid at -20°C 15mins at -20°C 
Methanol, 10% Polyethylene glycols -20°C 15mins on ice 
Methanol, 10% Polyethylene glycols -20°C, 
2% Sucrose 
15mins on ice 
70% Methanol PBS -20°C, 15mins on ice 
70% Methanol PBS -20°C, 2% 
sucrose 
15mins on ice 
Carnoy's solution (60% ethanol, 30% 
chloroform and 10% glacial acetic acid) 
(best for keeping RNA intact) -20°C, 
15mins on ice 
Carnoy’s Solution (60% ethanol, 30% 
chloroform and 10% glacial acetic acid) 2% 
sucrose 
15mins on ice 
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Figure 28.  Endpoint PCR of Naïve report cells following infection and fixation. 
Naïve reporter cells were infected with PIV5 VΔC VM2 at a high MOI of 10 for 18hrs.  
Cells were then fixed using the below fixation solutions prior to Endpoint PCR, 40 
cycles. 
1) 1% Formaldehyde (2% Sucrose) PBS 
2)  1% Formaldehyde (2% Sucrose) PBS, plus additional RNA crosslinking 
reversal step. 
3)  75% Ethanol, PBS  
4)  75% Ethanol, PBS, 2% Sucrose 
5)  95% Ethanol/ 5% Acetic Acid 
6)  95%/ 5% Acetic Acid, 2% Sucrose  
7)  90% Methanol, 10% Polyethylene glycols 
8)  90% Methanol, 10% Polyethylene glycols, 2% Sucrose  
9)  70% Methanol, PBS  
10)  70% Methanol PBS, 2% sucrose  
11)  Carnoy's solution (60% ethanol, 30% chloroform and 10% acetic acid)  
12)  Carnoy’s Solution, 2% sucrose,  
C = Large DI/ Small DI plasmid Control 
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3.3.4. Investigating the minimum number of cells required for DI 
detection by PCR following infection    
 
Following infection and live cell sorting of GFP+ve and GFP-ve cells, RNA would be 
extracted using TRIzol and probed via RT-QPCR for DIs..  A potential problem that 
can arise with infecting cell at a low MOI with PIV5 (wt), is that there could be too few 
GFP+ve cells generated during infection to live cell sort and then subsequently 
detect DIs by RT-QPCR.  At each step in the process, samples containing low 
numbers of cells cells can easily be degraded by the environment and by the cell sort 
itself.  This was illustrated earlier in the results section where only a tiny minority of 
cells were GFP+ve following a low MOI infection with PIV5 (wt) (3.2.5. Flow 
cytometry analysis of virus infected reporter cells).  To counter this, future 
infections will take place on cells seeded in a T25 flask to minimise losses during 
infection, trypsinisation and cell sorting.  Naïve reporter cells were infected at a high 
MOI of 10pfu/cell with PIV5 VΔC VM2 for 24hrs. Cells were then trypsinised and 
resuspended in 2% FCS/PBS and counted using a SLS HAE 2118 (improved 
Neubauer) haemocytometer.  Samples were then 10 fold serial diluted from 10k 
cells/100μl to ~10cells/100μl.  RNA was extracted from the samples and the Large 
and Small DIs probed by RT-PCR (Figure 29).   Encouragingly from the data, it was 
found that from a population of cells that had not been FACs sorted, the Large and 
Small DIs could be detected in samples containing ~10 cells.   
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Figure 29.  Detection of DIs following dilution of Naïve Reporter cells after 
infection. 
Naïve reporter cells were infected at a high MOI of 10 with PIV5 VΔC VM2 for 24hrs. 
Cells were then trypsinised and resuspended in 2% Foetal Calf serum (PBS, 0.01% 
Sodium Azide) and counted using a Haemocytometer.  Samples were then 10 fold 
serial diluted from 10k cells/100μl to ~10cells/100μl.  RNA was extracted from the 
samples and the Large and Small DIs probed by RT-PCR, 40 cycles. 
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3.3.5. RT-QPCR Detection of DIs from samples following PIV5 
infection  
 
The RT-QPCR protocol utilized is a two-step process, beginning with a reverse 
transcription step, where cDNA is synthesised from the total RNA extracted from 
infected samples and then used as a template for the RT-QPCR reaction. The levels 
of RNA are measured in real-time as it is amplified. For this study, SYBR Green 
(Eurogentec) was used, which is a double stranded intercalating dye that fluoresces 
when it binds to DNA. SYBR Green binds to any double-stranded DNA, including 
non-specific DNA and primer-dimer products. It is therefore important to include a 
dissociation curve (melt curve) in the PCR program that enables one to measure the 
specificity of the amplified product. If the amplified product is valid, it shows a single, 
sharp peak. 
 
To detect DIs via QPCR, gene specific primers were generated for the Large and 
Small DIs using DNA Strider (Table 3).  For QPCR, products must be below 250bps 
in size, and the primers products for the Large DI and Small DI are 150bps and 
162bps in size respectively.   NP is used as a representation of genomic virus RNA.  
During the Reverse transcription step, the NP reverse primer is used as this will 
enable the detection of genomic RNA and not messenger RNA for NP, which would 
be the case if Oligo dT was used instead.  In addition, primers were manufactured to 
a HPLC standard in order to provide sufficient purity/ stringency for the QPCR 
reaction, by reducing the occurrence of primer-dimer and non-specific products being 
generated due to errors in the primer sequences. 
 
To test the identification of DIs by QPCR using the HPLC primers, Naïve Reporter 
cells were infected with PIV5 VΔC VM2 at a high MOI of 10 for 24hrs.  
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Table 3.  HPLC Primers used for probing the Large DI, Small DI and NP during 
QPCR 
Large DI HPLC Primers 
Primer 
Name 
Primer Sequence Primer 
Binding 
on DI 
QPCR 
product Size 
LDI HPLC 
FWD 
5’- CAAGCTTGCACTTGATTCCA– 3’ 
Forward 
Loop 
of DI 
150bps 
LDI HPLC 
REV 
5’- GGATAGGTCTGGTTGGATCG– 3’ 
Reverse 
Stem 
of DI 
 
Small DI HPLC primers 
SDI HPLC 
FWD 
5'- ATCAGAATTGAGGATGGAAG-3’ 
Forward 
Loop 
of DI 
162bps 
SDI HPLC 
REV 
5’- GATATGTTTAGATTTCCTCGC– 3’ 
Reverse 
Stem 
of DI 
 
NP (Genomic RNA) HPLC Primers 
NP HPLC 
FWD 
5'- AGGGTAGAGATCGATGGCT-3’ 
Forward 
- 254bps 
NP HPLC 
REV 
5’-
GCTACATTAGGAAATTGATTGAGGGG
-3’ Reverse 
- 
 
Primers were ordered from Sigma-Aldrich. 
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RNA was extracted from cells using TRIzol (Invitrogen) and the RNA concentration 
measured using the Nanodrop ND-100 Spectrophotometer. Input RNA for all 
samples for the reverse transcription reaction were standardised at 1μg.   
 
The reverse transcription reaction was carried out using the Promega M-MLV-H 
RNase H Minus kit.   A 2.5μl volume of cDNA was then used in a 25μl reaction using 
the Eurogentec MESA Blue QPCR Mastermix Plus SYBR Green (low ROX) on the 
Stratagene Mx3005p QPCR thermocycler (Figure 30).  ROX is a reference dye used 
as an internal control that normalises against any fluctuations in the volume or 
concentration of the mastermix. This gives a higher reproducibility of the PCR assay.  
A low ROX concentration was used as high concentrations of ROX creates an 
oversaturated signal on the ROX channel and results in the normalized data 
containing more noise than the non-normalized data.  The QPCR protocol is 
displayed in Figure 30.  Initial primer concentrations used were 100μM.  Samples 
initially were performed in duplicate.   
 
Analysing the QPCR results, a strong signal was detected for the Large DI and the 
Small DI, as well as for the Large DI and Small DI control plasmids as expected. 
(Figure 31A, Figure 31B).  This indicates that the Large DI and the Small DI were 
present in the infected cells and the virus preparation.   In comparison, no Large DI 
or Small DI signal was detected for Mock infected cells.  Furthermore, for both the 
Large DI and the Small DI primer products, the melting curves only showed one large 
peak, whereby the results are thus valid as only one product had been generated.   
 
For further analysis of the QPCR products, the samples were visualised by DNA-
AGE (Figure 32).  QPCR samples were compared to Endpoint PCR samples, 
generated using the same cDNA used for QPCR from the previous reverse 
transcription reaction.   
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Figure 30.   Eurogentec QPCR Protocol 
A. QPCR component volumes 
B. Eurogentec Mesa Blue QPCR protocol.  The initial concentrations of the primers in 
the reaction mix were at 100μM.   
 
 
 
Component Volume (µl) 
2x Reaction Buffer 12.5 
Forward Primer 2.5 
Reverse Primer 2.5 
Water 5 
Input Material 2.5 
 
 
Eurogentec QPCR Protocol 
Step 1  Meteor Taq Activation 5mins  95°C 
Step 2  40 Cycles   15 sec 95°C 
      1min 60°C 
Step 3  Perform Melt curve 
         
A 
B 
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Figure 31.  Large DI and Small DI QPCR analysis following infection with PIV5 
VΔC VM2 
Naïve Reporter cells were infected with PIV5 VΔC VM2 at high MOI of 10 for 24hrs. 
RNA was extracted and samples analysed by RT-QPCR.    
A. QPCR analysis for the Large DI, including dissociation curve 
B. QPCR analysis for the Small DI, including dissociation curve 
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Figure 32. Comparison of QPCR (HPLC primers) and Endpoint PCR samples 
generated from Naïve reporter cells infected with PIV5 VΔC VM2.   
Naïve reporter cells had been infected with PIV5 VΔC CM2 at high MOI of 10 for 
24hrs.  RNA was extracted, and samples analysed by QPCR and by Endpoint PCR.   
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The Small DI and Large DI products generated by QPCR can be easily visualised.  
Samples generated by QPCR have a stronger signal than Endpoint PCR samples, 
illustrating the high sensitivity and appropriateness of the QPCR assay for DI 
detection from potentially low numbers of cells. 
 
 
3.3.6. Optimisation of QPCR Input DNA Plasmid control 
concentration 
 
It is important to optimise the concentration of the input DNA for the Large DI and 
Small DI and NP control plasmids.  Using the initial concentration found previously of 
1x10 -1ng/μl, ((3.3.1.Detection of the Large and Small DIs from Control Plasmids) 
10-fold serial dilutions were made of the plasmids and tested by QPCR (Figure 33).  
It was found that the optimal concentrations for the Large and Small DI plasmids 
were 1x10-2 ng/μl. The dissociation curves also gave rise to a single peak for all of 
the control plasmids, which indicated that no primer dimers were made during the 
reaction and that the primers did not bind non-specifically. 
 
 
3.3.7.  Optimisation of LDI, SDI and NP Primer concentration  
 
The Ct values for each primer pair from the real-time quantitative PCR 
assay were plotted as a standard curve (Figure 34). The slope of this curve gives the 
efficiency of the PCR reaction by the following equation (Pfaffl, 2001):  
 
Efficiency = 10(-1/slope) – 1.   
 
140 
 
 
A 
141 
 
 
 
B 
142 
 
 
 
Figure 33.   Optimisation of DI and NP control Plasmids 
A = Optimisation of Large DI control Plasmid by QPCR and dissociation curve 
B = Optimisation of Small DI Control Plasmid by QPCR and dissociation curve 
C = Optimisation of NP Control Plasmid by QPCR and dissociation curve 
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Figure 34.  Standard curves obtained for each primer 
To calculate the efficiency, the formula Efficiency = 10(-1/slope) – 1 was used. 
A = Large DI primers standard curve 
B = Small DI Primers standard curve 
C = NP Primers standard curve 
 
 
A  Large DI Primers Standard Curve  
B  Small DI Primers Standard Curve  
C  NP Primers Standard Curve  
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3.3.8.  Optimisation of the QPCR Reference Gene set 
 
When the slope of the standard curve is -3.32, the primer efficiency is 100%. 
Acceptable PCR efficiency is 100% ±10%. The Primer slope efficiency obtained from 
the machine software was 90.1% for the LDI primers; 92.9% for the SDI primers; 
102.7% for the NP primers.  All the primer combinations were in the acceptable 
range for PCR efficiency, and thus no further optimization is required.  All Forward 
and Reverse Primer concentrations for the Large DI, Small DI and NP will remain at 
100μM. 
 
In order to quantify the amount of DIs in infected samples, two different quantification 
methods are available, Absolute and Relative Quantification.  Absolute quantification 
requires a standard curve to plot the cycle threshold (Ct) values obtained from the 
PCR against known amounts of template, whereas relative quantification does not 
need a standard curve and instead shows the RNA levels of the gene of interest 
relative to a reference gene or untreated samples.  For this study, as we are 
answering the question “how much are DIs expressed in one sample to another?” i.e. 
measuring the fold difference in the expression of DIs between two different samples, 
Relative Quantification is the best method.  The relative values were quantified using 
the comparative Livak Ct method (Cikos et al., 2007; Livak &Schmittgen, 2001):  
 
Step 1 
Normalize the Ct of the sample target to that of the sample reference gene (ref) gene 
for both the test sample and the calibrator sample (i.e. Mock Naïve sample): 
ΔCt  = Ct test sample target  – Ct sample reference 
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Step 2 
Normalize the ΔCt of the test sample to the ΔCt of the calibrator: 
ΔΔCt = ΔCt test sample target – ΔCt calibrator 
 
Step 3 
Calculate the expression fold difference: 
2-ΔΔCt = normalized expression ratio 
 
The result is the fold difference of the target gene in the test sample to the calibrator 
sample, normalized to the expression of the reference gene. Normalizing the 
expression of the target gene to that of the reference gene compensates for any 
difference in the amount of sample tissue.    
 
However, there are many reference genes available in the cell, where for some 
reference genes their expression levels may be altered by virus infection.  In the 
Literature, the accepted method is to compare the samples to three housekeeping 
reference genes that do not vary in their expression levels when testing different 
experimental conditions such as virus infection.  In the literature, a combination of six 
reference genes have been identified for infections of cells, Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), Tubulin, peptidylprolyl isomerase A (PPIA), 
Actin, Succinate dehydrogenase complex, subunit A (SDHA) and TATA Binding 
Protein (Aleksandar Radonić et al. 2005; Watson et al. 2007; Mijatovic-Rustempasic 
S et al. 2013; Wilson WC et al. 2013; Fuller CM. 2010).   The reference gene HPLC 
primers are outlined in Table 4.  In order to test for the correct combination of 
reference genes, Naive reporter cells were infected with PIV5 (wt), PIV5 VΔC VM0, 
PIV5 VΔC VM2 and Mock infected for 18hrs at high MOI of 10pfu/cell.   
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Table 4.  Housekeeping gene HPLC primers used in QPC 
Housekeeping gene Primers 
GAPDH Forward 5’-ATGACATCAAGAAGGTGGTG-3’ 
Reverse 5’-CATACCAGGAAATGAGCTTG-3’ 
Tubulin Forward 5’-TCGTGGAATGGATCCCCAAC-3’ 
Reverse 5’-CTCCATCTCGTCCATGCCC-3’ 
PPIA Forward 5’-CCTGGTGGTGCATGCCTAGT-3’ 
Reverse 5’-CTCACTCTAGGCTCAAGCAATCC-3’ 
β-Actin Forward 5’-ACTCTTCCAGCCTTCCTTC-3’ 
Reverse 5’-ATCTCCTTCTGCATCCTGTC-3’ 
SDHA Forward 5’-TGGGAACAAGAGGGCATCTG-3’ 
Reverse 5’-CCACCACTGCATCAAATTCATG-3’ 
TATA Box BP 
 
Forward 5’-TGCACAGGAGCCAAGAGTGAA-3’ 
Reverse 5’-CACATCACAGCTCCCCACCA-3’ 
 
Primers were ordered from Sigma-Aldrich 
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Using the Mesa Blue Eurogentec protocol, samples were reverse transcribed and 
subjected to RT-QPCR following RNA extraction.   From the raw Ct values (Figure 
35A), fold differences in expression levels compared to Mock infected cells were 
calculated (Figure 35B).  From Figure 35B it can be seen that for all of the reference 
genes, their relative expression levels in PIV5 VΔC VM0, PIV5 VΔC VM2 and PIV5 
(wt) infected cells compared to that of Mock are remarkably similar.  All of the 
reference gene expression levels from infected cells are within +/- 0.2 fold of Mock 
infected cells.   
 
In addition to examining whether the reference gene expression levels in A549 
reporter are altered by infection, it is important to determine if the reference gene 
expression levels are altered by the expression of Interferon during virus infection. In 
order to determine this, A549 Reporter cells were Roferon A +/- for 16hrs reference 
gene expression level subsequently analysed by RT-QPCR (Figure 36).   
As shown in Figure 13, there was little difference in expression levels of the 
reference genes between cells treated +/- Interferon. The three reference genes that 
will be used in future studies will be β-Actin, GAPDH and PPIA.   
 
 
3.3.9.  Optimisation of the Reverse Transcription method  
 
There are three different methods for performing the reverse transcription step.  The 
first method involves separate reverse transcription reactions in different tubes for 
the Large DI, the Small DI, NP and the reference genes (Figure 37A).  Whilst this 
would prevent any interference between the different reverse transcription reactions, 
the disadvantage with this method is that Reference genes are being reverse 
transcribed in a separate reaction and tube to the sample targets (Large DI, Small DI 
and NP).  
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Figure 35.  Comparing expression levels of housekeeping genes following 
infection 
A = Graph of raw Ct values of reference gene expression levels from infected A549 
reporter cells.  Cells were infected with PIV5 (wt), PIV5 VΔC VM0, PIV5 VΔC VM2 
and Mock infected at a high MOI of 10pfu/cell for 18hrs prior to TRIzol RNA 
extraction.  Reverse transcription: Oligo (dT). 
B = Graph of Relative fold difference of reference gene expression levels to Mock 
infected cells following infection.   
Samples were performed in triplicate.  Error bars indicate the standard deviation of 
each data set. 
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Figure 36.  Expression levels of reference genes do not significantly alter 
between samples treated +/- Interferon.   
Naive reporter cells were treated with+/- Roferon A at 1000U per ml, 16hrs before 
RNA Trizol extraction. Reverse transcription with with olgio (dT).  QPCR probing for: 
GAPDH; Tubulin; PPIA; Actin; SDHA; TATA box Binding protein.  Samples were 
performed in triplicate.  Error bars indicate the standard deviation of each data set. 
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Figure 37.  Three different Reverse Transcription methods for RT-QPCR of 
samples. 
See text for details. 
B 
C 
A 
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By performing separate RT reactions, this means that reference gene cDNA products 
generated in relation to the target and subsequent QPCR analysis may be 
unrepresentative.  The second method is combining all the primers and reverse 
transcription reactions into one tube (Figure 37B).  The advantage of this method is 
that the cDNA products generated for the reference genes, NP, Large DI and Small 
DI are representative of each other and a direct stringent comparison can be made 
following QPCR.  A possible disadvantage of this method is that there could be 
interference between the primers for the Large DI and the Small DI. This is because 
in theory in a mixed tube for method 2, the Small DI primer could bind to Large DI 
RNA, generating a product.  However, this has not been visualised in the products 
generated by endpoint PCR in previous reactions.  The third method is a 
compromise, where if interference is detected between the Large DI and Small DI 
primers for Method 2, the Small DI and Large DI reverse transcription reactions can 
take place in separate tubes but have the reference gene primers combined with 
them respectively to give more of a representative result compared to Method 1 
(Figure 37C).   
 
To test the different reverse transcription methods, Naive reporter cells were infected 
with PIV5 VΔC VM0 for 18hrs at a high MOI of 10pfu/cell.  QPCR analysis of the 
different RT methods showed that there was minimal variation between LDI products 
generated and also minimal variation between SDI products generated (Figure 38). 
In conclusion Reverse Transcription Method 2, where the different RT reactions are 
combined into one tube and performed at the same time will be the method used, as 
it is the most representative of sample expression levels. 
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Figure 38.  QPCR analysis of DI expression levels between the three different 
Reverse Transcription methods 
Naïve reporter cells were infected with PIV5 VΔC VM0 at a high MOI of 10pfu/cell for 
18hrs.  RNA was extracted and reverse transcription carried out, evaluating the three 
different reverse transcription methods identified (Figure 37).  cDNA was analysed 
by RT-QPCR of the samples, probing for the Large DI and the Small DI. Samples 
were performed in triplicate.  Error bars indicate the standard deviation of each data 
set. 
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3.3.10. Flow cytometry gating optimisation for cell sorting 
 
Prior to cell sorting and collection, it is necessary to gate the populations of cells that 
are either GFP+ve or GFP-ve following infection.  As an example, Naïve reporter 
cells were +/- infected with PIV5 (wt) at a low MOI of 0.0001 pfu/cell for 4 days.  After 
incubation, cells were trpsinised and resuspended in 2% FCS/PBS (suspension 
solution). Immediate flow cytometry analysis of these cells displays that there is a 
spectrum of cell populations displaying a gradient of GFP intensity of infected cells 
compared to mock cells (Figure 39).  Mock cells display a discrete population of cells 
that are GFP-ve.  Using mock cell analysis as a base line, infected cells can be 
divided into a “true” GFP-ve population.  However, it is necessary to gate GFP+ve 
cells further up in the GFP intensity scale, in order to collect a “true” discrete 
population of GFP+ve cells that are not mixed with GFP-ve cells.  If a mixture of 
GFP-ve and GFP+ve cells were collected, this would invalidate subsequent QPCR 
analysis for the abundance of DIs. As a consequence, prior to each sample being 
cell sorted for GFP+ve and GFP-ve cells, a preliminary flow cytometry analysis was 
conducted in order to determine the appropriate gates using mock cells as a base 
line, as shown in Figure 39.  The “middle” mixed population of GFP+ve and GFP-ve 
cells was discarded.  
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Figure 39.  Example of Gating of GFP+ve and GFP-ve cell populations, prior to 
cell sorting and collection following infection with PIV5 (wt) 
Naïve reporter cells were +/- infected with PIV5 (wt) for 4 days at an MOI of 
0.0001pfu/cell.  Cells were trpsinised and resuspended in 2% FCS/PBS.  Live Cells 
were analysed by the Beckman Coutoure MOFLO (Cytomation) cell sorter.  Infected 
cells were analysed compared to Mock at a collection of 10,000 cells.  Infected cells 
were gated for GFP+ve and GFP-ve populations in comparison to mock (in pink 
gates, gated cells as a % of total cells shown next to each gate).  Following gating, 
GFP+ve cells and GFP-ve cells were collected separately at the same time by the 
cell sorter machine.  Collected cells were immediately spun down and RNA TRIzol 
extraction taken place, prior to RT-QPCR.     
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3.3.11. RT-QPCR Analysis of reporter cells following infection with 
PIV5 (wt) 
 
Flow Cytometry Analysis of reporter cells infected with PIV5 (wt) 
 
As the methods of cell sorting, reverse transcription and the RT-QPCR protocols for 
probing for DIs have been optimised, we can proceed to study the relative 
abundances of DIs present in GFP+ve and GFP-ve cell sorted samples following 
PIV5 (wt) infection.  Naïve, RIG-I KD, MDA5 KD and LGP2 KD reporter cells were 
infected with PIV5 (wt) at a low MOI of 0.0001pfu/cell for 4 days incubation.  A low 
MOI infection enables the analysis of DIs generated only during plaque development 
to be analysed.   In addition, a Naïve reporter cell set of samples were treated with 
the Z-VAD-FMK caspase family inhibitor (ZVAD; Enzo Life Sciences) at 100μM final 
concentration per sample.  This was performed as ZVAD is an inhibitor of apoptosis, 
and it was important to test for potential future experiments whether the addition of 
this chemical could enhance cell survival for subsequent analysis by RT-QPCR.  In 
addition, a Naïve reporter cell sample was also treated with Roferon A for 12hrs, 
before analysis by flow cytometry. 
 
Following infection/treatment, cells were trypsinised and resuspended in 2% 
FCS/PBS solution.   Samples were analysed by flow cytometry to decide the 
appropriate gates for sorting the cells into the respective GFP+ve and GFP-ve 
populations by comparing the infected sample to the mock sample as a base line.  In 
addition, the population distribution of GFP+ve cells as a % of total cells was 
recorded for each sample (Figure 40).  Analysing the flow cytometry data it is 
interesting to note that the results observed are comparable to those found 
previously (3.2.5. Flow cytometry analysis of virus infected reporter cells).  
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Figure 40. Flow cytometry analysis of reporter cells infected with PIV5 (wt) 
Naïve, RIG-I KD, MDA5 KD and LGP2 KD reporter cells were +/- infected with PIV5 
(wt) for 4 days at an MOI of 0.0001pfu/cell.  Naïve reporter cells also +/- treated with 
100μM ZVAD during infection.  A Naïve reporter cell sample was also treated with 
Roferon A for 16hrs.  Cells were trpsinised and resuspended in 2% FCS/PBS.  Live 
Cells were analysed by the Beckman Coutoure MOFLO (Cytomation) cell sorter.   
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Supporting the previous data (Figure 25A Graph 1), similar levels of GFP+ve cells 
as a % of total cells can be observed when studying the total % GFP+ve cells 
generated following infections of the Naïve and PRR knock down reporter cell lines 
with PIV5 (wt) (Figure 40).  Supporting the previous findings, PIV5 (wt) infection of 
Naïve reporter cells generates a heterocellular antiviral response. Only a minority of 
Naive reporter cells are positive for GFP expression, at 3.69%, and thus only a 
minority of cells have IFN induced by a viral PAMP generated during virus infection 
and replication.  In accordance with expectations, Naïve reporter cells treated with 
ZVAD during infection had a greater survival rate compared to untreated cells, in 
which 5.43% cells were positive for GFP expression.   
 
Compared to the other reporter cell lines that are knocked down for the PRRs, Naïve 
reporter cells have the highest % GFP+ve cells as a proportion of the total cell 
population.  This is unsurprising, as Naive reporter cells possess the full complement 
of PRRs that are able to sense viral PAMPs generated during viral infection and 
replication and subsequently induce the activation of the IFN-β promoter and the 
expression of GFP.   
 
PIV5 (wt) infections of the RIG-I KD reporter cell line generates far fewer GFP+ve 
cells compared to Naïve reporter cells. In contrast, the % of total cells that are 
GFP+ve in MDA5 KD and LGP2 KD reporter cells are similar in level to each  
other and are greater than the levels observed for RIG-I KD cells.  It can be 
concluded that in the absence of RIG-I expression, this has caused in far fewer 
instances RIG-I KD reporter cells that are able to recognise and respond to DI 
PAMPs generated during infection when compared to the higher levels of GFP+ve 
cells detected for the Naïve, MDA5 KD and LGP2 KD reporter cell populations. The 
RIG-I KD reporter cells, despite having a fully functional MDA5 sensor, are severely 
reduced in their ability to sense the viral PAMPs generated during PIV5 (wt) plaque 
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development and thus have negligible activation of the IFN-β promoter when 
compared to Naïve, MDA5 and LGP2 KD reporter cells that possess a RIG-I sensor.  
This data suggests that the majority of the DI PAMP populations generated during 
viral plaque development activate primarily RIG-I.  As there is some reduction in the 
% of GFP+ve cells observed for MDA5 KD and LGP2 KD reporter cells as a 
proportion of total cells when compared to the GFP+ve level observed for Naïve 
reporter cells, this suggests that some viral PAMPs are generated during viral plaque 
development that are capable of activating MDA5 mediated signalling, albeit that are 
generated at a far reduced rate compared to the generation of RIG-I sensed DI 
PAMPs. 
 
 
RT-QPCR of cell sorted GFP+ve and GFP-ve reporter cells  
 
Following flow cytometry analysis and gating of the samples, samples were then cell 
sorted into discrete populations of GFP+ve and GFP-ve cells.  GFP+ve and GFP-ve 
cells were collected in separate collection vials at the same time on ice.  Following 
the cell sorting procedure, cells were spun down and immediately RNA was TRIzol 
extracted.   RNA concentrations were measured and normalised between samples to 
allow comparison whereby 1μg of extracted RNA was used in the reverse 
transcription reaction.  Reverse transcription was carried out using the appropriate 
primers for detecting housekeeping genes (Oligo (dT)), PIV5 genomic NP (NP 
reverse primer), Primer A1 (LDI) and Primer A3 (SDI) by combining the reverse 
transcription reactions into the same tube by “Method 2” as described previously 
(3.3.8.  Optimisation of the Reverse Transcription method). The DI primers used 
in the detection of the Large DI and Small DI of PIV5 VΔC VM2 can be used to 
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detect the DIs generated during PIV5 (wt) infection. The DIs generated during PIV5 
(wt) infection will be a mixed population and different to those generated by PIV5 
VΔC (as shown in (Killip et al., 2013)),  The PIV5 (wt) DIs subsequently detected 
using the Large DI and Small DI primers will be referred to as the LDI primer product 
and the SDI primer product respectively.   
 
Following the reverse transcription step, samples were then subjected to RT-QPCR 
using the Mesa Blue Eurogentec protocol.  Samples were probed for the LDI primer 
product, the SDI primer product, PIV5 genomic NP and the housekeeping genes 
PPIA, β-Actin and GAPDH. Negative controls included non-primer control (NPC), 
non-template control (NTC), minus Mesa Blue (-SYBR) and minus Reverse 
transcription enzyme (-RT).  The positive control was the respective plasmid 
encoding the PIV5 VΔC Large DI, the PIV5 VΔC Small DI or PIV5 NP. The Ct values 
generated were then analysed using the Livak Ct method for the relative 
quantification of LDI primer products, SDI primer products and PIV5 genomic NP to 
the housekeeping genes.   
 
Analysing the data for the Large DI primer product relative to the housekeeping 
genes (Figure 41), as expected, Mock infected reporter cells and mock infected 
Naïve reporter cells treated with IFN did not contain any DIs.  It is striking to note that 
when comparing the relative abundance of DIs present in GFP+ve cells compared to 
the abundance of DIs present in GFP-ve cells, it is clear that DI products can be 
detected by RT-QPCR in GFP+ve cells, and this is observed when comparing Large 
DI primer product relative fold difference to β-Actin (Figure 41A), PPIA (Figure 41B) 
and GAPDH (Figure 41C).  In comparison, the relative fold difference of DI 
abundancy in GFP-ve reporter cells was vastly reduced when compared to DIs 
present in GFP+ve reporter cells.  
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Figure 41.  Relative quantification of LDI primer products to housekeeping 
genes following cell sorting of GFP+ve and GFP-ve cells. 
Reporter cells had previously been infected with PIV5 (wt) at a low MOI of 
0.0001pfu/cell for 4 days.  Following incubation, GFP+ve and GFP-ve cells were cell 
sorted using the Beckman Coutoure MOFLO (Cytomation) cell sorter.  RNA was 
TRIzol extracted and reverse transcribed.   RT-QPCR was performed, probing for the 
Large DI primer product.  Samples were performed in triplicate. The Ct values 
generated were then analysed using the Livak Ct method for the relative 
quantification of LDI primer product, to the housekeeping genes β-Actin (A), PPIA (B) 
and GAPDH (C).   
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For example, the fold difference between the Large DI primer product between Naïve 
reporter GFP+ve cells and GFP-ve cells is 6 fold.  There is a clear correlation 
between the presence of DIs and the generation of GFP+ve cells during viral plaque 
development in which there is activation of the IFN-β promoter.  That this pattern was 
replicated across all reporter cell samples, and the observation confirmed between 
three different housekeeping genes, gives credence to conclusion that DIs are the 
primary inducers of IFN.   
 
Furthermore, DIs were detected in GFP+ve RIG-I KD reporter cells.   Previous flow 
cytometry data suggested that PAMPs were generated that activated MDA5 during 
viral plaque development (Figure 25, Figure 40). GFP+ve cells observed for MDA5 
and LGP2 KD reporter cells as a % of total cells were lower than levels of GFP+ve 
cells observed for Naïve reporter cells.  As DIs were detected for GFP+ve RIG-I KD 
reporter cells, this supports the notion that a minority subset of DI populations that 
are generated during viral plaque development are capable of being recognised by 
MDA5, and subsequently inducing IFN.   
 
The above conclusions are firmly supported by the same patterns being observed 
when analysing the SDI primer product relative fold differences between GFP+ve 
and GFP-ve cells (Figure 42).  When analysing the SDI primer product abundance 
levels observed when compared to all three of the housekeeping genes, high levels 
of DIs were only detected in GFP+ve cells, and only low DI abundance levels were 
detected in GFP-ve cells.  This correlation between high DI levels and GFP+ve cells 
in which the IFN-β promoter has been activated, supports the conclusion that it is the 
DI PAMPs generated by errors in the replication of non-defective virus by the RNA 
polymerase during viral plaque development, that are recognised by the PRRs and 
subsequently leads to the PRR mediated activation of the IFN-β promoter and the 
subsequent induction of IFN. 
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Figure 42.  Relative quantification of SDI primer product to housekeeping 
genes following cell sorting of GFP+ve and GFP-ve cells. 
Reporter cells had previously been infected with PIV5 (wt) at a low MOI of 
0.0001pfu/cell for 4 days.  Following incubation, GFP+ve and GFP-ve cells were cell 
sorted using the Beckman Coutoure MOFLO (Cytomation) cell sorter.  RNA was 
TRIzol extracted and reverse transcribed.   RT-QPCR was performed, probing for the 
SDI primer product.  Samples were performed in triplicate. The Ct values generated 
were then analysed using the Livak Ct method for the relative quantification of SDI 
primer product, to the housekeeping genes β-Actin (A), PPIA (B) and GAPDH (C).   
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The PIV5 (wt) DIs primarily generated are Trailer DI copybacks, which do not contain 
the sequence for NP (Killip et al., 2013).  When performing the reverse transcription 
step, the reverse NP primer was used.  Thus when RT-QPCR was performed, only 
PIV5 genomic NP, and not NP mRNA (which is the complement sequence to 
genomic NP), would be detected.  Thus by analysing PIV5 genomic NP relative 
abundance, this is an indication of the abundance of non-defective wild-type virus in 
the cell, as only by normal viral replication would genomic NP be present at high 
levels in the sample.   
 
Analysing the relative levels of genomic NP in GFP+ve and GFP-ve reporter cells 
when compared to all three of the housekeeping genes, several patterns can be 
observed (Figure 43).  As expected, mock-infected cells did not contain any NP.  For 
all reporter cells, GFP-ve cells contained high levels of NP when compared to 
GFP+ve cells.  There is clear correlation between the high abundance of NP 
indicative of greater PIV5 (wt) non-defective virus replication and GFP-ve cells in 
which the IFN-β promoter has not been activated.  This is unsurprising, as GFP+ve 
cells have activation of the IFN-β promoter induced by DI PAMPs, and the 
subsequent expression and secretion of IFN by the cell would then activate the 
JAK/STAT signalling pathway, leading to the induction of ISGs and the generation of 
an antiviral state.  As a result viral transcription and replication in the GFP+ve cells 
would be inhibited, and thus contain less genomic NP when compared to GFP-ve 
cells.   This supports the previous immunofluorescence data (Figure 17) and flow 
cytometry (Figure 25, Figure 40) of low MOI infections of PIV5 (wt), where there are 
a subset of GFP+ve cells that are strongly positive for GFP expression and weakly 
positive for NP expression.  
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Figure 43.  Relative quantification of PIV5 NP to housekeeping genes following 
cell sorting of GFP+ve and GFP-ve cells. 
Reporter cells had previously been infected with PIV5 (wt) at a low MOI of 
0.0001pfu/cell for 4 days.  Following incubation, GFP+ve and GFP-ve cells were cell 
sorted using the Beckman Coutoure MOFLO (Cytomation) cell sorter.  RNA was 
TRIzol extracted and reverse transcribed.   RT-QPCR was performed, probing for 
PIV5 NP.  Samples were performed in triplicate. The Ct values generated were then 
analysed using the Livak Ct method for the relative quantification of PIV5 genomic 
NP, to the housekeeping genes β-Actin (A), PPIA (B) and GAPDH (C).   
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It can be observed that for all three sets of NP relative fold differences to 
housekeeping genes, the absence of the RIG-I PRR increased the relative 
abundance of NP in GFP-ve RIG-I KD reporter cells when compared to genomic NP 
levels found in GFP-ve cells of Naïve, MDA5 KD and LGP2 KD reporter cells. The 
NP relative fold difference between GFP-ve RIG-I KD reporter cells and GFP-ve 
Naïve reporter cells is far greater than the difference between GFP-ve MDA5/LGP2 
KD reporter cells and GFP-ve Naive reporter cells. This is due to in the absence of 
RIG-I sensor, the RIG-I KD reporter cells are unable to recognise the DI viral PAMPs 
generated during viral plaque development that activate RIG-I, reflected in the flow 
cytometry data (Figure 25, Figure 40) whereby far fewer GFP+ve cells were 
detected in RIG-I KD cells when compared to Naïve, MDA5 KD and LGP2 KD 
reporter cells. Thus in GFP-ve RIG-I KD reporter cells PIV5 is able to have a higher 
rate of replication and hence increased genomic NP expression detected, as there 
are fewer GFP+ve cells present in the cell population and thus fewer cells in which 
IFN is induced. A majority of the DI populations generated during viral plaque 
development and virus replication are thus primarily sensed by RIG-I.  
 
Some DIs generated during viral plaque development are PAMPs that are 
recognised by MDA5, and this supported where GFP-ve MDA5 KD reporter cells 
have a slightly higher abundance of genomic NP, indicative of increase non-defective 
wild-type virus replication compared to GFP-ve Naïve reporter cells (Figure 42).  
This pattern is observed when analysing the relative abundances of genomic NP for 
all three housekeeping genes. The DIs that activate MDA5 are generated at a far 
slower rate than those that activate RIG-I, as the genomic NP expression levels in 
GFP+ve MDA5 KD reporter cells are far lower than that of GFP-ve RIG-I KD reporter 
cells. The reason for this may be due to selection pressure on the generation of 
MDA5 activating DIs by the PIV5 V protein that directly inhibits MDA5.   
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3.3.12. Further analysing the relationship between the DI mediated 
activation of the IFN-β promoter on non-defective viral 
transcription and IFN antagonism by the V protein 
 
It was observed that during the flow cytometry analysis of reporter cells infected at an 
MOI of 0.0001pfu/cell with PIV5 (wt) over 2 days, that three populations with positive 
signals were measured following staining for NP (Figure 25, 3.2.5. Flow cytometry 
analysis of virus infected reporter cells).  As reporter cells were infected at a low 
MOI, only the DIs generated during viral plaque development that could mediate the 
activation of the IFN-β promoter. Firstly, there were reporter cells that were 
GFP+ve/NP-ve.  This indicates that a Trailer copyback DI was produced during virus 
replication in a neighbouring wild-type virus infected cell.  The DI egressed and 
infected the GFP+ve/NP-ve cell n, and the DI PAMP was recognized by the 
appropriate PRR, subsequently inducing the activation of the IFN-β promoter.  
 
A second population was observed that was GFP-ve/NP+ve.  This suggests that this 
cell population has been infected with a non-defective wild-type virus, and virus 
transcription has taken place without the co-infection of a DI or the generation of a DI 
during virus replication that is capable of being recognized by the PRRs.  Hence, this 
cell population is GFP-ve, and NP+ve. Interestingly, a third population was observed 
that was strongly GFP+ve and strongly NP+ve. During the development of the viral 
plaque, these cells could have been co-infected with a wild-type virus and DIs 
generated during virus replication. This DI would have been sensed by the PRRs, 
leading to the activation of the IFN-β promoter and hence GFP expression. However, 
this raises the question of the effect of co-infecting DIs on the IFN antagonist 
properties of non-defective, wild-type PIV5, i.e. the ability of the V protein of PIV5 
(wt) to block the DI mediated activation of the IFN-β promoter.  To further examine 
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the relationship between the ratio of DIs to wild-type virus and the ability of PIV5 V 
protein to inhibit the IFN induction signalling cascade a co-infection between PIV5 
wild-type virus and a DI rich PIV5 VΔC VM2 virus preparation was performed (Figure 
44).  Naïve reporter cells were infected for 18hrs with either PIV5 (wt) or PIV5 VΔC 
VM2 at 10 fold dilutions from a 1x10-8 pfu/ml virus stock.  Cells were also co-infected 
with PIV5 (wt) and PIV5 VΔC VM2 (Figure 44 I-L).  These cells were infected with 
PIV5 (wt) at 10-1 from the virus stock, and co-infected with PIV5 VΔC VM2 at 10 fold 
dilutions at 10-1, 10-2, 10-3, 10-4.  Cells were initially infected at high MOIs in order to 
ensure that there was a co-infection of a DI and wild-type virus.  Cells were then 
fixed and immunostained for NP and analysed by flow cytometry.    
 
Flow cytometry analysis revealed, as expected, that by decreasing the concentration 
of PIV5 (wt) from 10-1 to 10-4 when exclusively infecting Naive reporter cells with PIV5 
(wt), fewer Naïve reporter cells are thus infected with PIV5 (wt) and thus fewer GFP-
ve/NP+ve cells are detected as a proportion of total cells (Figure 44 A-D). When the 
concentration of the DI rich PIV5 VΔC VM2 virus is decreased in Naive reporter cells 
infected exclusively with PIV5 VΔC VM2, as expected the % of GFP+ve/NP-ve cells 
detected is reduced, as fewer cells have activation of the IFN-β promoter as fewer 
cells are infected with a DI (Figure 44 E-H).  The data presented above clearly 
demonstrate that high-multiplicity passage of PIV5 VΔC VM2 generates virus 
preparations that are efficient at activating the IFN response and that this ability 
correlates with an accumulation of DI genomes. 
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Figure 44. Flow Cytometry analysis of Co-infection of Naïve reporter cells 
by PIV5 (wt) and PIV5 VΔC VM2  
Naïve reporter cells were infected for 18hrs with either PIV5 (wt) or PIV5 VΔC VM2 
at 10 fold dilutions from a 1x108 pfu/ml virus stock. Cells were infected with PIV5 (wt) 
at 10-1, 10-2, 10-3, 10-4 (A-D); PIV5 VΔC VM2 at dilution 10-1, 10-2, 10-3, 10-4 (E-H).  
Cells were also co-infected with PIV5 (wt) and PIV5 VΔC VM2: PIV5 (wt) at 10-1 
dilution from stock, PIV5 VΔC VM2 at 10 fold dilutions at 10-1, 10-2, 10-3, 10-4 (I-L).  
Cells were then fixed and stained for NP, and then secondary stained with PE. GFP 
intensity is measured on the x-axis, NP-PE is measured on the y-axis.  Samples 
were analysed by flow cytometry on a Becton Dickinson FACSCaliber flow cytometer 
machine. 
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Figure 45.  PIV5 (wt) does not prevent activation of the IFN-β promoter by co-
infecting copyback DIs, despite encoding the V protein IFN antagonist.  
Naïve reporter cells were infected at an MOI of 10pfu/cell with PIV5 (wt), PIV5 VΔC 
VM2, or a co-infection with a 50:50 mixture thereof.  The cells were fixed at 18hr p.i., 
and GFP+ve cells and the distribution of NP (red), following immunostaining, were 
visualized by fluorescence microscopy. 
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When analysing the co-infection data of PIV5 (wt) co-infected with PIV5 VΔC VM2, at 
the highest concentration of PIV5 VΔC VM2 (Figure 44 I), the cell population pattern 
observed is similar to that when infecting cells exclusively with the highest 
concentration of PIV5 VΔC VM2 (Figure 44 E). As such, every cell in the co-infection 
is co-infected with non-defective virus that encodes a functional V protein, yet 
strikingly there was no inhibition of IFN induction signalling cascade, where the IFN-β 
promoter was activated in these cells (Figure 44 I). 
 
In comparison, when the concentration of PIV5 VΔC VM2 is reduced to 10-4 in the 
co-infected sample (Figure 44 L), the cell population distribution pattern is similar to 
that of exclusively infecting cells with PIV5 (wt) (Figure 44 A). By reducing the ratio 
of DIs to wild-type non-defective virus in the co-infection, the % of cells that are GFP-
ve/NP+ve is increases from 7.5% (Figure 44 I) to 90.8% (Figure 44 L), which is 
similar to cells exclusively infected with PIV5 (wt) at 89.9%. (Figure 44 A).  In effect, 
by reducing the ratio of DIs to wild-type virus in the co-infection, there has been a 
shift in cell population distributions which can be first identified when co-infecting 
wild-type virus with PIV5 VΔC VM2 at 10-3 (Figure 44 K). This suggests that by 
reducing the ratio of DIs to wild-type virus in a co-infection to a suitable level, wild-
type viral transcription is restored.  The data suggests that DIs are interfering with 
PIV5 (wt) NP expression despite the encoding of the IFN antagonist, the V protein.  
This indicates that DIs inhibited the synthesis of viral proteins expressed from non-
defective genomes, which would likely impact the ability of the virus to antagonize 
the IFN response.   Consistent with this finding, non-defective PIV5 (wt) is unable to 
inhibit IFN induction by co-infecting DI-rich PIV5 VΔC VM2 when viewed by 
immunofluorescence (Figure 45).  
 
Further analysing the co-infected cells, the % of GFP+ve/NP-ve cells decreases from 
40.3% (Figure 44 I) to 0.5% (Figure 44 L) as the DI ratio to wild-type virus is 
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reduced. This suggests that the reduction of NP+ve cells observed when co-infecting 
with higher DI ratios to wild-type virus, is due to the DI mediated induction of IFN and 
the subsequent expression of ISGs hostile to viral transcription, providing further 
evidence that DIs are the primary inducers of IFN.  Interestingly, the % of GFP+ve 
cells that are also NP+ve as proportion of total GFP+ve cells increases as the ratio of 
wild-type virus to DIs increases in the co-infected sample.  When co-infecting cells 
with the highest ratio of DIs to wild-type virus, the proportion of total GFP+ve cells 
that are NP+ve is 18% (Figure 44 I). However, when co-infecting with the lowest 
ratio of DIs to wild-type virus, the proportion of total GFP+ve cells that are NP+ve is 
86% (Figure 44 L).  This suggests that co-infecting PIV5 (wt) with a DI, the non-
defective virus can help DIs replicate and induce IFN. it must be emphasised that DIs 
do not require to replicate or be ico-infected with a non-defective virus to be 
recognised by the PRRs and to induce the activation of the IFN-β promoter, as 
evidenced by the generation of strongly GFP+ve cells weak for NP expression during 
a high MOI infection with DI rich PIV5 VΔC VM2 (Figure 44 E). 
 
 
 
DI activation of the IFN-β promoter in the absence of viral protein synthesis 
 
At each dilution of PIV5 (wt) (Figure 44 A-D) or PIV5 VΔC VM2 (Figure 44 E-H), 
cells that were strongly positive for virus NP, indicating normal virus transcription, 
were usually GFP-ve, whereas those that were GFP+ve were generally only very 
weakly NP+ve. Additionally, GFP+ve cells (weakly NP+ve) could clearly be observed 
even at high dilutions (10-4) of PIV5 (wt) (Figure 44 D) and PIV5 VΔC VM2 (Figure 
44 H) infections, where very few cells would have been infected with a non-defective 
virus. In cells infected at the highest concentration of PIV5 VΔC VM2 (Figure 44 E), 
whilst the majority of cells were strongly GFP+ve, the same cells were generally only 
NP-ve. In contrast, following infection with the highest concentration of PIV5 (wt), the 
175 
majority of reporter cells were strongly positive for NP, but were GFP-ve (Figure 44 
A).  There is a negative correlation between GFP expression and virus protein 
expression. Thus, for both DI-rich PIV5 VΔC VM2 and DI-poor PIV5 (wt) infections, 
very little (if any) virus protein synthesis and was occurring in those GFP+ve/NP-ve 
cells in which the IFN-β promoter had been activated.  This data suggests that the DI 
mediated activation of the IFN-β promoter and induction of IFN is independent of viral 
protein synthesis. 
 
 
How are the GFP+ve/NP+ve reporter cell population generated following PIV5 (wt) 
infection?  
 
As mentioned previously, a DI co-infecting with a non-defective wild-type virus 
generates the GFP+ve/NP+ve cell populations. The wild-type non-defective virus 
mediates the transcription of NP where the V protein IFN antagonist is unable to 
inhibit the DI mediated activation of the IFN-β promoter. However, a second possible 
explanation for the generation of the GFP+ve/NP+ve cell populations is by infection 
of these cells with a Leader copyback DI that would encode NP.  This Leader 
copyback DI could then be recognised by the PRRs, subsequently inducing the 
activation of the IFN-β promoter, and hence the NP+ve cells would be positive for 
GFP expression. This explanation is unlikely as from previous deep sequencing data 
of PIV5 (wt) DIs, the vast majority of DI copybacks generated during high multiplicity 
passaging were Trailer copyback DIs (Killip et al., 2013).  
 
In order to discount that the GFP+ve/NP+ve cell population is generated by infection 
with a Leader copyback DI, cells can be probed for PIV5 HN and for PIV5 NP.  As 
HN is located at the opposite terminus to NP on the PIV5 genome (Figure 8), HN is 
encoded in Trailer copyback DIs, but not in Leader copyback DIs.  Thus, if the 
176 
Leader copyback DI is the cause, then when probing co-infected cells in which the 
shift in cell populations is taking place in Figure 44 K due to the reduced ratio of DIs 
to wild-type virus, then there would be reduced levels of GFP+ve/HN+ve cells that 
would be detected in comparison to GFP+ve/NP+ve cells.  The previous co-infection 
experiment was repeated in duplicate, whereby Naïve reporter cells were infected for 
18hrs with either PIV5 (wt) or PIV5 VΔC VM2 at 10 fold dilutions from a 1x108 pfu/ml 
virus stock. Cells were also co-infected with PIV5 (wt) and PIV5 VΔC VM2. These 
cells were infected with PIV5 (wt) at 10-1 from stock, and co-infected with PIV5 VΔC 
VM2 at 10 fold dilutions at 10-1,10-2,10-3,10-4. Cells were then fixed and 
immunostained. One set of samples was probed for NP, and the second set were 
probed for HN and analysed by flow cytometry.   
 
Analysing the flow cytometry data (Figure 46), it can be observed that similar 
patterns of cell populations are detected when probing for either for NP or HN.  When 
probing for NP (Figure 46 E1) and HN (Figure 46 E2) of co-infected samples, at the 
highest co-infecting concentration of PIV5 VΔC VM2, the cell population patterns 
observed is similar to that when infecting cells exclusively with the highest 
concentration of PIV5 VΔC VM2 when probing for NP (Figure 46 C1) and HN 
(Figure 46 C2).  When the concentration of PIV5 VΔC VM2 is reduced to 10-2 in the 
co-infected sample when probing for either NP or HN (Figure 46 F1 and F2), the cell 
population distribution pattern shifts towards the cell population distribution observed 
when exclusively infecting with PIV5 (wt) (Figure 46 A-B).  The % of GFP-ve/NP+ve 
and GFP-ve/HN+ve cells of total cells increases as the ratio of DIs in the co-infection 
is reduced.  The co-infecting PIV5 (wt) has its transcription levels, i.e. GFP-ve/NP+ve 
and GFP-ve and HN+ve cells, beginning to be restored to levels observed when 
exclusively infecting cells with PIV5 (wt) (Figure 46 A-B) as the ratio of DI to wild-
type virus is reduced in the co-infection.  
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Figure 46. Flow Cytometry analysis of Co-infection of Naïve reporter cells 
by PIV5 (wt) and PIV5 VΔC VM2  
Naïve reporter cells were for 18hrs infected with either PIV5 (wt) or PIV5 VΔC VM2 
at 10 fold dilutions from a 1x108 pfu/ml virus stock. Cells were infected with PIV5 (wt) 
at 10-1,10-2, (A-B); PIV5 VΔC VM2 at dilution 10-1,10-2 (C-D).  Cells were also co-
infected with PIV5 (wt) and PIV5 VΔC VM2: PIV5 (wt) at 10-1 dilution from stock, 
PIV5 VΔC VM2 at 10 fold dilutions at 10-1,10-2, (E-F).  Cells were then fixed and 
stained for NP or HN, and then secondary stained with PE. GFP intensity is 
measured on the x-axis, viral protein-PE is measured on the y-axis.  Samples were 
analysed by flow cytometry on a Becton Dickinson FACSCaliber flow cytometer 
machine. 
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Figure 47.  Comparison of Naive reporter cells probed for HN and NP following 
a co-infection with PIV5 (wt) and PIV5 VΔC VM2  
Naïve reporter cells were for 18hrs co-infected with PIV5 (wt) or PIV5 VΔC VM2 at 
10 fold dilutions from a 1x108 pfu/ml virus stock. Cells were co-infected PIV5 (wt) at 
10-1 dilution from stock, PIV5 VΔC VM2 at 10-2.  Cells were then fixed and stained for 
NP or HN, and then secondary stained with PE and analysed by flow cytometry.  
Values were derived from flow cytometry analysis of cells probed for NP (Figure 46 
F1) and cells probed for HN (Figure 46 F2). 
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Further analysing the shift in co-infected cell population distributions at which the 
ratio of DIs to wild-type virus is reduced to an extent to allow non-defective virus 
transcription (Figure 46 E1 and E2), several patterns can be observed (Figure 47).   
Firstly, detected GFP-ve/NP+ve cells at 45% of total cells are greater than that of 
GFP-ve/HN+ve cells detected at 30%.  This reflects the transcriptional gradient of 
PIV5 (wt) gene expression, in which NP is expressed at far greater quantities due to 
it’s position as the first gene at the 3’ terminus of the PIV5 genome compared to HN 
in which the gene coding sequence is after P/V, M, F and SH. 
 
Secondly, the % of GFP+ve/NP-ve and GFP+ve/HN-ve cells are similar to each other 
at 31% and 29% respectively. This is to be expected, as both sets of samples that 
were probed either NP or HN were infected at the same co-infection virus 
concentrations and ratio of DIs to wild-type virus.  Thus the % of cells that are co-
infected with DIs that successfully interfere with NP or HN expression and which 
subsequently activate the IFN-β promoter is the same. Finally, GFP+ve/HN+ve cells 
can be detected in the co-infected sample.  This result implicitly shows that the 
GFP+ve/NP+ve cell population observed in co-infected samples is not due to 
infection with a Leader copyback DI that does not encode HN.  HN can be detected 
in a subset of GFP+ve cells that has been infected with wild-type virus hence leading 
to viral NP transcription and expression.  This cell population is co-infected with a DI, 
hence positive GFP expression following the DI mediated activation of the IFN-β 
promoter. In addition, the % of GFP+ve/HN+ve cells at 40% is greater than 
GFP+ve/NP+ve cells at 23% of total cells.  This is explained as in the GFP+ve/viral 
protein cell population, these cells are infected with a non-defective virus and a 
Trailer copyback DI which encodes HN, but not NP.  Thus during viral transcription, 
NP is transcribed from the non-defective virus, whereas HN is transcribed from the 
non-defective virus and the co-infecting Trailer copyback DI.   
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3.3.13. Section Summary 
 
We demonstrate that the DIs generated during PIV5 (wt) infection of reporter cells 
can activate the IFN induction cascade via the development of a robust method of DI 
detection by RT-QPCR and relative quantification of DIs via the Livak method - see 
the below diagram: 
 
 
PIV5 (wt) infected GFP+ve reporter cells, which had the IFN-β promoter activated, 
strongly correlated with the presence of DIs.  Correspondingly, DIs were minimally 
detected in GFP-ve reporter cells, comparative to mock cells, in which the IFN-β 
promoter was not activated.   This is a significant result, as this further affirms the 
model that DIs are the primary PAMPs that induce IFN.  Supporting the previous flow 
cytometry data, the DI populations generated are not equally recognized by the 
sensors as viral NP was greatly increased in PIV5 (wt) infected RIG-I KD reporter 
cells when compared to Naïve, MDA5 KD, LGP2 KD reporter cells, due to the RIG-I 
KD reporter cells being reduced in their ability to induce IFN.    
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4. DISCUSSION 
 
4.1.  The Heterocellular response to virus infection  
 
We investigated the activation of the IFN-β promoter by the PAMPs generated during 
plaque development following a low MOI infection of reporter cells infected with 
negative sense RNA viruses.  Infecting at a low MOI ensures that the cells at the 
initial site of infection are infected with wild-type virus, and not by any PAMPs 
present in the viral stock. It was clear from the immunofluorescence and flow 
cytometry of infected samples, that during plaque development only a minority of 
cells were positive for the expression of GFP and hence only a minority of reporter 
cells have activation of the IFN-β promoter and are responsible for the induction of 
IFN during an infection.   
 
It has been previously reported that the IFN-β gene shows heterocellular induction in 
response to either the synthetic dsRNA, poly(I:C), or Sendai virus (Apostolou and 
Thanos, 2008; Enoch et al., 1986; Hu et al., 2007; Senger et al., 2000; Zawatzky et 
al., 1985).  In none of these cases has the molecular basis of the restriction of 
induction been determined, but it has been generally assumed to be a property of the 
host cell, such as stage in the host cell cycle or transcription factor availability.  
However, in our experiments, given that GFP can be induced in at least 90% of the 
Naive reporter cells and even in reporter cells which have been blocked in their cell 
cycle (Chen et al., 2010), and that the reporter gene does not compete with the 
endogenous IFN-β gene, it clearly indicates that induction in these cells is not 
restricted by transcription factor availability or signaling pathway activation. 
Therefore, the heterocellular induction observed in the Naïve reporter cells must be 
due to the property of the infecting virus, rather than the ability of the cells to respond 
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to virus infection. It remains possible that different cell types might show very 
different percentages of cells able to support IFN-β induction, with some cell lines, 
including A549 cells, able to induce IFN in nearly every cell in a population. 
 
One possible explanation for the heterocellular response is that a virus infecting a 
cell that will go on to express GFP has been unable to block IFN induction by PAMPs 
that are generated during normal virus transcription or replication, either due to a 
defective property of the virus or a loss of expression of the IFN antagonist. If the 
loss of a functional V protein were the primary reason for IFN induction in infected 
cells, then it would be expected that with infection of reporter cells with PIV5 VΔC 
(VM0), which lacks a functioning V protein would activate the IFN-β promoter in all 
infected cells. However, we found instead that only a small minority of Naïve reporter 
cells expressed GFP when infected with PIV5 VΔC when analysed by flow cytometry 
and by immunofluorescence.  The most striking result of this study was that the loss 
of the PIV5 IFN antagonist did not lead to IFN-β promoter activation in all PIV5 VΔC-
infected cells.  The data presented here, and confirmed in a subsequent study (Killip 
et al., 2011), challenges the notion that paramyxoviruses generate PAMPs capable 
of activating the IFN response during their normal replication cycle, and we suggest 
that these PAMPs are not generated during normal non-defective PIV5 (wt) 
replication.  
 
In addition to its role as an IFN antagonist, the V protein itself controls both PIV5 
transcription and replication (Lin et al., 2005). In this regard it may be expected that 
due to the extensive deletion in V in PIV5 VΔC, this V-dependent regulation would be 
altered, leading to a possible increase in the generation of PAMPs capable of 
inducing IFN. However, our data indicate that the loss of this fine control of 
transcription and replication does not affect the level of activation of the IFN-β 
promoter during infection, since we do not see IFN-β promoter activation in the 
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majority of PIV5 VΔC (VM0) infected cells.  Since we have shown that non-defective 
PIV5 VΔC (VM0) does not generate PAMPs capable of activating the IFN-β promoter 
during its normal replication cycle (Killip et al., 2011), we suggest that, in this reporter 
system, DI viruses, generated due to errors in the viral polymerase, are primarily 
responsible for IFN induction during infection with PIV5, and will be discussed below.  
 
 
4.2.  The role of DIs as the primary inducers of IFN  
 
We demonstrate that the DIs generated during PIV5 (wt) infection can activate the 
IFN induction cascade via the development of a robust method of DI detection by 
RT-QPCR and relative quantification of DIs via the Livak method between different 
infected cell samples.  RT-QPCR conditions were optimized for reverse transcription 
step and housekeeping genes utilized for relative quantification of PPIA, β-actin and 
GAPDH. In order to test if DIs were the primary inducers of IFN, reporter cells were 
infected at a low MOI with PIV5 (wt) and were cell sorted into discrete GFP+ve and 
GFP-ve populations.  PIV5 (wt) infected GFP+ve reporter cells, which had the IFN-β 
promoter activated, strongly correlated with the presence of DIs.  Correspondingly, 
DIs were minimally detected in GFP-ve reporter cells, comparative to mock cells, in 
which the IFN-β promoter was not activated.   This is a significant result, as this 
further affirms the model that DIs are the primary PAMPs that induce IFN.   
 
 
Important features of PIV5 DIs  
 
Flow cytometry analysis of Naïve reporter cells infected at a high MOI with either DI-
poor PIV5 (wt) or DI-rich PIV5 VΔC VM2 revealed that here is a lack of correlation 
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between GFP and virus protein expression. For both PIV5 VΔC VM2 and PIV5 (wt) 
infections, very little (if any) virus protein synthesis was occurring in those cells in 
which the IFN-β promoter had been activated.  Further studies by the Randall group 
confirmed that the DIs of PIV5 can activate the IFN induction cascade and the IFN-β 
promoter in the absence of virus protein synthesis (Killip et al., 2012b).  Infection of 
reporter cells with PIV5 VΔC VM2 DI rich virus preparations could activate the IFN 
induction cascade and the IFN-β promoter during treatment with cyclohexamide 
protein synthesis inhibitor.  Activated p-IRF3 could be detected within 3hrs of 
infection with PIV5 VΔC VM2 and treatment with cyclohexamide.  This demonstrates 
that the DIs are able to be sensed by the PRRs, subsequently activating IRF3 and 
the IFN-β promoter, leading to the induction of IFN in the absence of either cellular or 
viral protein synthesis. As virus protein synthesis is an absolute requirement for 
paramyxovirus genome replication, these results indicate that these DI viruses do not 
require replication to activate the IFN induction cascade. 
 
 
The relationship between DIs and the V protein IFN antagonist of non-defective virus  
 
Flow cytometry analysis of reporter cells infected with PIV5 (wt) at a low MOI 
revealed a cell population that was strongly positive for NP and GFP expression.  
These cells are infected with a non-defective virus, hence NP expression, and a DI 
that induces the activation of the IFN-β promoter.  This indicates that V produced 
during non-defective wild-type virus transcription is unable to block IFN induction by 
PAMPs that are generated by DIs, either within cells in which the DI was initially 
generated, or in cells that have been co-infected with a wild-type virus and an IFN-
inducing DI. By performing co-infections at high MOIs with PIV5 (wt) and PIV5 VΔC 
VM2, we show that non-defective PIV5 (wt) is unable to prevent activation of the IFN-
β promoter by a co-infecting DI.  This result is not due to an inherent inability of the V 
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protein to prevent IFN induction by DI-related PAMPs generated during these 
infections, as a related study showed that pre-infection of reporter cells with PIV5 
(wt )was associated with a significant reduction in GFP expression when 
subsequently challenged with PIV5 VΔC VM2, compared to the level in cells that had 
not been pre-infected (Killip et al., 2013). Although the V protein is able to inhibit IFN-
β induction by PIV5 DI-derived PAMPs, it is only able to do so if present insufficiently 
large amounts before DI virus PAMPs are detected.  Thus, the data suggests that the 
IFN induction cascade would normally be activated only if a non-defective virus fails 
to generate sufficient V protein quickly enough to block activation of the IFN induction 
cascade by a co-infecting DI (GFP+ve/NP+ve cells), or in cells infected with DIs in 
the absence of a co-infecting non-defective virus (GFP+ve/NP-ve cells).   
 
Deep sequencing has revealed that the DIs of PIV5 that are generated during 
infection are primarily Trailer DI copybacks (Killip et al., 2013).  As mentioned 
previously, the GFP+ve/NP+ve reporter cell populations detected by flow cytometry 
would thus be generated by a co-infecting non-defective virus and a Trailer copyback 
DI.  However, the GFP+ve/NP+ve cell population could have been due to an 
infection with a Leader copyback DI that would encode NP, but not HN, that also 
induces IFN induction signaling cascade. Co-infected reporter cells with DI and non-
defective wild-type viruses were probed for NP and HN.  Co-infected cells that were 
HN probed displayed a similar cell distribution pattern to NP probed cells, i.e. HN 
could be detected in a subset of GFP+ve cells. This confirms that for both strong HN 
expression and for GFP expression to occur in the same reporter cell, you would 
need a co-infected trailer copyback DI and a non-defective virus.   
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The implications of DIs on virus replication and pathogenicity 
 
As mentioned previously, the work in this thesis and related studies have identified 
that co-infecting DIs with non-defective virus are capable of interfering with viral 
protein synthesis despite the encoding of a potent IFN antagonist, the V protein.  The 
inhibition of viral protein synthesis would thereby interfere with viral replication, which 
depends on viral protein synthesis.  Whilst the generation of DIs during viral 
replication, and the induction of IFN are detrimental to the successful viral 
transcription and replication of non-defective viruses, this feature of DIs could have 
added advantages to the survival of the virus in the host.    
 
As mentioned in the Introduction, non-defective virus and DI population dynamics are 
similar to that of predator prey relationships in which there are cyclical fluctuations in 
the ratio of DI to non-defective virions. The generation of DIs would initiate immune 
responses and suppress viral spread in the host, allowing the virus to transmit to 
another host before the virus kills the infected host via an acute infection.  One study 
examined the relationship between DIs and highly pathogenic dengue viruses 
(DENV) (Li et al., 2011).  DENV are arboviruses in the family Flaviviridae and are 
important human pathogens responsible for disease states described as dengue 
fever, dengue haemorrhagic fever and dengue shock syndrome.  DENV are 
transmitted to humans by Aedes mosquitoes, principally by Aedes aegypti. The four 
closely related DENV serotypes are antigenically distinct and often co-circulate in 
tropical regions where this disease is endemic. The nucleotide sequences of the 
single-stranded positive-sense RNA genomes of DENV are very diverse, and most 
viral genomes recovered from either of the natural hosts contain defects (e.g. intra-
genic stop codons, nucleotide insertions or deletions) that would render them non-
infectious. In this study, short fragments of dengue virus (DENV) RNA containing 
only key regulatory elements at the 3′ and 5′ ends of the genome were recovered 
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from the sera of patients infected with any of the four DENV serotypes. Identical RNA 
fragments were detected in the supernatant from cultures of Aedes mosquito cells 
that were infected by the addition of sera from dengue patients, suggesting that the 
sub-genomic RNA might be transmitted between human and mosquito hosts in DI 
viral particles. DENV preparations enriched for these putative DI particles reduced 
the yield of wild type dengue virus following co-infections of C6/36 mosquito cells. 
DENV DI particles may be a part of a broad spectrum of defects in the viral genome 
that attenuate disease and make these viruses very effective parasites. The studies 
suggest that these defective genomes impose a fitness burden on the DENV 
populations in which they are found that may result in attenuation of disease severity, 
allowing greater mobility of infected human hosts and therefore greater transmission 
of the virus. 
 
Like DEV, Japanese encephalitis virus is a mosquito-borne flavivirus. The virus has a 
normal transmission cycle between birds and mosquitoes but also a zoonotic 
transmission cycle with pigs serving as amplifier hosts from which infected 
mosquitoes transmit the virus to humans.  However, the mechanism of virus survival 
in various hosts is unclear, but is thought to involve DIs. Tsai et al identified the 
generation of DI RNAs of Japanese encephalitis virus in C6/36 mosquito cells (Tsai 
et al., 2007).  DI RNA-containing virions in supernatant fluids from persistently 
infected mosquito cells could be used to establish persistent infection in BHK-21 
cells. The correlation of DI RNA presence with cell survival, in comparison to acute 
infections, suggests that DI RNAs are contributing mechanistically to the 
establishment of persistent infection in both the mosquito and mammalian cells. 
 
Thus, future studies could examine the role of DIs in establishing persistent 
infections.  For example, a comparison of how easily persistent infections are 
established in cells that can produce and respond to IFN with those in which the IFN 
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response has been knocked out.  This could lead to the development of animal 
models for paramyxovirus infections in which DIs could have a key role in 
suppressing an acute infection, and the establishment of a persistent infection that 
would lead to increased virus transmission between hosts. 
 
 
4.3.  The role of RIG-I as the primary sensor of PIV5  
 
It has been demonstrated in this thesis via immunofluorescence, plaque assays, flow 
cytometry and RT-QPCR of cell sorted infected reporter cells that RIG-I is the 
primary sensor for the detection of the DI PAMPs generated during PIV5 replication.  
Reporter cells that are knocked down for RIG-I have larger plaques developed over 
the course of infection.  Furthermore, far fewer GFP+ve RIG-I KD reporter cells are 
detected compared to Naïve, MDA5 and LGP2 KD reporter cells following infection 
with PIV5 (wt). By removing the RIG-I sensor, reporter cells are significantly reduced 
in their ability to recognize the DI PAMPs generated during PIV5 infection, and 
consequently far fewer cells do not have activation of the IFN-β promoter when 
compared to Naïve, MDA5 KD and LGP2 KD cells. 
 
 It can also be concluded that the majority of the DI species generated during PIV5 
(wt) replication activate RIG-I, as the % of GFP+ve MDA5 KD reporter cells was not 
reduced to the extent of RIG-I KD GFP+ve reporter cells when compared to the 
relatively high levels observed for Naïve reporter cells.  The knock down of RIG-I has 
a severe detrimental effect on the ability of reporter cells to recognize the DI PAMPs 
that generated during plaque development.  The DI populations generated are not 
equally recognized by MDA5, rather, the data appears to show that the majority of 
the DI PAMPs generated are “tailored” for recognition by RIG-I, i.e. they contain RIG-
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I specific ligands.  Supporting this, viral NP was greatly increased in PIV5 (wt) 
infected RIG-I KD reporter cells when compared to Naïve, MDA5 KD, LGP2 KD 
reporter cells, due to the RIG-I KD reporter cells being reduced in their ability to 
induce IFN.   Thus PIV5 (wt) is further able to replicate at an increased rate in RIG-I 
KD reporter cells when compared to Naïve, MDA5 and LGP2 KD reporter cells.  This 
is supported by the plaque assay data where RIG-I KD reporter cell plaques were far 
larger than those observed for Naive and MDA5 KD reporter cells following infection 
with PIV5 (wt). 
 
It is intriguing that many paramyxoviruses do not appear to inhibit RIG-I, at least 
through their V proteins. There are a number of potential explanations for these 
observations. Firstly, paramyxoviruses may have other as yet uncharacterized 
mechanisms to limit the production of IFN. Secondly, paramyxoviruses may be able 
to survive and propagate in an environment in which limited amounts of IFN are 
made in a RIG-I-dependent manner. The limited induction of IFN via RIG-I may be 
necessary to prevent the unwarranted replication of the virus and subsequent 
pathogenicity in the host before the virus has had a chance to be transmitted to 
another host.  Thirdly, most paramyxoviruses encode mechanisms to disable IFN 
signaling, and in the case of PIV5 can even dismantle a pre-established IFN-
dependent anti-viral state (Didcock et al., 1999; Carlos et al., 2005). Both MDA5 and 
RIG-I are IFN inducible genes (Kang et al., 2002; Berghall et al., 2006; Matikainen et 
al., 2006; Siren et al., 2006; Veckman et al., 2006) and thus by blocking IFN 
signaling, paramyxoviruses will prevent the IFN dependent upregulation of both RIG-I 
and MDA5 (as well as other members of the IFN induction cascade) and will severely 
limit the eventual production of IFN by an infected cell.  
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The role of MDA5 and LGP2 in the induction of IFN following PIV5 (wt) infection 
 
Whilst the role of RIG-I as the primary sensor that detects the DI PAMPs generated 
during PIV5 (wt) infection, the data also points to a role of MDA5 and LGP2 in the 
induction of IFN.  Firstly, viral plaques in MDA5 KD reporter cells infected with PIV5 
(wt) were not the same size, but were smaller than those found for Naïve reporter 
cells.  Furthermore, flow cytometry analysis of PIV5 (wt) infected MDA5 KD reporter 
cells showed decreased numbers of GFP+ve cells when compared to Naïve reporter 
cells.  This demonstrates that DI PAMPs containing ligands unique to detection by 
MDA5 are being generated, as removal of the MDA5 sensor does reduce the % of 
total cells that are GFP+ve when compared to Naïve reporter cells.  Indeed, 
analysing the flow RT-QPCR data of cell sorted GFP+ve and GFP-ve cells, DIs were 
present in high abundance in GFP+ve RIG-I KD reporter cells.  These DIs are 
recognised by MDA5 and which subsequently induce the activation of the IFN-β 
promoter.  The DIs that activate MDA5 are generated at a far slower rate than those 
that activate RIG-I, as the genomic NP expression levels in GFP+ve MDA5 KD 
reporter cells are far lower than that of GFP-ve RIG-I KD reporter cells. The reason 
for this may be due to selection pressure on the generation of MDA5 activating DIs 
by the PIV5 V protein which directly inhibits MDA5.   
 
The role of LGP2 as an enhancer of MDA5 is supported by the flow cytometry and 
RT-QPCR data.  The % of cells that are GFP+ve is reduced when LGP2 is knocked 
down in reporter cells infected with PIV5 (wt). Indeed by knocking down LGP2, viral 
NP expression is increased compared to Naive reporter cells.  Thus MDA5 functional 
ability to sense DIs and subsequently activate the IFN-β promoter is reduced when 
LGP2 is knocked down.   
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Future work on DIs and their role as PAMPs and the induction of IFN 
 
It is unclear whether it is the DI genomes themselves, RNA products made from 
these DI genomes, the exposure of DI virus genome to RIG-I during RNA synthesis 
or dsRNA formed by base-pairing of the RNA products with the DI genome template 
that is responsible for activating the IFN induction cascade.  Further work needs to 
be performed to elucidate the precise nature of the PIV5 DI PAMPs that activate 
RIG-I.  
 
The development of a robust detection method for DIs by RT-QPCR in reporter cells 
that have been cell sorted into GFP+ve and GFP-ve cells, opens up the avenue for 
future studies in examining the specific trailer copyback DIs that are the PAMPs of the 
PRRs.  The DIs generated during infection are a mixed population of primarily different 
trailer copybacks DI species, and a small proportion of Leader copyback DIs (Killip et 
al., 2013). By scaling up the low MOI infection of PRR KD reporter cells from 25cm2 
flask to 300cm2 flasks, and by deep sequencing from CsCl purified nucleocapsids, the 
DI species/ sequences that activate either RIG-I or MDA5 could be determined 
following cell sorting of GFP+ve and GFP-ve cells.  Furthermore, by cloning a 
sequence encoding for a short RNA structure called PP7 recognition sequence (PRS) 
into PRR activating DIs, co-immunoprecipitation studies can be performed on the 
complexes formed upon RIG-I and MDA5 activation.  The cellular proteins involved in 
PRR recognition of DIs could then be identified.  An additional question is whether the 
PAMPs produced by DIs are the most important inducers of IFN in immune cells. 
Immune cell reporter lines where the PRRs are knocked down could be generated, 
and tested for DI mediated IFN induction. 
 
A further aim would be to identify the host cell and viral factors that influence the 
evolution/generation of DIs. We have already observed that the DIs generated during 
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PIV5 (wt) infection are able to overcome initial IFN antagonism of the V protein and 
inhibit viral transcription.  However, the influence of host cell factors such as the 
ISGs, and the V protein on DI evolution over the entire course of an infection has yet 
to be characterized, and this could have implications on DIs as antiviral agents.  
 
 
4.4.  DIs and their potential as antiviral agents 
 
DIs can detected from Naïve reporter cells infected with PIV5 (wt), and their positive 
impact on the activation of the IFN-β promoter following PRR recognition, and their 
negative impact on PIV5 (wt) transcription and virus spread has been examined in 
this thesis.   However, questions that need to be answered are the biological and 
clinical relevance of DIs in disease.  Future studies could focus on whether DIs can 
be detected in vivo in animal models of infection by negative sense RNA viruses, and 
whether DIs can be detected in clinical samples from infected patients.  Further to 
this, Dis could have role to play in inducing the cytokine storm immune response 
phenomenon in which the immune system goes into overdrive in response to viral 
PAMPs, damaging or killing the host. 
 
The IFN inducing properties of DIs and DI sequences could be used to induce IFN in 
vivo for enhancing the immunogenicity of vaccines, prophylactic treatment, treatment 
of acute and chronic viral and bacterial infections and possibly cancer therapy DIs 
could be an important factor in inducing an immune response for live attenuated 
vaccines. Shingai et al investigated the mechanism for differential type I IFN 
induction in monocyte-derived dendritic cells infected with representative MeV 
laboratory adapted and vaccine strains (Shingai et al., 2007).  Laboratory adapted 
and vaccine strains induced type I IFN in infected cells.  The wild-type strains in 
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contrast induced it to a far lesser extent. It was found that most of the IFN-inducing 
strains possessed DI RNAs of varying sizes.  
 
New vaccine designs are needed to control diseases associated with antigenically 
variable viruses, where the classical viral vaccine approaches using inactivated virus 
or live-attenuated virus have not been successful for some viruses, such as human 
immunodeficiency virus or herpes simplex virus. Therefore, new types of vaccines 
are needed to combat these infections such as utilizing the immunity inducing 
properties of DI viruses.  As vaccines, DIs potentially have advantages of both 
classical types of viral vaccines in being as safe as inactivated virus, as they are 
unable to replicate by themselves, but expressing viral antigens inside infected cells 
so that MHC class I and class II presentation can occur efficiently.  
 
Extensive in vivo studies have been performed on evaluating DIs as potential 
vaccines against influenza A virus, reviewed in (Dimmock & Easton, 2014).  
Influenza A virus has a segmented genome comprising eight molecules of single-
stranded, negative sense RNA. DI RNAs can arise from deletions in any segment, 
but originate most often from the three largest genomic RNAs.  Thus, influenza DI 
RNAs isolated in vitro or in vivo have a single, central deletion with a highly variable 
breakpoint, and maintain the 3′ and 5′ termini. DIs averaging 440 nucleotides in 
length have been found isolated in vivo from infected mice and sequenced. Complete 
protection of mice from disease caused by a lethal influenza A virus challenge has 
been reproducibly achieved following immunization with a DI influenza virus 
(Dimmock, 1996).  The authors further characterized this DI induced immunity 
whereby defective interfering virus protects better against virulent Influenza A virus 
than avirulent virus strains (Dimmock & Marriott, 2006). Using reverse genetics, they 
made virus preparations that contain a single defective RNA, 244 DI RNA (244/PR8).  
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When inoculated intranasally in mice, it has the ability to protect animals from serious 
infection with several different influenza A virus subtypes (Dimmock et al., 2008), and 
also of heterologous influenza B virus (Scott et al., 2011).  They also found that this 
DI induced immunity was found during in vivo experiments in the commonly used 
ferret model (Dimmock et al., 2012; Mann et al., 2006).   
 
In addition, the DIs of certain viruses could promote immunity against non-related 
viruses.  In the course of the study of DI influenza A virus 244/PR8, it was found that 
it also protected mice from infection with a genetically unrelated heterologous virus, 
pneumonia virus of mice, a member of the Paramyxoviridae family (Easton et al., 
2011).  It was determined that this mechanism is dependent on type I IFN mediated 
responses.  
 
 
4.5.  Concluding Remarks 
 
The arms race between our ability to generate novel antivirals and vaccines to the 
ever-changing viral threat continues in the 21st century despite the advent of 
advanced molecular and cellular techniques and technology.  The information age 
has only highlighted how vulnerable our antiviral drugs and vaccines are to genetic 
recombination events generating new viral strains such as with seasonal influenza, 
or by the antiviral drug mutations caused by the high error rate in virus replication by 
the viral replication machinery, such as with HIV and highly active antiretroviral 
therapy. Novel threats continue to emerge such as Nipah virus and increased 
transmissible strains of Ebola virus.  The IFN inducing properties of DIs may offer an 
important addition to our arsenal in the generation of vaccines and antivirals against 
these evasive and potent pathogens. 
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